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Abstract 
 
Focal adhesion kinase (FAK) and paxillin are proteins implicated in the mechanisms that link 
chronic alterations in mechanical force within skeletal muscle and its microvasculature to the 
functional adaptation seen with changes in physical activity. This thesis developed novel 
immunofluorescence microscopy methods to visualise and measure FAK and paxillin 
responses in human skeletal muscle and its microvasculature. Chapter 2 reveals high FAK 
protein content in the (sub)sarcolemma of skeletal muscle fibres and within the microvascular 
endothelial and vascular smooth muscle cell layers. Chapter 3 demonstrates that FAK protein 
content is increased at (sub)sarcolemmal and sarcoplasmic regions of skeletal muscle fibres 
and within the microvascular endothelium following 12 weeks resistance-type exercise 
training in elderly individuals. Chapter 4 shows that FAK and paxillin colocalise at the 
(sub)sarcolemma of skeletal muscle fibres and within the microvasculature. Chapter 5 
demonstrates that FAK and paxillin are increased at the (sub)sarcolemma and within the 
microvascular endothelium following 6 weeks endurance- and resistance-type exercise 
training in young previously sedentary individuals. The novel data generated in this thesis, in 
combination with recent literature findings, support the hypothesis that FAK and paxillin play 
an important role in upstream mechanotransduction signals that control skeletal muscle fibre 
hypertrophy, mitochondrial biogenesis, insulin sensitivity, microvascular function and 
angiogenesis.  
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1.1. Perspective: An ageing global population  
We are living amongst an ageing population. By the year 2050, it is expected that the global 
population of elderly individuals (defined by the UN as aged ≥60 years) will reach 2 billion 
representing a ~200% increase since 1950 (UN, 2002).  As a result, the global population of 
elderly individuals will outnumber the young (defined by the UN as aged ≤ 15 years) for the 
first time in the history of humanity (UN, 2002). This feat was already achieved in 1988 by 
more developed nations  and over the following decades, the greatest gains in life expectancy 
at birth will be in the developing regions (UN, 2002). The growth of the ageing population is 
partly attributable to the decline in global fertility rates (mean number of children per 
woman) (UN, 2011). This is particularly prevalent in developed nations where total fertility is 
below that needed to ensure a population replaces itself in size (UN, 2011). The ageing 
population is also attributable to improvements in medical care and the prevention and 
management of disease. These advances enable the continued improvement in life-
expectancy despite the increased risk of falls (Campbell et al., 1989; Tinetti et al., 1988) and 
the development of age-related chronic diseases such as obesity (Flegal et al., 2010), insulin 
resistance, type II diabetes (Fink et al., 1983; Rowe et al., 1983; Wild et al., 2004) and 
cardiovascular disease in elderly populations (Najjar et al., 2005). In Great Britain, 66% of 
individuals aged ≥75 years reported a long-standing illness or disability (www.ons.gov.uk) 
and an ageing population will present a significant socio-economic challenge to health care 
provision. Indeed, the estimated cost of UK hospital and community health services in 2009 
for people aged ≥65 years was already ~£47 billion, representing ~40% of the annual 
National Health Service (NHS) budget (www.parliament.the-stationery-office.co.uk).  
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1.1.1. ‘Usual ageing’  
The development of disease and the gradual decline in physical function is evidence of ‘usual 
ageing’ (Rowe and Kahn, 1997). One of the most visually obvious signs of the ageing 
process is the progressive involuntary loss of skeletal muscle mass and strength. The former 
is termed sarcopenia, where sarx means “flesh” and penia means “poverty” (Rosenberg, 
1989) and the latter is termed dynapenia, where dyna means “strength” (Clark and Manini, 
2008). Sarcopenia is associated with functional impairments and physical disability (Janssen 
et al., 2002) and dynapenia is associated with an increased risk of falls (LaStayo et al., 2003), 
dependency (Tinetti and Williams, 1997), self reported disability (Baumgartner et al., 1998; 
Janssen, 2006) and all cause mortality (Ruiz et al., 2008). Consequently, the deleterious 
effects of sarcopenia and dynapenia can have a considerable effect on the quality of life in 
elderly populations.  
Ageing is also associated with vascular endothelial dysfunction where blood flow-
mediated endothelium-dependent vasodilation of arteries, resistance vessels and skeletal 
muscle arterioles are impaired with age (Celermajer et al., 1994; Donato et al., 2009; Muller-
Delp et al., 2002). The age-associated development of insulin resistance and type II diabetes 
is also associated with impaired insulin-stimulated vasodilation of the terminal arterioles 
(Rattigan et al., 2006). Reductions in skeletal muscle microvascular blood flow, capillary 
recruitment and the capillary surface area available for nutrient (e.g. glucose, fatty acids and 
amino acids) and hormone (e.g. insulin) delivery may lead to sustained periods of 
hyperglycaemia and hyperinsulinaemia in elderly individuals (Rattigan et al., 2006; 
Wagenmakers et al., 2006). 
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1.1.2. Mechanical loading, physical (in)activity and ‘successful ageing’ 
The maintenance of skeletal muscle mass is dependent on the balance between the rates of 
skeletal muscle protein synthesis (major contributor to mass are the myofibrillar proteins) and 
skeletal muscle protein breakdown (Baar et al., 2006). Increasing the mechanical load of a 
skeletal muscle beyond that of daily living tasks (e.g. resistance-type exercise) can increase 
muscle protein synthesis in response to feeding so that synthesis rates exceed the rate of 
muscle protein breakdown, leading to net positive muscle protein balance (Tipton et al., 
1999). Performing frequent bouts of resistance-type exercise over at least 4 weeks results in 
the accretion of myofibrillar proteins, skeletal muscle hypertrophy and increased muscle 
strength (Tipton and Ferrando, 2008; Woolstenhulme et al., 2006). Conversely, a chronic 
reduction in the mechanical load of the skeletal muscle has the reverse effect leading to a loss 
of skeletal muscle mass and strength (Baar et al., 2006; Tipton and Ferrando, 2008). 
Consequently, the decline in physical activity rates with age (HSfE, 2010) has been suggested 
as a contributory factor in the development of sarcopenia and dynapenia in healthy 
individuals (Doherty, 2003). Therefore, frequent exposure to high mechanical loads is 
required to maintain skeletal muscle mass and strength in ageing. 
Performing regular bouts of resistance-type exercise is an effective strategy for 
combating sarcopenia and dynapenia, even in nonagenarians (Fiatarone et al., 1990). It is also 
recommended by the American College of Sports Medicine (ACSM) and the American Heart 
Association (AHA) for its positive effects on insulin sensitivity (Chodzko-Zajko et al., 2009; 
Haskell et al., 2007). The vasculature is also acutely and chronically sensitive to changes in 
mechanical stimulation and hemodynamic forces as a result of exercise training (Seals et al., 
2009). Resistance-trained older individuals show an absence of the age-related decline in 
femoral artery blood flow and vascular conductance (Miyachi et al., 2005) and resistance-
type exercise training (RT) can prevent the decline in arterial distensibility and increase 
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resting femoral blood flow and vascular conductance in previously untrained elderly 
individuals (Anton et al., 2006; Maeda et al., 2006). These studies collectively emphasise the 
importance of mechanical stimulation through physical activity and exercise training for 
maintaining skeletal muscle mass, macro and microvascular function and insulin sensitivity 
with age. Exercise training can therefore reverse and prevent ‘usual ageing’ and promote 
‘successful ageing’ where elderly individuals show comparatively high physical function, 
independence, engagement in life and have a lower risk of disease and mortality (Myers et 
al., 2002; Rowe and Kahn, 1997; Ruiz et al., 2008). 
 
1.1.3. Rationale  
Given the rapid growth in the proportion and number of the ageing population and the 
deleterious nature of sarcopenia on the quality of life, it is imperative that research advances 
our understanding of how skeletal muscle and its microvasculature adapts to physical 
(in)activity and the differences that exist between young and elderly individuals leading to 
anabolic resistance in the elderly. Understanding the molecular responses to exercise may 
help develop strategies and interventions to counteract sarcopenia and optimise the adaptive 
response to exercise training. The mechanism(s) that link physical activity to functional 
adaptation in the skeletal muscle and its microvascular tissues are not fully elucidated. 
However, mechano-sensitive proteins at the membrane of the skeletal muscle fibres and 
microvascular endothelial and vascular smooth muscle cells may play an important role 
(Carson and Wei, 2000; Martinez-Lemus et al., 2003). Integrins are transmembrane proteins 
that link contractile and hemodynamic forces to intracellular signalling (Carson and Wei, 
2000; Hynes, 2002; Martinez-Lemus et al., 2003). Upon mechanical stimulation, integrins 
signal through two immediately downstream proteins called focal adhesion kinase (FAK) and 
paxillin (Schaller et al., 1995). These two proteins have been implicated in the hypertrophic 
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and atrophic response of animal skeletal muscle to periods of increased loading and 
unloading (Fluck et al., 1999; Gordon et al., 2001) and are essential for normal vascular 
development (Hagel et al., 2002; Ilic et al., 1995). Consequently, they may play an important 
role in the adaptation of skeletal muscle and its microvasculature to exercise training.  
Currently, little is known about FAK and paxillin in human skeletal muscle and 
differences that might exist between young and old individuals.  Therefore, this PhD thesis 
will investigate the spatial distribution and content of FAK and paxillin and their response to 
exercise training in skeletal muscle fibres and their microvasculature in young and elderly 
individuals. The current chapter aims to describe how skeletal muscle fibres and their 
microvasculature ‘sense’ and convert mechanical stimuli into intracellular signalling. The 
review will conclude by summarising the key messages and highlights several areas in the 
literature regarded to be worthy of investigation at the start of this BBSRC funded PhD 
project before outlining the primary research objectives of the PhD thesis.   
 
1.2. Mechanical forces  
1.2.1. Tension, compression and shear forces  
Force (e.g. gravitational force) is a load applied to a structure. It has both magnitude 
(measured in Newtons) and direction and can alter the structure’s state (Burkholder, 2007) 
(e.g. the speed, direction or shape). Stress is defined as a force normalised to the surface area 
it is acting upon (measured in Newtons per square meter), thus stress is the product of force 
and surface area (Burkholder, 2007). Force applied perpendicular to the cell surface generates 
tensile or compressive stress and force applied within the plane of surface generates shear 
stress (Burkholder, 2007). Cells are exposed to internally generated and externally applied 
forces. Force generated from within a cell and transmitted from the cell interior and across 
the cell membrane is known as ‘inside out’ force transmission. Externally applied force is 
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transmitted across the cell membrane to the cell interior and is known as ‘outside in’ force 
transmission. Cellular force transmission is therefore ‘bi-directional’. 
At rest, skeletal muscles exert both tensile and shear forces on the musculoskeletal 
system and these forces increase when the skeletal muscle contracts during dynamic exercise.   
The tensile and shear forces are generated internally by the skeletal muscle and are an 
example of ‘inside out’ force transmission. Alterations in blood flow to meet the increased 
metabolic demand of the contracting skeletal muscle increases the hemodynamic forces 
acting upon the vascular wall.  These forces are also tensile and shear stress forces (e.g. fluid 
shear stress). The fluid shear stress that acts on the vascular wall is transmitted across the 
vascular cell membrane to the cell interior and is an example of ‘outside in’ force 
transmission.  
 
1.3. Skeletal muscle and force transmission 
1.3.1. Skeletal muscle function 
Skeletal muscle provides support and movement of the skeleton, stabilises joints and 
generates heat through metabolism. In young, healthy adults, it represents ~40% of body 
mass (~32 kg for an 80 kg male and ~24 kg for 60 kg female) and is therefore a substantial 
reservoir of protein which can be degraded into amino acids and released into the blood 
stream as precursors for the maintenance of organ and tissue mass such as the brain, heart, 
skin and liver and as precursors for liver gluconeogenesis (Wolfe, 2006). Skeletal muscle is 
also a store of lipid in the form of intramuscular triacylglycerols and glucose in the form of 
glycogen. Indeed, skeletal muscle accounts for >85% of glucose disposal in healthy young 
individuals during a hyperinsulinemic-euglycemic clamp (DeFronzo et al., 1981). Therefore, 
minimising the loss of skeletal muscle mass and preventing the loss of metabolic function 
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with age through high mechanical load exercise training will have a considerable effect on 
the risk of developing metabolic disorders (Rogers et al., 1990). 
 
1.3.2. Skeletal muscle ultrastructure and force transmission 
Skeletal muscle fibres are surrounded by an extracellular matrix (ECM) and have ~500 
myofibrils per muscle fibre which account for approximately 85% of the muscle fibre volume 
(Hoppeler, 1986). Myofibrils give the skeletal muscle fibre a striated appearance due to the 
abundance of contractile units (sarcomeres) running in series along the length of each 
myofibril (figure 1.1). Each sarcomere is composed of myosin (measuring 1.6 µm in 
diameter) and actin (1 µm in diameter) contractile filaments. Other proteins present in 
myofibrils and essential for the contractile process are troponin, tropomyosin, tropomodulin 
and nebulin. Actin and myosin slide past each other during contraction through acto-myosin 
cross bridge formation without a change in filament length (for review see (Huxley, 1974)). 
The Z-disk is at the boundary of each sarcomere and is an anchor site for actin and myosin 
(the latter via titin) from opposing sarcomeres (Clark et al., 2002).  Consequently, the tensile 
forces generated by acto-myosin contractile activity are transmitted to and received by the Z-
disk. This makes the Z-disk an important component in myofibrillar force transmission 
(Clark et al., 2002; Faulkner et al., 2001).  
The Z-disk is a complex protein-containing structure abundant in α-actinin (Faulkner 
et al., 2001). α-actinin binds to and cross-links the interdigitating actin filaments and titin 
from the opposing sarcomeres of a myofibril (Young et al., 1998). In longitudinally 
orientated skeletal muscle fibres, the number of α-actinin cross-linking layers (called Z-links) 
determines the Z-disk width (Luther, 2009). Fast twitch animal skeletal muscle fibres have 
narrow (30 to 70 nm) Z-disks (Luther, 2000) whilst slow fibres have wide (~100 nm) Z-disks 
(Yamaguchi et al., 1985). This difference between fibre-types is thought to reflect the 
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differences in mechanical strain that they experience in daily life (Luther et al., 2003). The Z-
disk of individual myofibrils align in register with the Z-disk of adjacent myofibrils and are 
linked at the Z-disk periphery by intermediate protein filaments such as desmin (Lazarides, 
1980). Desmin also links the sarcomeres of peripheral myofibrils to the sarcolemma where it 
plays an important role in muscle fibre integrity (Li et al., 1997b) and the transmission of 
force from contracting myofibrils to focal adhesions (see 1.3.2. and figure 1.1 and 1.4) and to 
the sarcolemma (Lazarides, 1980; Li et al., 1997b). The Z-disk is therefore central to the 
integration of myofibril contractile activity and the lateral transmission of force (shear stress) 
from the sarcomere to the sarcolemma of skeletal muscle fibres (Burkholder, 2007; Dawson 
and Hudlicka, 1993). 
 
1.3.3. The vasculature 
The skeletal muscle microvasculature includes secondary arterioles (13-18 µm in diameter 
(i.d.)) terminal arterioles (7 – 13 µm i.d.), capillaries (3.7 µm i.d.), post capillary venules (7 - 
13 µm i.d.) and collecting venules (9 - 18 µm i.d.) (Marshall and Tandon, 1984; Wiedeman, 
1963). Arterioles regulate blood flow into capillaries and therefore control the delivery of 
oxygen, hormone and nutrient-rich blood to the muscle fibres. Arterioles are largely 
comprised of vascular smooth muscle cells (VSMCs), which form a ring around the vessel 
perimeter, and endothelial cells which form a ring on the luminal side of the vessel. 
Capillaries and venules are largely composed of endothelial cells and a basement membrane.  
The major roles of the vascular endothelium are to regulate lumen diameter and vascular 
tone, control vascular permeability, extend the microvascular network (angiogenesis), 
produce anticoagulants and control pathological processes such as inflammation and 
atherosclerosis (Davies, 1995; Michiels, 2003). 
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Figure 1.1. Structural composition of the sarcomere and opposing sarcomeres within a skeletal muscle myofibril.  
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1.3.4. Ultrastructure of the vasculature and force transmission 
The luminal surface of the endothelium is covered with membrane-bound molecules such as 
glycoproteins and proteoglycans. This is known as the glycocalyx layer which extends from 
the apical surface of the endothelium into the lumen. It is in direct contact with erythrocytes 
and leukocytes and acts as a lubricating layer for the passage of these cells along the 
capillaries. The glycocalyx is therefore a barrier between the flowing blood and the apical 
surface of the endothelium (for review see (Reitsma et al., 2007; Tarbell and Pahakis, 2006; 
Weinbaum et al., 2007). The thickness of the glycocalyx depends on the luminal diameter. In 
the mouse carotid artery, the glycocalyx can measure 4.5 µm thick (Megens et al., 2007) and 
in human sublingual capillaries, it can measure 0.5 to 0.6 µm thick (Nieuwdorp et al., 2008). 
In the capillaries of hamster cremaster skeletal muscle, the glycocalyx can measure between 
0.4 and 0.5 µm thick (Vink and Duling, 1996). The glycocalyx layer is dynamic and rapidly 
replaced (<1 s) after crushing by leukocytes or by the initial motion of an erythrocyte in a 
tightly fitting capillary (Weinbaum et al., 2007). However, sustained disruption and 
degradation of the glycocalyx layer leads to vascular endothelial dysfunction such as 
impaired flow-mediated dilation (Nieuwdorp et al., 2006) and the development of a 
pathogenic state (Nieuwdorp et al., 2005). The glycocalyx is therefore thought to be vasculo-
protective. 
 The skeletal muscle microvasculature is constantly exposed to varied magnitudes of 
pressure, compression, tension (through cyclic stretch and vasoconstriction/dilation) and 
frictional shear forces (Davies and Tripathi, 1993). The latter is through the frictional shear 
force of flowing blood per unit of the endothelium, or more specifically, flowing blood per 
unit of the endothelial glycocalyx layer.  As the glycocalyx is in direct contact with the 
flowing blood, the glycocalyx is also thought to play an important role in hemodynamic force 
transmission and vasoregulatory responses (Tarbell and Pahakis, 2006). The glycocalyx is 
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connected to an intracellular cytoskeleton which enables the transmission of force throughout 
the endothelial cell. The glycocalyx is tethered to multiple sites which include the adherens 
junctions (via an actin cortical web), the cell nucleus and focal adhesions at the abluminal 
surface of the endothelium which anchor the endothelial cell to the ECM (Weinbaum et al., 
2007) (figure 1.2). This makes the glycocalyx an important component in the transmission 
and distribution of vascular mechanical forces (e.g. fluid shear stress) and as such, it may 
play a vital role in the acute stimulation of vasoregulatory processes and the microvascular 
adaptations to various modes of exercise training. 
Because of the glycocalyx, there is negligible fluid shear stress at the apical surface 
membrane of vascular endothelial cells (Orr et al., 2006). Fluid shear stress is measured in 
dyne (a unit of force) and is the force needed to accelerate a mass of 1 gram at a rate of 1 
cm/s
2
. One dyne equals 1 g/cm/s
2 
and is equivalent to 10 µN (10
-5
 Newtons). Vascular fluid 
shear stress can range between 10 to 70 dyne/cm
2 
in the arterial vasculature and from 1 to 6 
dyne/cm
2
 in the venous vasculature (Malek et al., 1999). Arterial fluid shear stress >15 
dyne/cm
2
 is considered atheroprotective, whereas fluid shear stress <4 dyne/cm
2
 can lead to 
atherosclerosis (Malek et al., 1999).  
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Figure 1.2. Structural composition of the glycocalyx layer on an endothelial cell. The glycocalyx is layer is tethered to focal adhesions 
through the intracellular cytoskeleton. The glycocalyx is also attached to adherens junctions through the actin cortical web. Stress fibres also 
connect the apical surface to focal adhesions.  
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1.3.5. Mechanotransduction  
Skeletal muscle and vascular endothelial and smooth muscle cells can convert mechanical 
forces into biochemical intracellular signals. This is known as mechanotransduction (Ingber, 
2006; Schlaepfer et al., 1999) and implies the presence of mechanical sensors that are acutely 
tuned to the imposed force (Frey et al., 2009; Hornberger et al., 2005). Davies outlined 4 
sequential steps in mechanotransduction. These include, 1) the physical deformation of 
mechano-sensitive cell surface components (e.g. focal adhesions); 2) the extracellular or 
intracellular transmission of force; 3) conversion of mechanical force into biochemical 
signals; and 4), stimulation of  downstream signalling pathways (Davies, 2009). 
Hornberger et al, (Hornberger et al., 2005) showed that skeletal muscle cells could 
‘sense’ and distinguish between different mechanical stresses. Uni-axial (tensile strain) and 
multi-axial cyclic stretch (non-uniform tensile strain through radial and circumferential axes) 
of murine C2C12 skeletal muscle cells in vitro both increased the phosphorylation of kinases 
upstream of the protein synthesis signalling pathway. However, multi-axial stretch also 
increased the phosphorylation of ribosomal S6 kinase (p70S6K) independent of paracrine 
factors (Hornberger et al., 2005). The authors concluded that mechanical activation of 
mechanosensory-mechanotransduction signalling pathways in skeletal muscle in vitro is 
specific to the type of mechanical forces applied (Hornberger et al., 2005).  
In bovine vascular endothelial cells in vitro, both oscillatory (0±15 dyne/cm
2
, 60 min) 
and laminar (15 dyne/cm
2
, 60 min) fluid shear stress increased endothelial nitric oxide (NO) 
production via activation and upregulation of endothelial nitric oxide synthase (eNOS) (Cai et 
al., 2004). However, this was through separate signalling pathways. Oscillatory flow 
stimulated eNOS through the calcium/ calmodulin-dependent protein kinase signalling 
pathway whilst laminar flow stimulated eNOS through cellular Src signalling, independent of 
calcium/calmodulin-dependent signalling (Cai et al., 2004). These findings demonstrated that 
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the activation of particular mechanotransduction pathways in vascular endothelial cells in 
vitro is specific to the type of shear stress imposed. 
Chronic exposure of cells and tissues to forces above or below those commonly 
encountered generally disturb cell homeostasis. The cell can respond to this challenge and 
regain homeostasis with an adaptation perfectly matched to the magnitude of applied forces. 
For example, the high mechanical loads associated with high-intensity RT can stimulate an 
increase in skeletal muscle fibre cross sectional area (CSA) in young and elderly individuals 
(Kosek and Bamman, 2008; Kosek et al., 2006). Conversely, a chronic reduction or loss of 
mechanical loading leads to skeletal muscle atrophy in young and elderly individuals 
(D'Antona et al., 2003; Hvid et al., 2010; Suetta et al., 2009). Sustained elevations in vascular 
shear stress during endurance-type exercise training (ET) are associated with chronic vascular 
arterial remodelling.  To reduce the shear stress, the femoral artery diameter widens, the 
intima-media thickness decreases and the lumen size increases when compared with 
untrained individuals (Dinenno et al., 2001). At present, it is incompletely known how 
applied forces are linked to the activation of gene transcription, translation and adaptation in 
the skeletal muscle fibres and vascular endothelial and smooth muscle cells. A discussion of 
the varied mechanical stimuli thought to play a role in mechanotransduction within skeletal 
muscle and the microvasculature is beyond the scope of this thesis and the reader is referred 
to the following reviews for a broader insight (Burkholder, 2007; Davies, 1995; Musi et al., 
2003; Tidball, 2005; Vandenburgh et al., 1993; West et al., 2010). The focal adhesions which 
anchor the Z-disks of peripheral myofibrils to the sarcolemma in skeletal muscle fibres and 
tether the glycocalyx to the ECM at the abluminal side of the endothelium (in 1.3.2 and 1.3.4) 
have been the focus of much research over the last 2 decades in a variety of cells (Carson and 
Wei, 2000; Goldmann, 2012a, b; Shyy and Chien, 2002; Zebda et al., 2012). The following 
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will briefly describe focal adhesions and will focus on the role of the focal adhesion-
associated proteins FAK and paxillin in skeletal muscle and microvascular tissues. 
 
1.3.6. Cell focal adhesions and force transmission 
Focal adhesions are specialised adhesion plaques or structures that facilitate force 
transmission in cells. These are localised to the cell membrane (Kanchanawong et al., 2010) 
and are regulated by chemical as well as mechanical stimuli. Focal adhesions are force-
dependent and assemble at points of applied force (Balaban et al., 2001; Riveline et al., 
2001). Their growth and size is in proportion to the applied force where a net accumulation of 
proteins are observed in mechanically-stressed focal adhesions (Balaban et al., 2001; Riveline 
et al., 2001). Cell focal adhesions are <200 nm in size (Franz and Muller, 2005) and are 
multi-functional, regulating cell adhesion to the ECM and cytoskeletal organisation and 
signalling. Focal adhesions therefore facilitate a bidirectional transmission of force between 
the ECM, cytoskeleton and cytoplasmic contractile machinery (Geiger et al., 2001).  
 
1.3.7. Focal adhesion structure 
In response to applied force, immature adhesions (nascent adhesions) rapidly associate with 
actin and myosin to become a focal complex and mature to focal adhesions after sustained 
actin and myosin tension generation and force transmission. Focal adhesions are 
disassembled within milliseconds at sites where the applied force is no longer present 
(Balaban et al., 2001), a process necessary for endothelial cell migration (Webb et al., 2004).  
Focal adhesions are composed of an integrin-signalling layer containing focal 
adhesion kinase (FAK) and paxillin, an intermediate force transduction layer containing talin 
and vinculin and an actin regulatory upper-layer that contains α-actinin and a number of other 
proteins (Kanchanawong et al., 2010). Focal adhesions can contain 156 distinct molecules 
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and nearly 690 interactions of which 55% are binding interactions and 45% are activation/ 
inhibition processes (Zaidel-Bar et al., 2007).  
Focal adhesions are therefore highly dynamic complex structures and are assembled 
and disassembled in response to mechanical forces to maintain normal cell function. The 
following section will now discuss the protein-containing structure in skeletal muscle that 
contains focal adhesions. It will concentrate on the integrin-signalling layer (Kanchanawong 
et al., 2010) and its role in skeletal muscle mechanotransduction with a particular focus on 
FAK and paxillin since this structural protein assembly is regarded to be the principle point 
of mechano-sensing (Goldmann, 2012a) (figure 1.3, 1.4). 
 
1.4. Force transmission in skeletal muscle  
1.4.1. Lateral force transmission  
The myotendinous junction (MTJ) and the sarcolemma are the two force-transmitting points 
in skeletal muscle fibres (Bloch and Gonzalez-Serratos, 2003; Monti et al., 1999). Street 
(Street, 1983) showed that an electrically-stimulated single fibre (that was still attached to 
muscle fibres at its distal end) could transmit >75% of the force to a force transducer through 
its adjacent connections with other muscle fibres, as described in these reviews (Bloch and 
Gonzalez-Serratos, 2003; Monti et al., 1999). Street (Street, 1983) also found a correlation 
between markers placed on a stretched sarcolemma and the underlying sarcomeres. This 
suggested a connection between the sarcomeres and the sarcolemma and these connections 
kept the sarcolemma in register with the sarcomere (Bloch and Gonzalez-Serratos, 2003; 
Monti et al., 1999). It is therefore thought that the lateral transmission of force from 
contracting myofibrils to the sarcolemma and then to adjacent muscle fibres before ending at 
the MTJ constitutes the greatest avenue of force transmission rather than longitudinally 
through the sarcomeres (Bloch and Gonzalez-Serratos, 2003; Monti et al., 1999).  
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1.4.2. Costameres 
The sarcolemmal connections were first visualised in avian skeletal muscle and were termed 
‘costameres’ (Greek where costa means rib and mere means part) (Pardo et al., 1983) based 
on their rib-like appearance, much like the metal bands around a wooden barrel (Ervasti, 
2003; Pardo et al., 1983). Costameres can be defined as subsarcolemmal protein assemblies 
that circumferentially align in register with the Z-disk of peripheral myofibrils and physically 
couple force-generating sarcomeres with the sarcolemma (Ervasti, 2003; Pardo et al., 1983). 
They may also span the I-band and anchor the M-line to the sarcolemma (figure 1.1.) 
(Mondello et al., 1996). During skeletal muscle contraction, costameres cause the 
sarcolemma to pleat into small and tolerable folds or ‘festoons’ which is thought to protect 
the sarcolemma from developing large festoons and the potential for sarcolemmal damage 
(Pardo et al., 1983; Street, 1983). 
Skeletal muscle costameres are composed of focal adhesions (1.3.2 and 1.3.3) which 
are known to contain integrins, vinculin, FAK and paxillin (Quach and Rando, 2006). They 
also contain other protein complexes such as the dystrophin-glycoprotein complex (DGC) 
(Bloch and Gonzalez-Serratos, 2003) (figure 1.4). As well as dystrophin, the DGC includes 
the α- and β-dystroglycans, the sarcoglycans, sarcospan, the syntrophins and α-dystrobrevin. 
Dystrophin binds to dystroglycan and actin and therefore forms a link between actin and the 
ECM (Chamberlain et al., 1997). The DGC functions to maintain the structural integrity of 
the muscle fibre and, in addition to focal adhesions, provides an avenue for force 
transmission. Costameres are dynamic structures and their focal adhesion and DGC protein 
content is modulated by periods of (un)loading (Chopard et al., 2005; Kosek and Bamman, 
2008; Woolstenhulme et al., 2006). Defects in certain costameric proteins such as dystrophin 
can increase the fragility and susceptibility of skeletal muscle fibres to contraction-induced 
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damage and lead to severe myopathies such as in Duchenne muscular dystrophy (Bloch et al., 
2004).  
Costameres therefore play an integral role in lateral force transmission, in maintaining 
the integrity of the sarcolemma and protecting the sarcolemma from contraction-induced 
damage. Sections 1.4.3. to 1.5. discuss the principle costameric proteins involved in 
mechanotransduction.  
 
1.4.3. Integrins  
Integrins are αβ heterodimeric transmembrane glycoprotein receptors for ECM proteins 
(Guan, 1997) and link the ECM to the intracellular actin cytoskeleton (for review see (Guan, 
1997; Hynes, 2002). Integrins do not contain an actin-binding site (Roca-Cusachs et al., 
2012), but are indirectly attached to the actin cytoskeleton through the structural and 
signalling protein talin (Calderwood et al., 1999), vinculin (Humphries et al., 2007) and α-
actinin (Otey et al., 1990; Pavalko et al., 1991).  
The extracellular domain of integrin α-subunit (120 – 180 kDa) is noncovalently 
bound to the integrin β-subunit (90 – 110 kDa) to form an ECM ligand binding site (Shattil et 
al., 2010). The large extracellular domain (>100 kDa) therefore binds the ECM and the short 
intracellular domain (>75 kDa) indirectly binds the actin cytoskeleton (Hynes, 1992) (figure 
1.3). A minimum of 18 different α- and 8 β-subunits have been identified and can form 24 
separate α- β-integrins in humans (Hynes, 2002). The α7 subunit is the primary α-integrin 
subunit in adult skeletal muscle and of its three isoforms (A, B, C), α7C is the most abundant 
(Martin et al., 1996). A spliced variant of the β1-subunit (β1D-subunit) is the most abundant 
in, and specific to, skeletal and cardiac muscle (van der Flier et al., 1995). The vascular 
endothelium can express a variety of αβ-subunits with α1β1 and α2β1 (Senger et al., 1997) 
and αvβ3, β5 integrins being particularly important in angiogenesis (Nisato et al., 2003).  
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1.4.4. Activation of integrins by force  
Integrins can be activated by ‘outside in’ mechanisms such as ECM ligand binding (known as 
ligation) and/ or through force (e.g. catch bonds). Integrins can also be activated through 
‘inside out’ mechanisms where cytoskeletal proteins such as talin bind to the β1-subunit 
(Calderwood et al., 1999; Friedland et al., 2009; Hynes, 2002; Moser et al., 2009; Roca-
Cusachs et al., 2012; Tadokoro et al., 2003). These induce a conformational change between 
the αβ subunits which facilitates bidirectional signalling (Hynes, 2002).   
Integrins cluster (known as aggregation) in focal adhesions upon ligand binding or 
when force is applied. This reduces the amount of force per integrin resulting in increased 
focal adhesion strength and resistance to force (Choquet et al., 1997). Integrins that are bound 
to magnetic ligand-coated beads (which impart tensile or twisting forces) demonstrate a high 
resilience to force which increases in proportion to the applied force (Matthews et al., 2004). 
Integrins then convert these forces into intracellular signalling through recruitment of 
intracellular signalling, adaptor and cytoskeletal proteins (Dey et al., 2011; Wang et al., 
1993). In murine skeletal muscle, overexpression of the α7β1-subunits increased muscle 
hypertrophy after a single and multiple bouts of eccentric exercise (Lueders et al., 2011; Zou 
et al., 2011). 
 
1.4.5. Integrin-mediated recruitment of cytoskeletal proteins  
Integrins are without enzyme activity so must recruit signalling proteins for integrin-mediated 
processes such as cell migration, cell growth and apoptosis (Hynes, 2002). Integrin 
aggregation and ligation is largely required for binding many cytoskeletal proteins 
(Miyamoto et al., 1995). Upon integrin activation, the β1-subunit serves as a docking site for 
focal adhesion kinase (FAK) (Guan and Shalloway, 1992; Guan et al., 1991), talin (along 
with vinculin) (Calderwood et al., 1999; Horwitz et al., 1986; Humphries et al., 2007; 
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Tadokoro et al., 2003) and α–actinin (Otey et al., 1990) which are independent of integrin 
tyrosine phosphorylation (Miyamoto et al., 1995) (figure 1.3 and 1.4). However, aggregation, 
ligation and the addition of tyrosine phosphorylation of integrins is required for the 
recruitment of the adaptor protein paxillin, signalling proteins such as cellular Src, members 
of the mitogen-activated protein kinase (MAPK) family such as extracellular signal-regulated 
kinase  (ERK) 1/2 and other signalling proteins such as phosphotidylinositol-3-kinase (PI3-
K) (Miyamoto et al., 1995).  
 
 
Figure 1.3 Integrin structure. Diagrammatic representation of α- and β-integrins that 
identifies extracellular matrix (ECM) ligands (e.g. fibronectin) and selected intracellular focal 
adhesion-associated protein binding sites. FAK, focal adhesion kinase. Adapted from 
(Schlaepfer et al., 1999).
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Figure 1.4. Schematic diagram of a skeletal muscle costamere composed of a focal adhesion and dystrophin-glycoprotein complex. α–
DG, α-dystroglycan; β-DG, β-dystroglycan; SG, Sarcoglycan; SP, Syntrophin; FAK, focal adhesion kinase.
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1.4.6. Focal adhesion kinase (FAK)  
FAK is a 125 kDa non-receptor cytoplasmic enzyme (Guan et al., 1991; Schaller et al., 1992) 
named by Schaller et al, on account of its localisation to and abundance in focal adhesions 
(Kanchanawong et al., 2010; Schaller et al., 1992). FAK is ubiquitously expressed and 
evolutionarily conserved across many species sharing ~90% identity (Guan, 1997; Parsons, 
2003) and is required for cell adhesion strength and cell stiffness (Fabry et al., 2011). Integrin 
ligation stimulates the direct recruitment of FAK to the integrin β1-subunits and their 
interaction is accompanied by increased FAK tyrosine phosphorylation (Guan et al., 1991). 
Consequently, FAK has been suggested to play a pivotal role in integrin-mediated signalling 
and force sensing (Guan, 1997; Parsons, 2003; Schlaepfer et al., 1999). This was robustly 
demonstrated in vivo in mice with a knockout of the FAK gene (Ilic et al., 1995). The mice 
died within 8.5 days of embryo, presenting with poor development of the heart and blood 
vessels consequent to defects in vasculogenic and angiogenic processes (Ilic et al., 1995).  
 
1.4.7. FAK structure 
FAK is composed of 3 distinct regions where the central kinase domain is flanked by N-
terminal and C-terminal domains (Parsons, 2003; Schlaepfer et al., 1999). The N-terminal 
contains an erythrocyte band 4.1, erzin, radixin, moesin (FERM) domain which is linked to the 
catalytic kinase domain by a linker segment and the kinase domain is linked to the C-terminal 
domain by a proline rich region (Arold et al., 2002) (figure 1.5). The N-terminal domain 
regulates the localisation and binding of FAK to the cytoplasmic tail of β1 integrins since 
deletion of the C-terminal had no effect on FAK localisation (Schaller et al., 1995). FAK is 
localised to focal adhesions by its C-terminal domain (Hildebrand et al., 1993). This contains 
a focal adhesion targeting (FAT) domain which is composed of protein binding domains and 
multiple phosphotyrosine binding sites that facilitate interaction with proteins such as paxillin 
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(Tachibana et al., 1995). The FAT domain contains two paxillin binding sites (Gao et al., 
2004; Scheswohl et al., 2008) where only one functioning site is required for paxillin to target 
FAK to focal adhesions (Scheswohl et al., 2008). However, two functioning paxillin binding 
sites are essential for maximal FAK phosphorylation and maximal FAK-mediated 
downstream signalling (Scheswohl et al., 2008).  
Integrin clustering stimulates FAK autophosphorylation on Tyr
397
 (Guan et al., 1991; 
Parsons, 2003; Schaller et al., 1994) which is situated in the linker segment between the N-
terminal and kinase domains. Autophosphorylation creates a high-affinity binding site for 
proteins containing Src homology (SH) 2 domains. These include the protein tyrosine kinases 
such as cellular Src and the p85 subunit of PI3-K (Chen et al., 1996) which are both linked to 
striated muscle hypertrophy (Glass, 2010; Marin et al., 2008). Following the binding of Src at 
Tyr
397
, Src then phosphorylates FAK on Tyr
576/ 577
 which is necessary for maximum FAK 
activation (Calalb et al., 1995) and can also phosphorylate FAK on Tyr
925
 (Schlaepfer and 
Hunter, 1996) (figure 1.5). The latter creates an SH2 binding site for growth factor receptor-
bound protein 2 (Grb2) which leads to activation of the ERK-MAPK signalling cascade 
(Webb et al., 2004). In skeletal muscle, FAK can also be phosphorylated on Tyr
397
 by non-
integrin stimuli such as insulin (Goel and Dey, 2002), insulin-like growth factor-I (IGF-I) 
(Baron et al., 1998) and vascular endothelial growth factor (VEGF) in endothelial cells 
(Abedi and Zachary, 1997; Avraham et al., 2003). FAK phosphorylation and activation is 
also dependent upon the integrity of the actin cytoskeleton. Inhibition of actin polymerisation 
by cytochalasin (a toxin that binds to the barbed ends of actin filaments) prevents the 
activation of FAK by a variety of stimuli such as fluid shear stress (Li et al., 1997a), integrins 
(Lipfert et al., 1992) and VEGF (Abedi and Zachary, 1997). 
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1.4.8. Inactive FAK 
FAK is not constitutionally active and in the absence of mechanical stimuli, maintains a 
dephosphorylated and inactive state when FAK is localised to the C-terminal region of 
myosin heavy chain in cardiomyocytes (Fonseca et al., 2005). Evidence suggests the 
inactivity of FAK is maintained through the interaction of its N-terminal FERM domain with 
its kinase domain. (Cooper et al., 2003). Indeed, FAK phosphorylation and activity were 
increased in experiments that truncated the N-terminal domain and overexpression of the N-
terminal domain reduced FAK phosphorylation and activity (Cooper et al., 2003). 
It is thought that the FERM domain maintains inactive FAK in a closed conformation 
through protein to protein and protein to membrane interactions. The FERM domain contains 
three sub-domain lobes (F1, F2 and F3) which appear to inhibit FAK through two known 
mechanisms. Firstly, the F1 lobe binds to the linker segment containing the 
Tyr
397
autophosphorylation site thereby masking the phosphorylation site. Secondly, the 
Tyr
576/ 577
 phosphorylation sites are hidden or “sequestered” between the F1 and F2 lobes 
(Cooper et al., 2003; Lietha et al., 2007). It is thought that this conformation prevents FAK 
activation by restricting FAK-associated proteins (e.g. Src) from accessing the 
phosphorylation and kinase domains (Lietha et al., 2007). Cooper and colleagues (2003) 
proposed a model whereby proteins such as paxillin bind to inactive FAK’s FAT domain 
thereby stimulating FAKs localisation to focal adhesions. FAK subsequently binds to the 
cytoplasmic tail of integrin β1-subunits where the integrin cytoplasmic tail is thought to 
displace the FERM-mediated autoinhibition thereby leading to FAK activation. 
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Figure 1.5. Diagrammatic structure of focal adhesion kinase (FAK). A) FAK Tyr
397 
autophosphorylation site is a target of cellular Src (Src) and the p85 regulatory subunit of 
phosphatidylinositol-3 kinase (PI3-K). Binding of c-Src and p85 stimulates 
autophosphorylation of FAK which leads to increased Tyr
576/577
 phosphorylation for maximal 
FAK activation. B) In its inactive state, the FERM domain subdomains F1 and F2 mask the Tyr397 
and Tyr
576/577 
phosphorylation sites preventing access of Src and PI-3K. FERM, erythrocyte band 4.1, 
erzin, radixin, moesin; F. A. T, focal adhesion targeting domain; Pro, proline-rich region; 
VEGFR, vascular endothelial growth factor receptor. 
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1.4.9. FAK-related non-kinase (FRNK) 
FAK is also negatively regulated by its endogenous competitor FAK-related non-kinase 
(FRNK) (Schaller et al., 1994). FRNK is a separate expression of FAK’s 42 kDa C-terminal 
FAT domain that transiently blocks the formation of focal adhesions, inhibits the binding of 
FAK and paxillin and their tyrosine phosphorylation (Richardson and Parsons, 1996) and 
displaces FAK from focal adhesions (Heidkamp et al., 2002). In rat skeletal muscle, FRNK 
abolished the FAK-mediated upregulation of slow twitch muscle gene expression (Durieux et 
al., 2009). 
 
1.4.10. Paxillin  
Paxillin is a 68 kDa adaptor protein (Glenney and Zokas, 1989) named after the Latin 
“Paxillus” meaning stake or peg which reflected its role as a scaffold for focal adhesion 
structural and signalling proteins (Turner et al., 1990). Paxillin is evolutionarily conserved 
(Brown and Turner, 2004) and binds to β1 integrins (Miyamoto et al., 1995; Schaller et al., 
1995). It contains a vinculin- (Turner et al., 1990) and FAK-binding domain (Turner and 
Miller, 1994) which suggests paxillin may play an important role in integrin-signalling and 
mechanotransduction. This was critically demonstrated in vivo where mice with a paxillin 
knock out gene died after 9.5 days of embryo consequent to developmental defects in the 
heart and ex-vivo abnormalities in cell migration (Hagel et al., 2002). The latter was 
attributed to poor FAK localisation and impaired FAK and MAPK phosphorylation (Hagel et 
al., 2002). 
 
1.4.11. Paxillin structure 
Paxillin is divided into N- and C-terminal domains and has no enzyme activity. It’s N-
terminal domain contains 5 protein binding sites (LD motifs) of which two are FAK-binding 
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sites (Brown et al., 1996) which have equal affinity for FAK and are both required for the 
highest binding affinity of paxillin with FAK (Thomas et al., 1999). Its C-terminal domain 
contains 4 LIM domains (Lin11, IsI-1, Mec-3) which can mediate protein-protein interaction 
and are binding sites for proteins such as Src (Weng et al., 1993). LIM domain 3 is the 
principle determinant for targeting paxillin to focal adhesions (Brown et al., 1996). 
Binding of the FAK/Src complex with paxillin phosphorylates paxillin on Tyr
31
 and Tyr
118 
(Richardson et al., 1997; Schaller and Parsons, 1995; Thomas et al., 1999). Paxillin is also 
phosphorylated on tyrosine by PI3-K (Casamassima and Rozengurt, 1998) and ERK and by 
p38 MAPK on Ser
83
 (Huang et al., 2004a; Ishibe et al., 2004) and by Jun N-terminal kinase 
(JNK) on Ser
178
 (Huang et al., 2004b) (figure 1.6). For a more detailed discussion on 
additional paxillin binding proteins the reader is referred to the following reviews (Brown 
and Turner, 2004; Deakin and Turner, 2008; Turner, 2000). 
 
 
 
 
Figure 1.6. Diagram of the paxillin structure and identification of some of the protein 
binding domains, focal adhesion targeting domains and phosphorylation sites. PI3-K, 
phosphotidylinositol-3 kinase; LIM, Lin11, IsI-1, Mec-3. SH2, Src homology 2. 
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1.5. FAK and paxillin responses to physical (in)activity in skeletal muscle  
1.5.1. Acute responses of FAK and paxillin to loading 
At present, the effect of mechanical loading on skeletal muscle FAK and paxillin 
phosphorylation is limited. In rodent L6 skeletal muscle cells in vitro, FAK Tyr
576/577
 
phosphorylation (a marker of maximal FAK activity) was increased after 30 min of uni-axial 
cyclic stretch and remained elevated for up to 60 min post-stretch (Atherton et al., 2009). The 
uni-axial stretch also increased Akt kinase activity and ERK 1/2 and p70S6K phosphorylation 
during the 60 min post-stretch period (Atherton et al., 2009). Fluck et al (Fluck et al., 1999) 
subjected the rooster anterior latissimus dorsi skeletal muscle to stretch-overload by placing 
a weight equal to 10% of its body mass on the wing.  In vivo FAK and paxillin tyrosine 
phosphorylation increased within 1.5 days of stretch-overload and remained elevated for up 
to 13 days of stretch (Fluck et al., 1999). FAK and paxillin tyrosine phosphorylation also 
increased at 1 and 8 days of overload of the rat m. soleus and m. plantaris through surgical 
ablation of the m. gastrocnemius (Fluck et al., 1999; Gordon et al., 2001).  
In human m. vastus lateralis skeletal muscle, FAK Tyr
576/577 
phosphorylation 
increased immediately after an acute bout of endurance- or resistance-type exercise in the 
untrained and trained state (12 weeks ET or RT) and remained elevated for up to 4 hours post 
exercise. In addition, a higher resting FAK Tyr
576/577 
phosphorylation was reported post-
training (Wilkinson et al., 2008). These data suggest FAK and paxillin are rapidly 
phosphorylated in response to stretch and overload in animal and human skeletal muscle. It 
also suggests there is no difference in the capacity of endurance- and resistance-type exercise 
to activate FAK despite the different magnitudes of force generated.  
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1.5.2. Evidence for a role of FAK and paxillin in skeletal muscle hypertrophy 
FAK and paxillin protein concentration increased ~200% in hypertrophied rooster ALD after 
7 days of stretch overload as described above in 1.5.1 (Fluck et al., 1999). Overload of the rat 
m. soleus (as described in 1.5.1) increased skeletal muscle mass after 8 days of loading and 
this was accompanied by an increase in FAK and paxillin protein concentration (>600%) 
compared with sham-operated controls (Fluck et al., 1999). FAK and paxillin protein content 
also increased after 8 days of overload of the m. plantaris muscle through surgical ablation of 
the gastrocnemius (Gordon et al., 2001).  
These studies do not confirm a causative role for FAK and paxillin in skeletal muscle 
hypertrophy. However, in cardiomyocytes, an increase in FAK protein expression and 
phosphorylation was observed in the hypertrophied left ventricle of aortic-banded mice 
(Clemente et al., 2007). Interestingly, the load-induced hypertrophy of the left ventricle was 
prevented and reversed by targeting FAK with small interfering RNA (siRNA) in vivo 
(Clemente et al., 2007). In addition, Cre-Lox recombination of the FAK gene of murine 
cardiomyocytes (cardiomyocyte-specific FAK gene deletion) blunted the aortic-band-induced 
left ventricular wall thickness in vivo (DiMichele et al., 2006). Taken together, these studies 
suggest a chronic increase in FAK and paxillin protein expression in response to increased 
mechanical loading in animal skeletal muscle. The changes in protein expression after 
loading are also accompanied by an increase in skeletal muscle mass. This suggests a 
potential role for FAK and paxillin in skeletal muscle hypertrophy. However, at the start of 
this PhD thesis, there was no information on FAK and paxillin protein expression and their 
response to exercise training in human skeletal muscle. In addition, the studies described 
above used western blotting analysis of whole skeletal muscle homogenates which does not 
provide information on fibre- and microvascular-specific responses to exercise training in 
humans.  
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1.5.3. FAK-activated downstream signalling pathways in vivo and in vitro 
There is a paucity of information on the downstream targets of FAK-activated signalling in 
human skeletal muscle in vivo. However, there are two in vitro studies in rat skeletal muscle 
that have generated important information. Durieux et al, (2009) induced local 
overexpression of FAK in the rat m. soleus using gene electrotransfer of cytomegalovirus 
(CMV) promoter-driven expression plasmid which encoded a chicken non-constitutively 
active FAK gene (pCMV-FAK). The m. soleus (primarily slow twitch fibres) was initially 
subjected to 7 days of unloading before mechanically re-loaded with normal cage activity for 
1 day. FAK overexpression increased the expression of genes associated with slow twitch 
skeletal muscle fibres in vivo which included the MHC type I isoform and increased the 
protein content of nuclear-encoded mitochondrial proteins such as cytochrome oxidase IV, 
but not mitochondrially-encoded proteins such as cytochrome oxidase I (Durieux et al., 
2009). The authors speculated that this was due to a lack of increased energy consumption in 
the model employed  (Durieux et al., 2009).  
Using similar techniques, Klossner et al, (2009) showed that after 7 days of unloading 
by tail suspension in vivo mechanical re-loading of the murine m. tibialis anterior (primarily 
fast twitch fibres) led to FAK Tyr
397
 phosphorylation and Akt-independent phosphorylation 
of p70S6K (Klossner et al., 2009). These studies imply that increases in FAK protein 
expression and FAK Tyr
397
 phosphorylation are upstream of the molecular adaptation that 
follows increases in skeletal muscle workload and that the targeted signalling pathways differ 
between slow oxidative and fast glycolytic muscle fibres.  
In vitro studies that have investigated FAK-mediated downstream signalling in 
skeletal muscle are lacking. However, cyclic uni-axial stretch (15%) of neonatal rat 
ventricular myocytes increased FAK Tyr
397
 phosphorylation and reduced the high baseline 
association of FAK with Src homology phosphatase 2 (Shp2) (Marin et al., 2008). Myocyte 
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depletion of Shp2 by siRNA increased the phosphorylation of FAK Tyr
397
, Src, Akt, tuberous 
sclerosis 2 (TSC2), and p70S6K in non-stretched myocytes. In addition, Shp2 depletion also 
stimulated hypertrophy of non-stretched neonatal rat ventricular myocytes. Conversely, FAK 
depletion through siRNA blunted cyclic stretch-induced FAK Tyr
397
, Src, Akt, TSC2, and 
p70S6K phosphorylation and myocyte hypertrophy (Marin et al., 2008). This study suggests 
that FAK may play an important role in the protein synthesis signalling pathway and may be 
an upstream regulator of hypertrophy in neonatal rat ventricular myocytes. Future studies will 
have to show whether FAK also has this role in human skeletal muscle. A schematic of the 
proposed role of FAK in the adaptation of skeletal muscle fibres to exercise is presented in 
figure1.7. 
 
1.5.4. FAK and paxillin responses to skeletal muscle unloading 
Mechanical unloading of the skeletal muscle leads to a loss of skeletal muscle mass, cross-
sectional area and a reduction in FAK tyrosine phosphorylation (de Boer et al., 2007; Glover 
et al., 2008; Gordon et al., 2001). FAK total protein content in the m. soleus, plantaris and 
gastrocnemius muscles decreased by >40% after 7 days of rat hindlimb unloading via tail 
suspension (Gordon et al., 2001). This was accompanied by a significant reduction in FAK 
tyrosine phosphorylation corrected to total FAK protein in only the m. soleus muscles 
(Gordon et al., 2001). Unloading also modulated the FAK and paxillin response in a fibre-
type specific manner with their protein concentration increased in the m. soleus, but 
decreased in the m. plantaris and gastrocnemius muscles. The authors speculated that the 
increased FAK protein concentration in the m. soleus was a compensatory response of the m. 
soleus to the lack of mechanical stimulation (Gordon et al., 2001). 
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Figure 1.7. Proposed role of endurance-(ET) and resistance-type (RT) exercise training 
in integrin-mediated activation of FAK and skeletal muscle fibre adaptation. ET leads to 
the activation and translocation of peroxisome proliferator activated γ coactivator-1α 
(PGC1α) to the nucleus. The interaction of PGC1α with nuclear respiratory factor-1 (NRF-1) 
increases the expression of nuclear- (e.g. cytochrome oxidase IV; COX IV) and 
mitochondrial-encoded genes necessary for increased oxidative capacity and mitochondrial 
biogenesis (Yan et al., 2011) which may involve FAK (Durieux et al., 2009). RT-induced 
activation of FAK leads to the Akt-independent phosphorylation of ribosomal protein S6 
kinase (p70S6K) (Klossner et al., 2009) possibly through a FAK-mediated phosphorylation 
and inhibition of tuberous sclerosis complex 1/ 2 (TSC 1/ 2) (Marin et al., 2008). This 
liberates mammalian target of rapamycin (mTOR) to phosphorylate and inhibit eukaryotic 
initiation factor 4 binding protein-1 (eIF4-BP1), leading to the formation of the translation 
initiation complex eIF4F, increased protein synthesis and skeletal muscle fibre hypertrophy.   
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In humans, FAK Tyr
576/577
 phosphorylation in the m. vastus lateralis (mixed fibre types) was 
reduced by 30% at the mid-phase (10 days) of cast immobilisation (de Boer et al., 2007), and 
was reduced by ~23% after 14 days knee-braced immobilisation  (Glover et al., 2008). 
Moreover, these studies also reported a decline in the rates of muscle protein synthesis. Taken 
together, these studies suggest that a reduction of skeletal muscle mechanical load in animals 
and humans leads to a reduction in FAK tyrosine phosphorylation and muscle-specific 
alterations in FAK protein concentration in rats. These alterations may also occur in elderly 
skeletal muscle in response to the reported reductions in physical activity levels and the 
adoption of a sedentary lifestyle (HSfE, 2010). Consequently, FAK may play an important 
role in the mechanisms that lead to a loss of skeletal muscle mass and the etiology of 
sarcopenia. Regulation of FAK by physical (in)activity may therefore be of significance to 
young and elderly sedentary individuals.  
 
1.5.5. Localisation of FAK and paxillin in skeletal muscle fibres  
Immunohistochemistry (Fluck et al., 1999; Fluck et al., 2002) and fluorescence microscopy 
(Durieux et al., 2009; Klossner et al., 2009; Quach and Rando, 2006) have been used to 
visualise FAK and paxillin in animal skeletal muscle. In rats, a high FAK protein content was 
present in the sarcolemma in transversely and longitudinally orientated skeletal muscle fibres 
of the m. soleus and m. extensor digitorum longus (EDL) (Fluck et al., 2002). Sarcolemmal 
FAK was observed in the majority of type I fibres in the m. soleus, but only in 50% of EDL 
muscle fibres (Fluck et al., 2002). This was consistent with the greater total FAK protein 
content measured with western blots in m. soleus compared with m. plantaris and m. 
gastrocnemius muscles by Gordon et al., (2001). In addition, <15% of EDL type IIb fibres 
showed FAK sarcolemmal immunolabeling. These data suggest that in animal skeletal 
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muscle, a high FAK protein content is present in the sarcolemma primarily in type I muscle 
fibres.  
In the same study, the m. soleus and EDL muscles were then explanted and the 
authors cross-reinnervated the m. soleus with EDL nerve fibres. As a consequence, 
sarcolemmal FAK immunolabeling was reduced in m. soleus type I fibres and was increased 
in EDL type I and type II fibres. The authors suggested that the firing rate of the innervating 
nerve and the muscle fibres recruited controlled the localisation of FAK at the sarcolemma. 
As type I fibres are the predominant fibres recruited during free living and standing in rats, 
the authors speculated that the greater sarcolemmal FAK immunolabeling in type I fibres was 
an adaptive response to the higher overall mechanical load experienced daily by postural 
muscles (Fluck et al., 2002).  
In addition to the sarcolemmal immunolabeling observed by Fluck et al (Fluck et al., 
1999; Fluck et al., 2002), Durieux et al, (2009) also reported an intense FAK intracellular 
immunoreactivity in type I compared with type II fibres after local overexpression of FAK 
through electro-gene transfer. In adult mouse transversely orientated EDL skeletal muscle, 
FAK was distributed along the sarcolemma, but also as striations that spanned the full width 
and perpendicular to the direction of the fibre (Quach and Rando, 2006). These striations 
colocalised with α5 integrins, vinculin and α-actinin over the I band and M band and 
confirmed that FAK was localised to costameres in murine skeletal muscle fibres (Quach and 
Rando, 2006). There is a paucity of data regarding the localisation of paxillin in mammalian 
skeletal muscle. In murine myoblasts, paxillin was localised to focal adhesions, and in murine 
myotubes, was localised to maturing costameres overlying the Z-disk (Quach and Rando, 
2006).  
These data suggest FAK and paxillin are localised to areas of force transmission 
corresponding to costameres in rat skeletal muscle. However, the spatial distribution of FAK 
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and paxillin in human skeletal muscle has not been investigated, nor its protein expression. 
Furthermore, no studies have investigated whether FAK and paxillin colocalise in human 
skeletal muscle fibres and their microvasculature. 
 
1.6. Mechanotransduction in the microvasculature 
1.6.1. Activation of FAK and paxillin by shear force and cyclic stretch 
The brush-like structures of the endothelial glycocalyx layer are thought to have a flexural 
rigidity which allows the glycocalyx to tolerate fluid shear stress-induced deformations 
(Weinbaum et al., 2003). It is estimated that the tips of the glycocalyx fibres undergo a 
maximum deformation of <10 nm at a shear stress of 10 dyne/cm
2
 (Weinbaum et al., 2007) 
(figure 1.7). It is thought that this transmits a bending moment through the glycocalyx to the 
cytoskeleton below the apical surface (Weinbaum et al., 2007). Consequently, the glycocalyx 
acts as a force transducer by transmitting fluid shear stress forces through the intracellular 
cytoskeleton to the abluminal focal adhesions (Florian et al., 2003; Weinbaum et al., 2007). 
Weinbaum and colleagues (Weinbaum et al., 2007) also discuss the possibility that the 
glycocalyx is held under an axial tension and changes in fluid shear stress pulls with varying 
degrees of force on the glycocalyx thereby affecting the state of the underlying cellular 
cytoskeleton (Weinbaum et al., 2007). In experiments where the glycocalyx is degraded, the 
apical surface acts as a force transducer by transmitting force through stress fibres to focal 
adhesions (Weinbaum et al., 2007). It should also be noted that the fluid shear stress forces 
acting on the luminal membrane are balanced by the forces exerted by focal adhesions to 
keep the endothelial cell anchored to the ECM and remain in place. Therefore, focal 
adhesions can still sense fluid shear stress forces independent of the glycocalyx (Tarbell and 
Pahakis, 2006; Tarbell et al., 2005).  
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FAK and paxillin are heterogeneously distributed in intracellular regions in static 
bovine aortic endothelial cells and human umbilical vein endothelial cells (Li et al., 2002; Li 
et al., 1997a; Mattiussi et al., 2006).  Laminar fluid shear stress stimulates their rapid (within 
~1 min) tyrosine phosphorylation, maximal activation and their translocation to focal 
adhesions (Li et al., 2002; Li et al., 1997a; Mattiussi et al., 2006).  
Integrins and the FAK/Src complex have been shown to regulate fluid shear stress-
activated flow-mediated dilation (FMD) of animal coronary arterioles (Koshida et al., 2005; 
Muller et al., 1997). The prevailing mechanism is that fluid shear stress-induced eNOS 
phosphorylation leads to the increased production of NO by eNOS and the diffusion of NO 
from the endothelium into the VSMC. This leads to the formation of cGMP in VSMCs, 
VSMC relaxation and vasodilation (McAllister and Laughlin, 2006). In rat coronary 
arterioles, fluid shear stress increased FAK Tyr
397
 autophosphorylation and this was 
associated with increased Akt and eNOS Ser
1179
 phosphorylation (Koshida et al., 2005). The 
latter is equivalent to eNOS Ser
1177
 phosphorylation in the human eNOS sequence which 
augments eNOS activity and NO production. FMD of rat coronary arterioles was inhibited 
with the NOS inhibitor N-nitro-L-arginine methyl ester (L-NAME) and inhibition of FAK 
Tyr
397
 by a Tyr
397–specific blocking antibody abolished eNOS Ser1179 phosphorylation and 
FMD (Koshida et al., 2005). This study suggests that FAK may play an important role in 
FMD and a lack of FAK protein content and tyrosine phosphorylation may lead to 
endothelium-dependent vascular dysfunction. A summary of the potential mechanisms are 
summarised in figure 1.7.  
Cyclic stretch of endothelial cells can also stimulate FAK and paxillin tyrosine 
phosphorylation and their recruitment to focal adhesions in vitro (Katanosaka et al., 2008; 
Naruse et al., 1998; Yano et al., 1996a; Yano et al., 1996b). These studies collectively 
demonstrate that FAK and paxillin are stimulated and activated by fluid shear stress and 
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cyclic stretch and these proteins may play an important role in endothelial 
mechanotransduction. 
 
1.6.2. Role of FAK and paxillin in endothelial cell migration and angiogenesis  
Endothelial cell sprouting and migration is one of the principle steps in angiogenesis (Prior et 
al., 2004; Risau, 1997). Angiogenesis has been reported to occur in response to both ET 
(Andersen and Henriksson, 1977; Klausen et al., 1981) and RT (Green et al., 1999; Hepple et 
al., 1997; McCall et al., 1996) and is linked to shear stress and mechanical stretch of vascular 
endothelial cells (Prior et al., 2004). This implies that FAK may play a potential role in the 
signalling mechanisms that lead to angiogenesis. In agreement with this suggestion is the 
observation that overexpression of the FAK gene in mice increased angiogenesis in the 
ischemic hindlimb (Peng et al., 2004), while conditional knock out of the FAK gene in mice 
led to a disorganised and apoptotic blood vessel appearance in developing embryos (Shen et 
al., 2005). In addition, deletion of FAK in endothelial cells from floxed FAK mice reduced 
endothelial cell survival, proliferation and capillary development in vitro (Shen et al., 2005). 
Increases in FAK protein content and tyrosine phosphorylation within the microvascular 
endothelium may therefore play an important role in the mechanisms by which exercise 
training increases angiogenesis and capillary density. On the other hand, decreases in FAK 
content and phosphorylation may contribute to the rarefaction (reductions in capillary 
density) that is seen in sedentary elderly individuals  (Coggan et al., 1992).  
VEGF plays an important role in exercise induced angiogenesis (Bloor, 2005) and 
circulating plasma VEGF concentration is increased in humans after endurance- (Kraus et al., 
2004) and resistance-type exercise (Gavin et al., 2007). In cultured human umbilical vein 
endothelial cells and porcine aorta endothelial cells, VEGF rapidly phosphorylated FAK and 
paxillin with similar kinetics in a dose response dependent manner (Abedi and Zachary, 
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1997; Qi and Claesson-Welsh, 2001). In unstimulated human umbilical vein endothelial cells, 
FAK and paxillin were localised to intracellular regions and sparsely distributed, but 10 min 
of stimulation by VEGF potentiated their recruitment and colocalisation with the plasma 
membrane and focal adhesions (Abedi and Zachary, 1997). Binding of FAK to the C-terminal 
of the VEGF receptor phosphorylates FAK leading to FAK-mediated recruitment and 
phosphorylation of PI3-K (Abedi and Zachary, 1997; Qi and Claesson-Welsh, 2001). The 
latter protein is important for VEGF-mediated cell migration and angiogenesis since defects 
in the p110α subunit of PI3-K cause embryonic lethality (Graupera et al., 2008). Blocking of 
FAK through FRNK significantly inhibited focal adhesion formation and the spreading and 
migration of VEGF-stimulated human brain microvascular endothelial cells (Avraham et al., 
2003). This emphasises the importance of FAK and FRNK in VEGF-mediated endothelial 
cell migration. 
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Figure 1.8. Schematic of fluid shear stress-induced deformation of luminal endothelial 
glycocalyx fibres and the subsequent transmission of force along the intracellular 
cytoskeleton to abluminal focal adhesions. Mechanotransduction of fluid shear stress by 
focal adhesions leads to endothelial cell migration and angiogenesis via stimulation of the 
extracellular signal-regulated kinase (ERK 1/ 2) signalling pathway. Activation and 
phosphorylation (P) of FAK also leads to activation of endothelial nitric oxide synthase 
(eNOS) and the subsequent increase in nitric oxide (NO) production. ECM, extracellular 
matrix; FAK, focal adhesion kinase; PI3-K, phosphotidylinositol-3-kinase.
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1.6.3 FAK and paxillin in vascular smooth muscle cells 
Information on FAK and paxillin in VSMCs contained within human skeletal muscle are 
lacking. However, FAK and paxillin are highly expressed in tracheal smooth muscle  (Tang 
et al., 1999; Turner et al., 1991) and FAK is necessary for VSMC growth and migration 
(Hauck et al., 2000; Koshman et al., 2011; Sundberg et al., 2003). In unstimulated isolated 
tracheal smooth muscle fibres, FAK and paxillin was distributed throughout the cell as 
assessed by immunofluorescence microscopy (Opazo Saez et al., 2004). After stimulation by 
the contractile agonist acetyl-choline, FAK and paxillin were rapidly localised to membrane-
associated focal adhesions for increased tension development and contraction (Opazo Saez et 
al., 2004). FAK and paxillin play an important role in smooth muscle actin cytoskeleton 
dynamics and force production (for review see (Gerthoffer and Gunst, 2001; Gunst and 
Zhang, 2008) and paxillin-null cells prevented the acetyl-choline-induced force production 
(Opazo Saez et al., 2004). FAK and paxillin are also tyrosine phosphorylated in VSMCs by 
the contractile agonist angiotensin-II (Polte et al., 1994; Turner et al., 1995) and have been 
proposed to mediate angiotensin-II-stimulated VSMC constriction (for review see (Mehta and 
Griendling, 2007). Taken together, these studies suggest FAK and paxillin are important in 
regulating VSMC contractile activity and vascular dilation, but their localisation and 
distribution in human skeletal muscle had not been investigated at the start of the current PhD 
research (October 2009). 
 
1.7. FAK and skeletal muscle insulin signalling 
There are two known insulin signalling pathways in skeletal muscle that regulate glucose 
uptake. These include the APS-CAP-Cbl (APS, Adaptor molecule containing Pleckstrin 
homology and Src homology-2 domains; CAP, c-Cbl-associated protein; Cbl, Casitas B-
lineage Lymphoma) signalling pathway and the insulin receptor substrate 1- (IRS-1) PI3-K-
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Akt signalling pathway. The role and relative contribution of the APS-CAP-Cbl pathway in 
insulin-stimulated glucose uptake is poorly understood (Chang et al., 2004),  but evidence has 
been presented that it plays a role in insulin-stimulated actin cytoskeletal remodelling and 
glucose transporter-4 (GLUT-4) translocation in a TC10-independent manner (Ishiki and 
Klip, 2005; JeBailey et al., 2004). The most widely researched and understood signalling 
pathway leading to GLUT4 translocation occurs via IRS-1-PI3-K-Akt signalling and in vitro 
and in vivo evidence has been presented that FAK plays a regulatory role in insulin-
stimulated glucose uptake and glycogen synthesis via this pathway in skeletal muscle  (Bisht 
and Dey, 2008; Bisht et al., 2007; Bisht et al., 2008; Huang et al., 2006). 
 
1.7.1. Insulin signalling through FAK-IRS-1-PI3-K  
Insulin binds to the transmembrane insulin receptor which stimulates autophosphorylation of 
the IR. This leads to the tyrosine phosphorylation of insulin receptor substrate-1 and 2 (IRS-
1/2) and the creation of docking sites for SH2 domain-containing proteins such as PI3-K 
(Backer et al., 1992; Myers et al., 1992). Binding of IRS-1 to the p85 subunit of PI3-K leads 
to an increase in PI3-K p110 catalytic enzyme activity (Backer et al., 1992; Myers et al., 
1992) which promotes the production of the phosphatidylinositol-3-phosphate compounds 
PI(3,4,5)P3, PI(3,4)P2 and PI3P within the plasma membrane and leads to the recruitment of 
phosphoinositol-dependent protein kinase 1 (PDK1) to the plasma membrane. Akt (2 
isoforms are expressed in human skeletal muscle) is recruited with PDK1 to the plasma 
membrane and is phosphorylated by the richtor-mTOR complex on Ser
473
 (Sarbassov et al., 
2005) and PDK1 on Thr
308/309 
(Filippa et al., 2000).  
 Akt then phosphorylates Akt substrate 160 kDa (AS160) which, possibly in 
combination with APS-CAP-Cbl pathway (Ishiki and Klip, 2005), leads to glucose 
transporter-4 (GLUT-4) translocation to the sarcolemma and t-tubules . GLUT-4 is the 
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principle protein in the facilitated diffusion of insulin-stimulated glucose uptake in skeletal 
muscle fibres (Watson and Pessin, 2001). Protein kinase C zeta (PKCζ) is also activated by 
the insulin-stimulated PI3-K-PDK1 signalling pathway leading to a remodelling of the actin 
cytoskeleton and GLUT-4 translocation (Liu et al., 2007).   
FAK has been shown to directly interact with the insulin receptor leading to its 
insulin-stimulated phosphorylation on Tyr
397
 in C2C12 murine skeletal muscle cells (Goel 
and Dey, 2002). FAK (via its C-terminal domain) then directly interacts with the insulin 
receptor substrate-1 (Lebrun et al., 1998) leading to FAK-mediated tyrosine phosphorylation 
of IRS-1 (Bisht et al., 2007; Lebrun et al., 1998). In C2C12 skeletal muscle cells, insulin-
stimulated FAK also leads to the phosphorylation of PI3-K and PKC in vitro (Bisht et al., 
2007; Goel and Dey, 2002). FAK overexpression through transfection of C2C12s with 
plasmid constructs containing encoding for the wild-type FAK gene increased insulin-
stimulated FAK phosphorylation and resulted in a 40% increase in insulin-stimulated glucose 
uptake compared with control wild-type C2C12s (Bisht et al., 2007). Overexpression of FAK 
stimulated a FAK-mediated remodelling of the actin cytoskeleton and GLUT-4 translocation 
following insulin stimulation (Bisht and Dey, 2008).  
To test the hypothesis that inhibition of FAK impaired insulin signalling and insulin-
stimulated glucose uptake in skeletal muscles, C2C12s were made insulin resistant through 
the chronic (3 days) presence of insulin (100 nmol/L) in the cell growth medium (Bisht et al., 
2007).  The authors demonstrated that FAK phosphorylation was reduced in insulin resistant 
C2C12 skeletal muscle cells in response to 10 min of insulin stimulation, leading to impaired 
glucose uptake (Bisht et al., 2007). However, the impaired glucose uptake was reversed when 
insulin resistant cells were overexpressing FAK (Bisht et al., 2007). A reduced expression of 
FAK via siRNA inhibition in the skeletal muscle of rats in vivo after 4 weeks siRNA 
inhibition (Bisht et al., 2008) was associated with hyperglycaemia, hyperinsulinaemia and 
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impaired insulin-stimulated glucose uptake in vivo (Bisht et al., 2008). The authors attributed 
the insulin resistance to reductions in the phosphorylation and protein content of IRS-1 and 
Akt after FAK silencing
 
compared with controls (Bisht et al., 2008).  
Insulin also acts on the microvasculature as a means of increasing insulin-stimulated 
glucose uptake (Barrett et al., 2009; Barrett et al., 2011). Binding of insulin to its receptor on 
the luminal side of the endothelium leads to phosphorylation of the insulin receptor and the 
phosphorylation of the IRS-1-PI3-K-PDK-1-Akt-eNOS signalling cascade (Rattigan et al., 
2006). The NO produced by eNOS then diffuses into the smooth muscle thereby stimulating 
vasodilation (Rattigan et al., 2006). Barrett et al (2009) propose a model whereby terminal 
arterioles regulate blood flow through capillaries and insulin-stimulated vasodilation of the 
terminal arterioles leads to the recruitment of previously underperfused capillaries. This 
increases microvascular blood volume and the capillary surface area available for the uptake 
of insulin and nutrients (glucose, amino acids and fatty acids) into the interstitial fluid 
surrounding the skeletal muscle fibres (Barrett et al., 2009). A role for FAK and paxillin in 
insulin-stimulated microvascular recruitment today has not been reported.  
 
1.7.2. Insulin resistance 
Insulin resistance is defined as a reduced responsiveness of a target cell (e.g. adipose tissue, 
liver or skeletal muscle) or a whole organism to the insulin concentration to which it is 
exposed (Shanik et al., 2008). Chronic insulin resistance can lead to a decline in glucose 
tolerance with advancing age and can eventually develop into type II diabetes (non-insulin 
dependent diabetes mellitus), a disease particularly prevalent in elderly populations (Wild et 
al., 2004). Impaired skeletal muscle insulin-stimulated glucose uptake among others has been 
linked to the increased availability of circulating free fatty acids and triglycerides (Schenk et 
al., 2009). Interestingly, FAK tyrosine phosphorylation was reduced in the rat hindlimb 
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skeletal muscle after a 2 week high fat diet compared with controls (Bisht et al., 2007). A 
reduction in FAK phosphorylation in response to lipid oversupply to skeletal muscle from 
high fat feeding, may therefore contribute to obesity-related insulin resistance. On the other 
hand, activation of FAK through frequent participation in physical activity (walking, cycling, 
sport) may be a potential mechanism that contributes to the improved insulin sensitivity that 
has been observed up to 48 hours post exercise (Mikines et al., 1988; Perseghin et al., 1996) 
and the higher insulin sensitivity observed with exercise training (Dela et al., 1992; Rogers et 
al., 1990) even in type II diabetic patients (Dela et al., 1995).  
 
1.8. Elderly skeletal muscle 
Skeletal muscle is essential for the completion of daily activities and the maintenance of 
mobility and social engagement in the environment. In a post-mortem study on 43 previously 
healthy men aged between 15 and 83 years, skeletal muscle area peaked at 24 years of age 
(Lexell et al., 1988) and declined at a rate of 3-5% per decade before an accelerated loss in 
the 6
th
 decade. Between the ages of 24 to 50 years, a 10% reduction in muscle area was 
observed, but this increased to 30% between 50 and 80 years of age. The mean reduction of 
muscle area from the age of 24 to 80 years was 40% (Lexell et al., 1988). Estimates from 
longitudinal studies suggest muscle is lost at ~0.6% per year (Janssen and Ross, 2005). In 
individuals aged >50 years, the speed at which appendicular skeletal muscle mass is lost 
predicts all cause mortality regardless of age, body composition and health status (Szulc et 
al., 2010). Lower limb muscle mass is particularly affected compared with upper limbs 
(Janssen et al., 2000) which may contribute to impaired mobility with age (Janssen et al., 
2002). The loss of skeletal muscle mass can be offset by gains in fat mass which may mask 
the loss of muscle and may lead to sarcopenic obesity (Baumgartner, 2000). At the whole 
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muscle level, fat and connective tissue may infiltrate the skeletal muscle resulting in a 
marbled appearance (Goodpaster et al., 2001). 
 
1.8.1. Defining sarcopenia and its epidemiology 
Rosenberg (Rosenberg, 1989) coined the term sarcopenia (loss of skeletal muscle mass with 
age) as a means of attracting attention to a scientifically under-researched area of clinical 
significance. This definition implies that everybody who loses skeletal muscle mass with age 
is sarcopenic (100% prevalence) (Janssen, 2010) and makes no attempt to classify how much 
muscle can be tolerably lost before clinically significant functional impairments manifest.  
 Attempts have been made to distinguish those individuals with and without 
substantial muscle loss (sarcopenic) and although no definition is universally accepted 
(Visser, 2009), the definition of sarcopenia proposed by Baumgartner et al (Baumgartner et 
al., 1998) as muscle mass/height
2 
that is more than 2 standard deviations below the mean 
reference value for young males and females is often used (Baumgartner et al., 1998; Di 
Monaco et al., 2011; Iannuzzi-Sucich et al., 2002)  
 Using this definition, Baumgartner et al (Baumgartner et al., 1998) reported up to 
24% of people in New Mexico aged <65 years and 50% of people aged >80 years would 
fulfil the criteria for sarcopenia as assessed using dual x-ray absorptiometry (DEXA). 
Sarcopenia was more prevalent in men aged >75 years (58%) compared with women of the 
same age (45%) (Baumgartner et al., 1998). Iannuzzi-Suchi (Iannuzzi-Sucich et al., 2002) 
reported similar prevalence rates in New England Caucasians where ~53% of men and 31% 
women aged >64 years were classified as sarcopenic. Lower rates have been reported in 
China where ~12% of men and ~8% or women aged >70 years were classified as sarcopenic 
(Lau et al., 2005). In Italy (Di Monaco et al., 2011), France (Rolland et al., 2003) and 
Denmark (Tanko et al., 2002), between 58%, 9.5% and 12% of women aged >70 years were 
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sarcopenic. Although the prevalence is variable depending upon the country of origin, these 
data suggest the prevalence of sarcopenia increases with age, with elderly men appearing 
particularly susceptible in later life compared with women. 
  
1.8.2. Muscle strength  
The loss of muscle strength (dynapenia) can occur at rates which exceed the loss of muscle 
mass (Clark and Manini, 2008). Cross-sectional studies have reported a 20 – 40% loss of 
knee extensor strength in individuals aged between 65 and 90 years (Frontera et al., 1991; 
Murray et al., 1980; Young et al., 1985). It should be noted, however, that there is great inter-
individual variability in the rate of dynapenia. In a 10 year longitudinal study, approximately 
one third of individuals aged ~60 years at baseline showed no loss of strength at follow-up 
(Hughes et al., 2001) 
  
1.8.3. Muscle fibre characteristics 
The decline in CSA may be partially attributable to a loss of muscle fibre number.  Indeed, a 
post-mortem assessment of the m. vastus lateralis muscle recovered from men aged 19-37 
and 70-73 years demonstrated fewer muscle fibres in the elderly (~364,000 fibres) compared 
with the young (~478,000 fibres) (Lexell et al., 1983) with apparently no fibre-type 
specificity (Klitgaard et al., 1990; Lexell et al., 1986). Atrophy of skeletal muscle fibres is 
heavily implicated in the loss of skeletal muscle CSA and the response is generally fibre-type 
specific. Type I fibre CSA is generally well maintained with age even in individuals aged 
>85 years  (Andersen, 2003; Lexell et al., 1988), however, type II fibre CSA is particularly 
affected by the ageing process (Essen-Gustavsson and Borges, 1986; Klitgaard et al., 1990; 
Kosek et al., 2006; Larsson et al., 1978; Lexell, 1995; Lexell et al., 1986; Lexell et al., 1988; 
Verdijk et al., 2007). In individuals aged >85 years, Andersen (Andersen, 2003) reported that 
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type I fibre CSA atrophied in size by 25% compared with 25 year olds, whereas type II fibres 
atrophied by 57%. Ageing skeletal muscle also demonstrates fibre type grouping rather than 
the random distribution observed in the young (Lexell et al., 1986) and a lower muscle 
capillarisation compared with young individuals (Coggan et al., 1992; Degens et al., 1993). 
Although it is hypothesized that FAK and paxillin protein content of human skeletal muscle 
and its associated microvasculature will decrease with ageing and the adoption of a sedentary 
lifestyle, no studies have measured FAK and paxillin and their response to exercise training 
in human skeletal muscle and its microvasculature.  
 
1.8.4. Resistance training and impaired mechanotransduction 
RT is recommended for young and elderly individuals (Chodzko-Zajko et al., 2009), 
particularly for its ability to increase skeletal muscle strength (Fiatarone et al., 1990; Frontera 
et al., 1988; Grimby et al., 1992; Hakkinen et al., 1998; Hakkinen et al., 2001b; Izquierdo et 
al., 2001; Kosek et al., 2006; Lexell et al., 1995; Verdijk et al., 2009a; Verdijk et al., 2009b) 
and reduce or prevent progressive type II skeletal muscle fibre atrophy that is seen in many 
elderly individuals (Fiatarone et al., 1990; Frontera et al., 1988; Kosek et al., 2006; Verdijk et 
al., 2009a; Verdijk et al., 2009b). The elderly can achieve similar relative gains in skeletal 
muscle strength as the young after RT (Hakkinen et al., 2001a; Hakkinen et al., 1998; 
Holviala et al., 2006; Newton et al., 2002) and several studies show no difference between 
age groups in chronic hypertrophic response to RT (Hakkinen et al., 1998; Ivey et al., 2000), 
especially when based on percentage gains in muscle CSA per day of training (Narici et al., 
2004).  
However, these findings are not universally observed (Kosek and Bamman, 2008; 
Kosek et al., 2006; Lemmer et al., 2000; Martel et al., 2006; Welle et al., 1996). Emerging 
evidence suggests that the protein synthesis response of ageing skeletal muscle to acute bouts 
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of endurance and resistance-type exercise is impaired compared with young individuals 
(Drummond et al., 2008; Kumar et al., 2009; Williamson et al., 2003). For example, there 
was a blunted post-exercise elevations in p70S6K and eukaryotic initiation factor-4 binding 
protein-1 (4EBP-1) phosphorylation in elderly individuals following acute bouts of resistance 
exercise performed at 60-90% 1 RM in the fasted state (Kumar et al., 2009). In addition, 
Williamson et al (Williamson et al., 2003) reported a fall in ERK 1/2, p38 MAPK and JNK 
phosphorylation after 70% 1RM knee extensor exercise in the elderly, whereas their 
phosphorylation increased in the young. These studies suggest an impaired ability for 
mechanotransduction to stimulate anabolic signalling pathways in senescent tissues and 
contribute to the development of anabolic resistance with advancing age. The role of FAK 
and paxillin in skeletal muscle anabolic resistance has not been investigated. Most important, 
however, is the observation that an increase in load by elevated intraluminal pressure failed to 
increase FAK Tyr
925
 phosphorylation compared with young rats (Rice et al., 2007). This 
suggests impairments may also be observed in the activation of FAK by acute increases in 
mechanical load with age.  
Age-associated impairments in endothelium-dependent vasodilation can begin as 
early as the 4
th
 decade (Gerhard et al., 1996) leading to impaired FMD of the brachial artery 
(Celermajer et al., 1994; Donato et al., 2007; Eskurza et al., 2004) and forearm resistance 
vessel (Gerhard et al., 1996) and rat skeletal muscle arterioles  (Delp et al., 2008; Muller-
Delp, 2006; Muller-Delp et al., 2002; Spier et al., 2007). A reduced NO bioavailability has 
been proposed to be an important underlying mechanism (for review see (Seals et al., 2011). 
This suggests impairments in vascular mechanotransduction also develop with age. As 
discussed earlier, FAK has been shown to regulate fluid shear stress-activated eNOS (and 
thus NO production by eNOS) (Koshida et al., 2005), therefore, FAK may play a critical role 
in maintaining vascular function with age.  
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1.9. Importance of immunofluorescence microscopy  
To date, the studies reporting the effect of mechanical (un)loading on FAK and paxillin 
responses within animal and human skeletal muscle have used western blot analyses on 
whole muscle homogenates (de Boer et al., 2007; Fluck et al., 1999; Gordon et al., 2001; 
Klossner et al., 2009; Wilkinson et al., 2008). Western blotting is valid for estimating 
changes in protein content in whole muscles, but it does not give information on the relative 
distribution of FAK and paxillin in muscle fibres and within the microvasculature. This is an 
important gap in the literature that warrants investigation. In addition, Western blotting does 
not provide information on tissue-specific responses to (un)loading without contamination 
from other cells and tissues.  
Immunofluorescence microscopy allows this distinction and may be an invaluable 
tool for elucidating the effect of physical (in)activity on FAK and paxillin localisation and 
changes in content in skeletal muscle fibres and its microvasculature. This is of particular 
relevance in ageing skeletal muscle and the (micro)vasculature since mechanotransduction to 
contractile and hemodynamic stimuli are potentially impaired in some elderly populations 
(Celermajer et al., 1994; Donato et al., 2007; Drummond et al., 2008; Eskurza et al., 2004; 
Kumar et al., 2009; Williamson et al., 2003). Immunofluorescence microscopy can provide 
informative images concerning the localisation and distribution of structural proteins (Pardo 
et al., 1983) and can provide (semi)quantitative data on changes in protein content as a 
consequence of physical (in)activity (Anastasi et al., 2008) or  ageing (Donato et al., 2009). 
Scientific knowledge regarding the localisation of FAK and paxillin is currently restricted to 
animal skeletal muscle fibres and there is no information regarding the localisation of FAK 
and paxillin in the endothelial and smooth muscle layer of the microvasculature of skeletal 
muscle.  
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Consequently, there is a need to develop immunofluorescence microscopy assays to 
investigate the localisation and distribution of these focal adhesion-associated proteins in 
human skeletal muscle fibres and within the skeletal muscle microvascular endothelial and 
vascular smooth muscle layers. These assays are necessary to fully understand how 
mechanical stimuli and exercise training lead to structural and functional adaptations that lead 
to improved endurance capacity, skeletal muscle hypertrophy and increases in insulin 
sensitivity in young and elderly individuals. 
 
1.10. Thesis overview and aims 
Chapter 1 discussed how cells, specifically skeletal muscle fibres and their 
microvasculature, ‘sense’ externally applied or internally generated force, pressure and load 
and translate these mechanical stimuli into intracellular signalling (mechanotransduction). 
Two candidate proteins in integrin-mediated mechanotransduction (FAK and paxillin) were 
specifically identified and their potential role in the mechanotransduction and adaptation of 
skeletal muscle and the microvasculature to (un)loading was explained. The importance and 
advantages of immunofluorescence microscopy as a tool for investigating these proteins in 
human skeletal muscle in vivo were also emphasised, yet the literature regarding the 
visualisation of FAK and paxillin is restricted to cell culture or animal skeletal muscle fibres.  
Therefore, the aim of chapter 2 was to develop reliable and repeatable 
immunofluorescence microscopy methods for the first investigations of the subcellular 
localisation and fibre-type distribution of FAK in skeletal muscle fibres of young healthy 
recreationally active men. The study also aimed to visualise the FAK subcellular distribution 
in the endothelium and VSMC layer of the skeletal muscle microvasculature.   
In rat skeletal muscle, loading is associated with increased FAK protein expression. 
However, the response of FAK to exercise training in human skeletal muscle and its 
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microvasculature has not been investigated. The aim of chapter 3 was to investigate the 
effect of 12 weeks RT on FAK in the skeletal muscle fibres and the microvascular 
endothelium of skeletal muscle of previously sedentary elderly men. A second aim was to 
validate the methods developed in chapter 2 for the investigation of human skeletal muscle 
adaptation to exercise training. It was hypothesised that RT would increase FAK in the 
skeletal muscle fibres thus contributing to the increased force production following RT, and 
within the microvascular endothelium. 
FAK and paxillin are direct binding partners and both proteins share similar responses 
to (un)loading. However, the spatial distribution of paxillin has not been investigated in 
mammalian skeletal muscle.  Therefore, the aim of chapter 4 was to develop reliable and 
repeatable immunofluorescence microscopy methods to perform the first investigations of 
paxillin in human skeletal muscle and its microvasculature as in chapter 2. A second aim was 
to investigate the colocalisation of FAK and paxillin in these tissues. It was hypothesised that 
paxillin would be expressed in the plasma membrane region of skeletal muscle fibres and the 
endothelium and VSMC layer of the skeletal muscle microvasculature and that paxillin would 
colocalise with FAK in these cells and subcellular locations. 
There is only one study in the literature which has reported FAK responses (changes 
in phosphorylation) to exercise training in human skeletal muscle which was 12 weeks long 
and used Western blot analyses (Wilkinson et al., 2008). There is no information available in 
humans on the response of paxillin to exercise training and whether shorter training periods is 
sufficient to increase the protein expression of these focal adhesion-associated proteins in 
human skeletal muscle. Therefore, chapter 5 aimed to utilise the novel immunofluorescence 
techniques developed in chapter 2 and 4 and build on chapter 3 to investigate the effect of 6 
weeks ET and RT on FAK and paxillin in skeletal muscle fibres and their microvasculature 
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of previously sedentary young men. It was hypothesised that the increased force production 
during exercise would increase FAK and paxillin protein expression in these tissues.  
Chapter 6 (General Discussion) discusses the findings of each experimental chapter 
in context of the wider literature and suggests potential avenues for future research based on 
the findings in this thesis.  
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Chapter 2 
 
Immunofluorescent visualisation of focal 
adhesion kinase in human skeletal muscle 
and its associated microvasculature 
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2.1. Abstract 
Within animal skeletal muscle, focal adhesion kinase (FAK) has been associated with load-
dependent molecular and metabolic adaptation including the regulation of insulin sensitivity.  
This study aimed to generate the first visual images of the localisation of FAK within human 
skeletal muscle fibres and its associated microvasculature using widefield and confocal 
immunofluorescence microscopy.    
Percutaneous muscle biopsies taken from five lean, active males, were frozen and 5 
µm cryosections were incubated with FAK antibodies for visualisation in muscle fibres and 
the microvasculature. Anti-myosin heavy chain type I was used for fibre type differentiation. 
Muscle sections were also incubated with anti-dihydropyridine receptor (DHPR) to 
investigate co-localisation of FAK with the t-tubules. FITC-conjugated Ulex europaeus 
Agglutinin I stained the endothelium of the capillaries, while anti-smooth muscle actin 
stained the vascular smooth muscle of arterioles. Fibre type differences in the intensity of 
FAK immunofluorescence was determined with image analysis software.  
In transversely and longitudinally orientated fibres, FAK was localised at the 
(sub)sarcolemmal regions. In longitudinal fibres, FAK staining also showed uniform 
striations across the fibre and co-staining with DHPR suggests FAK associates with the t-
tubules.    There was no fibre-type difference in sarcoplasmic FAK content. Within the 
capillary endothelium and arteriolar smooth muscle, FAK was distributed heterogeneously as 
clusters. 
This is the first study to visualise FAK in human skeletal muscle microvasculature 
and within the (sub)sarcolemmal and t-tubule regions using immunofluorescence microscopy. 
This technique will be an important tool for investigating the role of FAK in the intracellular 
signalling of human skeletal muscle and the endothelium of its associated microvasculature. 
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2.2. Introduction 
Extracellular matrix proteins interact with cells to generate intracellular signals important in 
cell growth, survival and migration (Schlaepfer et al., 1999). This interaction is achieved by 
transmembrane proteins linking extracellular proteins to the actin cytoskeleton (Schlaepfer et 
al., 1999). In skeletal muscle, these transmembrane proteins form costameres which contain a 
dystrophin/glycoprotein complex and an integrin associated-complex (Bloch and Gonzalez-
Serratos, 2003). Costameres circumferentially align in register with the Z-disk of peripheral 
myofibrils and connect the sarcomeres with the sarcolemma (Ervasti, 2003; Pardo et al., 
1983). At the junction between the integrins and the actin cytoskeleton are focal adhesions 
which convert integrin- (e.g. mechanical) and non-integrin (e.g. hormonal) stimulation into 
intracellular signalling (Schlaepfer et al., 1999). Focal adhesions are formed from proteins 
such as paxillin, talin, vinculin and focal adhesion kinase (FAK) (Kanchanawong et al., 
2010). 
FAK is a cytoplasmic non-receptor tyrosine kinase (Parsons, 2003; Schaller, 2001; 
Schlaepfer et al., 1999) implicated in the transduction of mechanical stimuli such as loading 
and unloading. In skeletal muscle, loading is associated with increased FAK tyrosine 
phosphorylation (Klossner et al., 2013; Wilkinson et al., 2008) and protein content (Fluck et 
al., 1999; Gordon et al., 2001), leading to FAK mediated stimulation of the protein synthesis 
signalling pathway (Klossner et al., 2009) and skeletal muscle hypertrophy in animals 
(Durieux et al., 2009; Fluck et al., 1999; Gordon et al., 2001) and elderly humans (Flueck et 
al., 2011; Narici et al., 2011). Conversely, unloading reduced FAK tyrosine phosphorylation 
in rat soleus skeletal muscle after 7 days of tail suspension (Gordon et al., 2001) and in 
human skeletal muscle after 10 and 14 days of leg immobilisation (de Boer et al., 2007; 
Glover et al., 2008). 
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Non-integrin stimuli such as insulin can also modulate FAK (Baron et al., 1998; Goel and 
Dey, 2002a, b; Knight et al., 1995) with FAK shown to regulate insulin action in skeletal 
muscle (Bisht and Dey, 2008; Bisht et al., 2007; Bisht et al., 2008; Huang et al., 2006). 
Insulin can stimulate the rapid reorganisation of the sub-membrane actin filaments in L6 
myocytes leading to the docking of GLUT-4 at the plasma membrane (Tong et al., 2001). 
Recent evidence in C2C12 skeletal muscle cells suggest this remodelling is FAK mediated 
(Bisht and Dey, 2008), possibly through direct phosphorylation by the insulin receptor (Goel 
and Dey, 2002b). FAK also phosphorylates IRS-1 and regulates IRS-1 associated PI3-K 
activity (Lebrun et al., 1998) leading to GLUT-4 translocation via the reorganised actin 
filaments and glucose uptake (Bisht and Dey, 2008; Bisht et al., 2007; Huang et al., 2006). 
Down-regulation of FAK in C2C12 skeletal muscle cells reduced basal and insulin-
stimulated FAK tyrosine phosphorylation, prevented insulin-stimulated actin remodelling, 
impaired insulin signalling and the associated GLUT-4 translocation, glucose uptake and 
glycogen synthesis (Bisht and Dey, 2008; Bisht et al., 2007; Goel and Dey, 2002a; Huang et 
al., 2006). Furthermore, in vivo FAK inhibition reduced insulin-mediated FAK, IRS-1 and 
Akt phosphorylation and glucose uptake resulting in the development of hyperglycaemia and 
hyperinsulinaemia (Bisht et al., 2008).  
Immunohistochemistry (Fluck et al., 1999; Fluck et al., 2002) and 
immunofluorescence microscopy techniques (Durieux et al., 2009; Klossner et al., 2009; 
Klossner et al., 2013; Quach and Rando, 2006) have been used to visualise the distribution of 
FAK within cross-sections of animal skeletal muscle and have shown FAK to be more 
abundant in type I slow oxidative fibres (Fluck et al., 2002; Gordon et al., 2001). FAK is 
localised in both the sarcolemmal and sarcoplasmic regions in animal skeletal muscle 
(Durieux et al., 2009; Fluck et al., 1999; Klossner et al., 2009) where it aligns with the Z-disc 
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in longitudinally orientated muscle fibres (Quach and Rando, 2006). In C2C12 muscle cells, 
FAK is localised along the actin cytoskeleton (Bisht and Dey 2008; Huang et al, 2006).  
FAK is also present within vascular endothelial cells, transmitting the mechanical 
stimulation of fluid shear stress into biochemical signals (Ishida et al., 1996; Li et al., 2002; 
Li et al., 1997; Wang et al., 2009). It plays an important role in blood vessel morphogenesis 
(Ilic et al., 2003) and angiogenesis (Ilic et al., 1995; Peng et al., 2004; Shen et al., 2005) and 
is a target of vascular endothelial growth factor (Abedi and Zachary, 1997; Avraham et al., 
2003). FAK has been visualised using immunofluorescence microscopy in cultured human 
pulmonary artery and umbilical vein endothelial cells (Shikata et al., 2003; Wu et al., 2003) 
but not, to the authors’ knowledge, in the microvasculature perfusing human skeletal muscle. 
Because of the diverse role of FAK in skeletal muscle, endothelial metabolism, and 
structural adaptations, immunofluorescence microscopy methods to visualise and analyse the 
content, distribution and association of FAK with other proteins is an important tool in fully 
elucidating FAK’s role(s) in human skeletal muscle and its associated microvasculature. This 
technique may provide important insights into the regulation of skeletal muscle mass and 
insulin sensitivity.    
Therefore, in the present study we aimed to generate the first visual images of the 
distribution and localisation of FAK within human transversely and longitudinally orientated 
skeletal muscle fibres and its associated microvasculature using widefield and confocal 
immunofluorescent microscopy. 
 
2.3. Materials and Methods 
Muscle samples 
Muscle samples from the m. vastus lateralis of 5 lean recreationally active males (mean ± 
SD; age 20 ± 2 y; BMI 22.6 ± 1.1 kg/m
2
)  were obtained using the Bergstrom percutaneous 
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needle technique (Bergstrom, 1975) and blotted free of excess blood, and dissected free from 
fat and connective tissue. Samples were embedded in Tissue Tek OCT compound (Sakura 
Finetek Europe, Zoeterwoude, The Netherlands) and immediately frozen in liquid-nitrogen 
cooled isopentane (Sigma-Aldrich, Dorset, UK). All tissues were kept at -80°C until required. 
For each muscle sample, 5µm cryosections were cut at -30°C, placed on room temperature, 
uncoated glass slides (VWR International Ltd, Leicestershire, UK) and fixed immediately in 
acetone and ethanol. Muscle cross-sections were cut to visualise FAK within transversely 
orientated muscle fibres and the associated endothelium and vascular smooth muscle. 
Longitudinally orientated muscle fibres were used to visualise FAK's arrangement along the 
sarcomere. 
 
Immunofluorescence staining 
All chemicals, unless stated otherwise, were purchased from Sigma-Aldrich. Phosphate 
buffered saline (PBS; 137 mM sodium chloride, 3 mM potassium chloride, 8 mM disodium 
hydrogen phosphate and 3 mM potassium dihydrogen phosphate, pH of 7.4) was used for 
dilution of antibodies, reagents and for washing steps. 
Sections were fixed in acetone and ethanol (3:1) for 5 min followed by 3 x 5 min 
wash in PBS. Sections were incubated for 2 h with 1:100 dilution of the rabbit polyclonal N-
terminal (A17) and C-terminal C20 region specific FAK antibodies (Santa Cruz, USA). The 
former has been used successfully in staining rodent skeletal muscle (Durieux et al., 2009; 
Fluck et al., 2002; Klossner et al., 2009; Quach and Rando, 2006) and the C-terminal specific 
FAK antibody (C-FAK) was used to validate the localisation of the N-terminal FAK 
antibody. To assess fibre type differences in FAK content, sections of muscle were cut and 
stained with FAK antibodies co-incubated with 1:100 dilution of anti-myosin heavy chain 
type I (developed by Dr. Blau; DSHB; A4.840-c) and 1:400 dilution of anti-dystrophin 
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(Sigma-Aldrich, UK). The latter was used as a marker for the sarcolemma and identification 
of individual cell membranes since dystrophin is localised to the sarcoplasmic surface of the 
sarcolemma (Davies and Nowak, 2006). Type II fibres remained unstained.  
Muscle sections were also incubated with 1:25 dilution of anti-calcium channel L type 
dihydropyridine receptor alpha 2 subunit (DHPR; Abcam ab2864) for visualisation of 
transverse-tubules (t-tubules). To identify FAK within capillaries, muscle sections were 
incubated with 1:200 dilution of the FITC-conjugated Ulex europaeus Agglutinin I (UEA-I) 
lectin (Vector Laboratories, UK) and 1:100 dilution of anti-α-smooth muscle actin for the 
identification of vascular smooth muscle (α-SMA; ab18460, Abcam, UK). After incubation, 
sections were washed 3 x 5 min in PBS, blotted dry and then the appropriately targeted 
fluorescently conjugated secondary antibodies were applied for 30 min. These included 1:200 
dilutions of goat anti-rabbit IgG 488 and 594 and goat anti-mouse IgM 350, IgG2a and IgG2b 
488 and 594 fluorophores (Invitrogen, UK). For negative controls and the assessment of 
background fluorescence, the primary antibody was omitted and in all cases, the fluorescence 
signal was removed. Sections were then washed for 3 x 5 min in PBS before blotting dry and 
applying cover slips mounted in a glycerol and mowiol 4–88 solution in 0.2 M Tris-buffer 
(pH 8.5) with the addition of 0.1% 1,4-diazobicyclo-[2,2,2]-octane (DABCO) antifade 
medium. 
A competition experiment for FAK signal specificity was also performed by co-
incubating FAK with a FAK-specific blocking peptide (FAK A-17 sc-557 P; Santa Cruz). 
The concentration of the blocking peptide was 10x higher than the FAK primary antibody. 
On separate glass slides, sections were stained either with FAK or FAK co-incubated with the 
blocking peptide using the same protocol as previously described.  
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Fluorescence microscopy 
For the initial visualisation of FAK in skeletal muscle and microvasculature, images were 
taken using a Nikon E600 microscope coupled to a SPOT RT KE colour three shot CCD 
camera (Diagnostic Instruments Inc., MI, USA). DAPI UV, FITC and Texas Red excitation 
filters were used to visualise the Alexa Fluor 350, 488 and 594 fluorophores, respectively. 
Detailed digital images of the microvasculature and skeletal muscle were acquired using an 
inverted confocal microscope (Leica DMIRE2, Leica Microsystems) with a 63x oil 
immersion objective. The Alexa Fluor 488 and 594 fluorophores were excited with a 488 nm 
line of the argon laser and 594 nm line of the Helium-Neon laser for excitation, respectively. 
Images used to investigate colocalisation of FAK with DHPR, Lectin and α-SMA were 
captured sequentially.  
All images were processed using Image-Pro Plus 5.1 software (Media Cybernetics, 
MD, USA). Two sections per participant were cut and placed on the same slide and 
duplicated on a second slide for FAK quantitation with five regions of interest (ROI) captured 
per muscle section on the widefield microscope. ROI’s covering areas of all transversely 
orientated muscle fibres were selected and used to measure FAK immunoreactivity in a fibre-
type specific manner. A total of 109 ± 15 transversely orientated fibres were analysed per 
cross section and fibre type specificity was determined from the mean fluorescence signal 
intensity of 48 ± 7 type I and 61 ± 10 type II individual whole human muscle fibres, 
respectively. All fibres that were in the longitudinal plane were excluded from FAK 
quantitation. Using the appropriate dystrophin image, a participant-specific intensity 
threshold was selected and used to identify complete individual muscle fibres. The fibre 
outline was then overlayed onto the raw FAK image for quantitation of sarcoplasmic FAK 
fluorescence intensity.  
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Confocal microscopy was used for comparison between sarcoplasmic and sarcolemmal FAK 
immunofluorescence. Duplicate slides were prepared as above, except only 3 sections were 
investigated across both slides, with 5 region of interests (ROI’s) captured per section. As 
there was no sarcoplasmic fibre-type specificity determined using widefield microscopy 
(figure 2.3), muscle fibres captured with confocal microscopy were pooled and a total of 74 ± 
19 transversely orientated whole muscle fibres were analysed per person. Sarcoplasmic and 
sarcolemmal FAK immunofluorescence was quantified using the dystrophin outline 
surrounding the whole muscle fibres as above.    
 
Western blot 
Snap frozen skeletal muscle tissue was powdered in liquid nitrogen using a pestle and mortar 
and mixed on ice with lysis buffer (RIPA buffer (Cell Signalling) to which a complete mini 
protease inhibitor tablet was added (Roche Diagnostics, Mannheim, Germany) before 
homogenisation with a hand held homogeniser. Samples were centrifuged for 20 min at 
10,000 g at 4ºC with the supernatant removed and a small aliquot used for protein 
determination (Pierce BCA assay kit; Pierce, Rockford, IL, USA). Samples were diluted to a 
total protein concentration of 3 µg/µl and loaded in 15 µl aliquots (45 µg) before separation 
by electrophoresis on 12% SDS polyacrylamide gels (Thermo Scientific, Rockford, IL, 
USA). The proteins were transferred to a nitrocellulose membrane for 2 hours at 25 V and 
incubated for 5 min with Ponceau S to determine transfer efficacy. The membranes were then 
washed for 1 min in 0.1 M NaOH. After 3 x 1 min wash with deionised water, the 
membranes were incubated for 60 min in 5% dry non-fat milk (NFM) in PBS and 0.05% 
Tween (PBST) blocking solution. The membranes were incubated overnight at room 
temperature with the N-terminal specific FAK antibody (1: 1500) diluted in 5% bovine serum 
albumin and PBST blocking solution. Membranes were washed 3 x 5 min in PBST and 
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blocked for 60 min in NFM in PBST. The membranes were then incubated for 60 min with a 
HRP-conjugated anti-rabbit IgG secondary antibody (FAK, 1:5000). After a 2 x 5 min and 1 
x 15 min wash in PBST, membranes were treated for 5 min with enhanced 
chemiluminescence HRO detection reagent (GE Healthcare, Amersham, UK) and bands were 
identified and captured. 
 
Statistical Analyses 
Mean fluorescence intensity was used as a measurement of total FAK content at the 
sarcolemma and across the 2 fibre types. Data are expressed as mean ± SEM and compared 
using a paired samples t-test (SPSS v15). Significance was set at P < 0.05.  
 
2.4. Results 
Specificity of the N-terminal specific FAK antibody in human skeletal muscle 
Figure 2.1 shows representative widefield fluorescence microscopy images of N-terminal (A) 
and C-terminal specific antibodies (C-FAK) (B). Both images demonstrate distinct 
immunofluorescence at the (sub)sarcolemmal regions. Co-incubation of N-terminal FAK 
with a FAK-specific peptide (C) abolished the strong FAK-specific sarcolemmal 
immunoreactivity and control experiments omitting the primary antibody also removed 
sarcolemmal immunoreactivity. Western blot analysis (E) identified a band at ~125 kDa 
which corresponded to FAK’s molecular weight of 125 kDa (Schaller et al., 1992). Two 
bands at ~90 and ~50 kDa were also detected which have previously been observed in human 
skeletal muscle when using this antibody (Flueck et al., 2011) and are known FAK cleavage 
fragments (Carragher et al., 1999).   Taken together, these data suggest the FAK A-17 N-
terminal specific primary antibody is specific for skeletal muscle FAK protein in agreement 
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with past research (Durieux et al., 2009; Fluck et al., 1999; Fluck et al., 2002; Klossner et al., 
2009; Quach and Rando, 2006).  
 
Localisation of FAK in skeletal muscle fibres 
Figure 2.1A shows representative widefield fluorescence microscopy images of skeletal 
muscle stained with anti-FAK and anti-myosin heavy chain type I. In many transversely and 
longitudinally orientated fibres, a strong FAK fluorescence was detected at the sarcolemmal 
area compared with the sarcoplasm (figure 2.2A and B). Indeed, FAK immunoreactivity was 
104 ± 4% greater at the sarcolemma compared with the sarcoplasm (P = 0.001). Quantitative 
image analysis from transversely orientated skeletal muscle fibres revealed no fibre type 
difference in sarcoplasmic FAK content (figure 2.3).   
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Figure 2.1. Immunofluorescent visualisation of focal adhesion kinase (FAK) in human 
skeletal muscle. A) Representative widefield microscopy images of FAK in transversely 
orientated m. vastus lateralis type I and type II skeletal muscle fibres. N-terminal region 
specific FAK (red, left) co-incubated with anti-myosin heavy chain type I (MHC type I, blue) 
for muscle fibre type differentiation and anti-dystrophin (DYS, green) antibodies for 
visualisation of the fibre membrane (right). There was a strong FAK immunoreactivity at the 
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sarcolemmal and subsarcolemmal regions of the muscle fibre (arrows). B) Representative 
images of C-terminal region specific FAK showed a similar (sub)sarcolemmal FAK 
immunoreactivity as the N-terminal FAK. C) Representative images of N-terminal FAK co-
incubated with a FAK-specific blocking peptide. The inclusion of a specific blocking peptide 
abolished the FAK-positive signal at the sarcolemma. D) Negative control experiment 
omitting the N-terminal primary antibody removed the positive signal. E) Western blot of the 
N-terminal FAK antibody using homogenised m. vastus lateralis human skeletal muscle. For 
all images bars are 50 µm. 
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Figure 2.2. Mean sarcolemmal and sarcoplasmic focal adhesion kinase (FAK) 
immunoreactivity assessed using confocal microscopy. (A) Sarcolemmal FAK 
immunoreactivity compared to the sarcoplasm. Data was quantified by pooling both fibre 
types with 74 ± 19 whole muscle m. vastus lateralis fibres analysed. Data are means ± SEM. 
n=5. * Significantly different compared with the sarcoplasm (P=0.001). (B)  Representative 
images of FAK (red, left) and dystrophin (DYS, green, right) captured using confocal 
microscopy. Note that FAK appears in the form of clusters along the sarcolemma (arrow). 
Bars are 5 µm.   
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Figure 2.3. Mean focal adhesion kinase (FAK) fluorescence intensity of type I and type 
II muscle fibres assesed using widefield microscopy. There was no difference in 
sarcoplasmic FAK content between type I and type II muscle fibres from human m. vastus 
lateralis. Data are related to type I fibres and are mean ± SEM. n=5. Data was quantified 
from 48 ± 7 type I and 61 ± 10 type II whole transversely orientated fibres. 
 
When longitudinally orientated type I and type II fibres were viewed using widefield (figure 
2.4A) and confocal microscopy (figure 2.4B), FAK staining revealed an evenly distributed, 
highly organised structure running perpendicular to the fibre’s longitudinal direction and 
spanning the full width of the fibre. Representative confocal microscopy images of anti-FAK 
staining in combination with the t-tubule marker, anti-DHPR (figure 2.4B) suggest that FAK 
colocalises with the t-tubular network.  
 
FAK and the microvasculature 
Representative confocal images of the endothelium within skeletal muscle are presented in 
figure 2.5. FITC-conjugated UEA-I lectin successfully stained the endothelium of capillaries 
(far left panel, upper row) and larger microvessels (likely arterioles) in skeletal muscle (far 
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left panel, bottom row) as evidenced by the intense fluorescent signal surrounding the lumen 
of each vessel. The FAK antibody successfully stained the same vasculature (middle panel 
upper and lower), with FAK distributed heterogeneously within the endothelium (lower, 
arrow). Merged images for FAK and lectin demonstrate clear colocalisation (upper and 
lower far right panels). 
Figure 2.6 represents typical confocal microscopy images of arterioles in human 
skeletal muscle identified by the positive staining of the vascular smooth muscle (far left 
panel). Anti-FAK staining again demonstrated a ring-like structure around the periphery of 
the blood vessel (middle panel) and merged images clearly illustrate the presence of FAK in 
vascular smooth muscle (far right panel). It should be noted that FAK also appeared to be 
distributed heterogeneously within the vascular smooth muscle (lower middle, arrow). 
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Figure 2.4. Distribution of focal adhesion kinase (FAK) and dihydropyridine receptor (DHPR) in longitudinally orientated skeletal 
muscle. (A) Representative widefield immunofluorescence microscopy of FAK (green) (left), the DHPR (red) (middle) and type I muscle fibres 
(MHC-type I; blue; right) in m. vastus lateralis muscle fibres. FAK and DHPR staining revealed structures running adjacent to the longitudinal 
direction and spanning the full width of the muscle fibre. B) Representative confocal image of a type I fibre (8x zoom). Co-staining of FAK with 
DHPR (right) suggests these structures are t-tubules and that FAK may colocalise with the t-tubules. Bars are 25 µm (A) and 2.5 µm (B).  
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Figure 2.5. Immunofluorescence confocal microscopy to show visualisation of focal adhesion kinase (FAK) in the endothelium of human 
skeletal muscle microvessels.  Microvessels such as capillaries (lectin, green, left) are shown amongst transversely orientated muscle fibres 
(upper) and in greater resolution (lower). FAK (red, middle) colocalises with lectin (merged, right). Bars are 50 µm and 5 µm, respectively. 
Notice the heterogeneous distribution of FAK (red, lower middle, arrow) within the endothelium. 
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Figure 2.6. Immunofluorescence confocal microscopy to show visualisation of focal adhesion kinase (FAK) in vascular smooth muscle 
(SMA). Bars are 10 µm. Arterioles were identified using anti-α-smooth muscle actin (SMA) (green, left). A strong immnuofluorescent signal for 
FAK (red, middle) (arrow) is detected at the periphery of the arteriole forming a ring-like structure (arrow). FAK also appeared to be distributed 
heterogenously in the form of clusters (arrowhead). Note that FAK is present within the smooth muscle and the endothelial cell layer (merged, 
right). 
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2.5. Discussion 
This is the first study using immunofluorescence microscopy to report the distribution and 
localisation of FAK in human skeletal muscle and its associated microvasculature. We also 
support and enhance previous reports of animal muscle detailing FAK’s distribution and 
localisation in transversely and longitudinally orientated muscle fibres.  
In figure 1 and 2, a strong immunoreactivity for FAK was detected at the sarcolemmal 
regions in both fibre types when compared with deeper areas of the muscle fibre. Our 
findings are consistent with previous studies where sarcolemmal and subsarcolemmal 
staining has been observed in the rooster anterior latissimus dorsi (Fluck et al., 1999), rat m. 
soleus, m. extensor digitorum longus (Durieux et al., 2009; Fluck et al., 2002) and tibialis 
anterior (Klossner et al., 2009). Although fibre type specific sarcolemmal FAK 
immunoreactivity was not measured in the present study, observations from animal studies 
suggest FAK protein content at the sarcolemma is specific to the fibres recruited and is higher 
in oxidative compared with fast glycolytic muscle fibres (Fluck et al., 2002). More recent 
data using electrotransfer of a FAK-expression plasmid suggest FAK is a load-dependent 
governor of type I fibres since rat type I muscle fibres showed greater sarcoplasmic FAK 
content compared with type II fibres and upregulation of proteins involved in mitochondrial 
respiration (Durieux et al., 2009). However, in recreationally active human m. vastus lateralis 
skeletal muscle, sarcoplasmic type I fibre specificity was not observed (figure 3) which may 
be due to differences in the methods and/ or species investigated.   
 The presence of FAK at the sarcolemma is consistent with FAK’s interaction with the 
transmembrane integrins (Parsons, 2003; Schaller, 2001; Schlaepfer et al., 1999) and it’s role 
in converting mechanical stimuli from loading and unloading into intracellular signalling in 
animal skeletal muscle (Fluck et al., 1999; Gordon et al., 2001; Klossner et al., 2009) and 
humans (de Boer et al., 2007; Flueck et al., 2011; Glover et al., 2008; Narici et al., 2011; 
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Wilkinson et al., 2008). Indeed, rats subjected to 7 days of hindlimb unloading and 
subsequent reloading increased FAK tyrosine phosphorylation between 1 and 6 h. FAK 
tyrosine phosphorylation preceded the phosphorylation of p70S6K at 24 h (Klossner et al., 
2009), which previously has been shown to correlate with increased muscle mass following 
resistance exercise (Baar and Esser, 1999). Furthermore, a positive correlation between the 
gain in muscle thickness and an increase in FAK content has been reported in elderly men 
and women after 12 weeks of skiing training compared with sedentary controls (Narici et al., 
2011). These findings suggest an important role for FAK in increasing skeletal muscle 
protein synthesis and muscle mass in response to training.  
The localisation of FAK at the sarcolemma also supports FAK’s role in insulin 
signalling (Bisht and Dey, 2008; Bisht et al., 2007; Bisht et al., 2008; Huang et al., 2006) 
since the insulin receptor is also expressed at the sarcolemma (Karlsson and Zierath, 2007) 
and upon insulin stimulation, directly phosphorylates FAK (Baron et al., 1998; Goel and Dey, 
2002b). Defects in human skeletal muscle insulin signalling and glucose uptake have been 
reported in insulin resistant type 2 diabetic patients, but these studies have typically focused 
on insulin signalling intermediates such as IRS-1, PI3-K and Akt (Karlsson and Zierath, 
2007). FAK may regulate insulin-stimulated glucose uptake since a reduction in basal FAK 
tyrosine phosphorylation after FAK-silencing in vivo was associated impaired insulin-
stimulated skeletal muscle IRS-1 and Akt phosphorylation and the development of insulin 
resistance within 2 weeks (Bisht et al., 2008).  
In longitudinally orientated rat skeletal muscle fibres visualised using 
immunohistochemistry (Fluck et al., 2002), there was little evidence of FAK in the 
sarcoplasm.  In the present study, however, immunofluorescence using both widefield (figure 
2.4A) and confocal (figure 2.4B) microscopy revealed a highly ordered structure running 
perpendicular to the direction of the muscle fibre in both fibre types. These structures 
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resemble not only costameres as suggested previously (Ervasti, 2003; Pardo et al., 1983; 
Quach and Rando, 2006), but also the t-tubular network (Lauritzen et al., 2008a; Lauritzen et 
al., 2008b; Lauritzen et al., 2006). T-tubules are invaginations of the plasma membrane that 
run deep into the muscle fibre. The combined t-tubules have a surface area up to 3 fold that of 
the sarcolemma (Ploug et al., 1998; Wang et al., 1996) and after insulin stimulation, have a 
surface area up to 9 times greater than the sarcolemma, supporting ~94% of GLUT-4 
mediated glucose uptake (Wang et al., 1996). FAK has been reported in the t-tubules of 
vascular smooth muscle, playing an important role in regulating the function of the L-type 
calcium channel (Wu et al., 2001). The DHPR antibody was used as a marker for t-tubules 
and for the first time in human skeletal muscle, showed the colocalisation of FAK with 
DHPR. On the basis of this colocalisation, this may suggest that FAK plays a significant role 
in insulin receptor and IRS-1 signalling in the t-tubular membranes. The t-tubules have been 
shown to contain components of the insulin signalling pathway such as the insulin receptor, 
PI3-K and upon insulin stimulation, by far the largest proportion of GLUT-4 (Lauritzen et al., 
2008a; Lauritzen et al., 2008b; Lauritzen et al., 2006).  
Within the vasculature, FAK is required for endothelial morphogenesis (Ilic et al., 
2003) and angiogenesis (Peng et al., 2004; Shen et al., 2005). Given the similarities in 
endothelial and skeletal muscle insulin signalling upstream of Akt (Zeng et al., 2000), it is 
possible that FAK may also play a role in vascular insulin action.  The present study 
demonstrates for the first time that, within the microvasculature of human skeletal muscle, 
FAK is distributed heterogeneously in the form of clusters within the endothelium and 
vascular smooth muscle (figure 2.5 and 2.6). This pattern of distribution might reflect large 
focal adhesions awaiting integrin- (e.g. shear flow) and/or non-integrin- (e.g. insulin) 
mediated stimuli (Schlaepfer et al, 1999). Therefore, the localisation and phosphorylation 
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status of FAK within the skeletal muscle microvasculature in the presence of such stimuli 
warrants further investigation.   
In conclusion, this study has used widefield and confocal immunofluorescence 
microscopy to expand on the findings of previous research on FAK. This study provides the 
first immunofluorescence images of FAK in human skeletal muscle with FAK’s distribution 
and localisation confirming images previously reported from animal muscle. This study also 
provides the first images of FAK showing colocalisation with DHPR, suggesting its presence 
in the t-tubules. Finally, this study provides the first images of FAK within the human 
skeletal muscle microvasculature.  Immunofluorescence staining is a valuable method for 
visualising FAK in skeletal muscle and the associated microvasculature. This technique may 
provide important insights into the potential role of FAK in elevating insulin sensitivity up to 
48 h after acute exercise (Mikines et al., 1988; Perseghin et al., 1996) and in exercise training 
adaptation. Future research should investigate how insulin and exercise modulate the protein 
content, phosphorylation, activity, distribution and localisation of FAK in skeletal muscle in 
different populations to include comparisons between sedentary and physically active, young 
and old, and insulin sensitive and resistant. 
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Chapter 3 
 
Increased focal adhesion kinase in the 
skeletal muscle fibres and microvascular 
endothelium of elderly humans after 12 
weeks resistance-type exercise training 
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3.1. Abstract 
Resistance-type exercise training (RT) can reverse the age-associated decline in skeletal 
muscle mass, strength and limb blood flow. Focal adhesion kinase (FAK) responds to 
mechanical forces in skeletal muscle and within the vascular endothelium, but it is unknown 
how RT may affect the FAK protein content in these tissues. This study tested the hypothesis 
that a 12 week RT program would increase FAK within the skeletal muscle and its 
microvascular endothelium of previously sedentary elderly individuals. 
Ten healthy elderly males (mean ± SEM) aged 73 ± 2 y completed 12 weeks RT with 
leg strength assessed and percutaneous m.vastus lateralis muscle biopsies collected pre- and 
post-intervention. Cryosections were incubated with anti-FAK antibodies for visualisation in 
muscle fibres and co-incubated with anti-dystrophin to identify the sarcolemma and anti-
myosin heavy chain type I for fibre-type determination. Ulex europaeus Agglutinin I was 
used to stain the endothelial layer of the skeletal muscle microvasculature and to investigate 
its FAK content. Measures of fibre cross-sectional area (CSA) were also made and images 
were captured using widefield and confocal immunofluorescence microscopy.  
RT increased leg extension and leg press strength by 29 ± 3% and 23 ± 3% (P < 
0.001), respectively. Pre-RT mean type II fibre CSA was smaller than type I fibres (P < 
0.01), but the difference was abolished after type II fibre CSA increased 24 ± 9% post-RT (P 
< 0.01) with no change in type I fibres. There were no fibre type differences in sarcoplasmic 
FAK content pre- or post-RT. RT increased type II fibre sarcoplasmic FAK content by 40 ± 
13% (P < 0.01) with a trend to increase in type I fibres  (16 ± 6.5%; P = 0.057). RT increased 
(sub)sarcolemmal FAK protein content by 27 ± 7% (P < 0.01) and skeletal muscle 
microvascular endothelial FAK content by 24 ± 8% (P < 0.05). These data suggest FAK 
protein content is increased in hypertrophied elderly skeletal muscle fibres and within the 
skeletal muscle microvascular endothelium after 12 weeks RT. 
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3.2. Introduction 
The age-associated loss of skeletal muscle mass (sarcopenia) (Rosenberg, 1989) and strength 
(dynapenia) (Clark and Manini, 2008) can increase the risk of falls (Janssen et al., 2002; Roe 
et al., 2009), self-reported disability (Janssen, 2006) and dependency (Tinetti and Williams, 
1998). Dynapenia is also an independent risk factor for all cause mortality (Ruiz et al., 2008). 
Sarcopenia begins in the 4
th
 and 5
th
 decade  with the loss of skeletal muscle mass estimated at 
a rate of ~0.6% per year (Janssen, 2010) or between 3 – 5% per decade (Lexell et al., 1988). 
It is characterised by a combined loss of type I and type II muscle fibre number (Lexell et al., 
1986) and specific type II fibre atrophy (Charette et al., 1991; Lexell et al., 1986; Verdijk et 
al., 2007). The causes of sarcopenia are likely multifactorial (Doherty, 2003), with the age-
associated decline in physical activity rates (Haskell et al., 2007) considered an important 
contributor (Doherty, 2003).  
 Resistance-type exercise training (RT) is recommended for older people (Chodzko-
Zajko et al., 2009) as it offers an effective treatment for increasing skeletal muscle strength 
(Fiatarone et al., 1990; Kosek et al., 2006; Lexell et al., 1995; Verdijk et al., 2009b) and 
inducing type II skeletal muscle fibre hypertrophy in the elderly (Fiatarone et al., 1990; 
Frontera et al., 1988; Kosek et al., 2006; Verdijk et al., 2009a; Verdijk et al., 2009b). The 
molecular mechanisms are not fully defined, but proteins proximal in the 
mechanotransduction signalling cascade may play an important role. Focal adhesion kinase 
(FAK) is a growth factor- and mechano-sensitive protein localised to regions corresponding 
to costameres in human skeletal muscle (chapter 2 of this thesis). Costameres are 
subsarcolemmal protein assemblies that link the Z-disk of peripheral myofibrils to the 
sarcolemma and facilitate the lateral transmission of force from the contracting myofibrils to 
the sarcolemma and extracellular matrix (Ervasti, 2003; Pardo et al., 1983). Increased 
mechanical loading of animal and human skeletal muscle leads to increased FAK 
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phosphorylation (Fluck et al., 1999; Klossner et al., 2009; Wilkinson et al., 2008) and protein 
abundance (Fluck et al., 1999; Gordon et al., 2001). FAK has been linked to the skeletal 
muscle protein synthesis signalling pathway and load-induced hypertrophy (Fluck et al., 
1999; Klossner et al., 2009; Wilkinson et al., 2008) but ageing may impair the response of 
FAK to mechanical load (Rice et al., 2007) and inhibition of FAK can prevent load-induced 
left ventricle hypertrophy in rats (Clemente et al., 2007; DiMichele et al., 2006). Therefore, 
FAK may play a role in mechanical load-induced skeletal muscle hypertrophy, but the effect 
of RT on FAK in elderly human skeletal muscle remains to be explored.   
FAK is highly expressed in the human skeletal muscle microvascular endothelium of 
young recreationally active individuals (chapter 2). The vascular endothelium is exposed to 
mechanical and hemodynamic forces (Davies and Tripathi, 1993) and the transmission of 
fluid shear stress forces from the luminal glycocalyx to abluminal focal adhesions 
(Weinbaum et al., 2007) leads to FAK phosphorylation  (Li et al., 2002; Li et al., 1997; 
Mattiussi et al., 2006). Evidence suggests FAK may play a role in endothelium-dependent 
vasodilation as inhibition of FAK blocked flow mediated dilation (FMD) of rat coronary 
arterioles (Koshida et al., 2005). Ageing is associated with impaired endothelial-dependent 
vasodilation (Seals et al., 2011) leading to blunted FMD in rat skeletal muscle arterioles 
(Delp et al., 2008; Muller-Delp et al., 2002). RT has been shown to prevent or improve the 
age-associated decline in limb blood flow (Anton et al., 2006; Maeda et al., 2006; Miyachi et 
al., 2005; Phillips et al., 2012), but investigations of FAK within the skeletal muscle 
microvascular endothelium of elderly individuals have not been reported.  
The response of FAK to increased mechanical loading of skeletal muscle have been 
investigated using Western blot analyses of whole muscle homogenates (Fluck et al., 1999; 
Gordon et al., 2001; Klossner et al., 2009; Wilkinson et al., 2008). This technique is not able 
to measure the FAK protein content in skeletal muscle without the potential contamination 
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from the microvasculature and vice versa. The advantage of immunofluorescence microscopy 
techniques described in chapter 2 of this thesis is that measures of FAK content can be made 
specifically in these distinct regions without contribution from neighbouring cells.  
Therefore, this study aimed to make the first investigations of FAK in elderly skeletal 
muscle fibres and within the skeletal muscle microvascular endothelium in response to RT. 
The methods developed in chapter 2 of this thesis were used to test the hypothesis that 12 
weeks of progressive RT would increase FAK content in the (sub)sarcolemmal and 
sarcoplasmic regions of skeletal muscle fibres and within the microvascular endothelium in 
previously untrained healthy elderly humans and that this would occur alongside hypertrophy 
of type II fibres and increases in skeletal muscle strength 
 
5.2. Methods 
Participants 
Ten healthy elderly males (mean ± SEM; 73 ± 2 y; BMI 26.6 ± 1.3) participated in a 12 week 
RT programme after providing written informed consent. The study was performed according 
to the Declaration of Helsinki and was approved by the Medical Ethics Committee of the 
Academic Hospital, Maastricht. The study formed part of a larger project investigating the 
clinical benefits of exercise intervention in the elderly as described in detail elsewhere 
(Verdijk et al., 2009b).  
 
Study design  
The participants were enrolled in the RT programme subject to health screening with 
anthropometric measurements (height, body mass) and maximal strength and dual energy x-
ray absorptiometry (DEXA) recorded pre- and post-intervention. Blood samples were 
collected before the training intervention began and 4 days after the final post-intervention 
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strength assessment for the measurement of plasma glucose and insulin concentrations as 
described (Verdijk et al., 2009b).  Resting, fasted percutaneous needle biopsies were 
collected from the m. vastus lateralis of the right leg 3 days before the training intervention 
began and 4 days after the final post-intervention strength assessment. 
 
Strength assessment 
Maximal leg strength was determined using one-repetition maximum (1RM) strength tests on 
leg extension and leg press machines (Technogym, Rotterdam, The Netherlands). Participants 
were familiarised with the proper lifting technique during an initial familiarisation trial and 
their 1RM estimated using the multiple repetitions testing procedure (Mayhew et al., 1995). 
At a later date, participants returned for the final pre-training assessment of their 1RM. 
Subsequent 1RM tests were performed at 4 and 8 weeks of the intervention and 2 days after 
completion of their final RT session.  
 
Resistance-type exercise training intervention 
Participants completed 3 supervised RT sessions per week for 12 weeks comprising 5 min 
warm-up on a cycle ergometer, followed by 4 sets of leg extension and leg press exercise and 
a 5 min cool down on a cycle ergometer. Each training session was performed in the morning 
and at the same time of day. All subjects consumed breakfast 1.5 h before each training 
session and had lunch 2 h after each training bout. The workload was increased from 60% 
1RM (10-15 repetitions per set) to 75% 1RM (8-10 repetitions) on each machine during the 
first 4 weeks. Starting at week 5, the workload increased to 4 sets at 75% - 80% 1RM (8 
repetitions) on each machine. Participants were allowed to rest between sets and exercises for 
between 1.5 and 3 min. The workload intensity was manipulated according to the 1RM tests 
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performed in week 4 and 8 and if the participants could lift more than 8 repetitions in 3 of the 
4 sets.  
 
Immunofluorescence microscopy 
Any visible fat or connective tissue was removed from the muscle samples before being 
embedded in Tissue-Tek (Sakura Finetek, Zoeterwoude, The Netherlands) and immediately 
frozen in liquid nitrogen-cooled isopentane. Five µm thick cryosections were cut at -30°C 
with pre- and post-training sections from a single participant placed on the same room 
temperature uncoated glass slides. The sections were incubated with N-terminal specific anti-
FAK antibody, anti-myosin heavy chain type I (MHC type-I; developed by Dr. Blau; DSHB; 
A4.840c) and anti-dystrophin before incubating with the appropriate secondary antibodies as 
previously described (chapter 2). The anti-dystrophin was used as a marker for the 
sarcolemma as its protein content did not change after 8 and 12 weeks of RT or endurance 
training in human skeletal muscle (Parcell et al., 2009; Woolstenhulme et al., 2006). To 
investigate endothelial FAK content, sections were co-incubated with FITC-conjugated Ulex 
europaeus Agglutinin I (endothelial marker) (Vector Laboratories) as described (chapter 2). 
Cover slips were applied with a mounting solution containing antifade medium.  Background 
fluorescence was assessed using negative controls where the primary antibody was excluded. 
Controls were also performed to detect bleed-through of each fluorophore in the respective 
excitation filters. In all cases the fluorescence signal was abolished.  
 
Image capture and analysis 
FAK was visualised using widefield and confocal immunofluorescence microscopy. 
Widefield images of skeletal muscle fibres and the microvascular endothelium were captured 
using a Nikon E600 microscope with a 40 x NA objective with a SPOT RT KE colour three 
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shot CCD camera (Diagnostic Instruments Inc., MI, USA). Because of the intense FAK 
immunofluorescence intensity in the microvasculature, exposure times were optimised for 
image collection of each region to prevent pixel saturation. DAPI UV (340 – 380 nm), FITC 
(465 – 495 nm) and Texas Red (540 – 580 nm) excitation filters were used to visualise the 
Alexa Fluor 350 (MHC type I), 488 (dystrophin, lectin UEA-I) and 594 fluorophores (FAK). 
Detailed digital images of FAK and dystrophin were captured with an inverted confocal 
microscope (Leica DMIRE2, Leica Microsystems) with a 63 x 1.4 NA oil immersion 
objective.  The 488 nm line of the argon laser excited the Alexa Fluor 488 fluorophore (MHC 
type-I) and the 594 line of the Helium-Neon laser excited the Alexa Fluor 594 fluorophore 
(FAK).  
Image processing was completed using Image-Pro Plus 5.1 (Media Cybernetics, MD, 
USA). Muscle fibre CSA (µm
2
) was determined through an automated method based on 
individual specific threshold settings or, where necessary, by manually tracing along the 
dsytrophin-stained border. Only fibres determined as transversely orientated were included in 
the CSA analysis if the fibre roundness factor was <1.639 (roundness = perimeter
2/4πarea 
where a perfect circle = 1.0, pentagon = 1.163, square = 1.266 and equilateral triangle = 
0.639) (Kosek et al, 2006). A total of (mean ± SD) 93 ± 39 and 87 ± 37 pre- and post-RT 
transversely orientated muscle fibres were analysed per individual for CSA.  
For quantitation of FAK (sub)sarcolemmal immunofluorescence intensity, 10 - 15 
widefield images were captured across 3 sections for pre- and post-RT and a total of (mean ± 
SD) 54 ± 16 and 52 ± 21 pre- and post-RT transversely orientated muscle fibres were 
analysed as before (chapter 2). All longitudinally orientated muscle fibres were excluded 
from quantitation. Fibre-type specific (sub)sarcolemmal FAK immunoreactivity was not 
measured, therefore the muscle fibres captured with widefield microscopy were pooled and 
the mean FAK (sub)sarcolemmal immunofluorescence intensity determined. The same 
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images were used to quantitate the sarcoplasmic FAK immunofluorescence intensity of 
complete type I and type II transversely orientated skeletal muscle fibres. Endothelial FAK 
immunofluorescence intensity was quantitated from a total of 256 ± 40 and 296 ± 60 
microvessels pre- and post-RT.    
 
Statistical analysis 
Pre- and post-training data were analysed using a paired t-test (SPSS for Windows version 
17; Chicago, IL). To investigate changes in muscle fibre CSA, a two way analysis of variance 
was performed with time (pre vs post) and fibre type (type I vs type II) as within subject 
factors. Where a significant effect was found, a paired t-test was used to identify the effect of 
time on fibre-type CSA and/or differences between fibre types at pre- and post-RT. Data are 
presented as mean ± SEM and statistical significance was set at P ≤ 0.05.  
 
3.3. Results 
Participant characteristics 
Participant characteristics are displayed in table 3.1. There was no change in fasting glucose 
homeostasis (fasting glucose, insulin, HbA1c and HOMA) with RT. Percent body fat and fat 
mass decreased with RT by  4.3 ± 1.3% and 4.5 ± 1.3%, respectively (P < 0.01) without 
change in total lean mass. Leg strength was significantly increased after 12 weeks RT. Leg 
extension 1RM increased by 29 ± 3 % from 85 ± 5 kg to 110 ± 6 kg (P < 0.001) and leg press 
1RM strength increased by 23 ± 3% from 166 ± 9 kg to 202 ± 9 kg, respectively (P < 0.001).  
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Table 3.1 Participant characteristics  
     
Characteristic Pre Post 
 
Age (y)          72.2 ± 2  
Body mass (kg) 76.9 ± 3.6 76.7 ± 3.6 
Height (m)   1.70 ± 0.01   1.70 ± 0.01 
BMI (kg/m
2
) 26.5 ± 1.1 26.4 ± 1.1 
Fasting glucose (mmol/L)   5.7 ± 0.2   5.6 ± 0.1 
Fasting insulin (µIU/mL) 11.1 ± 1.8 11.1 ± 1.5 
HOMA Index   2.9 ± 0.4   2.8 ± 0.4 
HbA1c (%)   5.8 ± 0.1   5.8 ± 0.1 
Body fat (%) 22.4 ± 2.6     21.6 ± 2.7  * 
Lean mass (kg) 55.9 ± 1.5 56.4 ± 1.6 
Fat mass (kg) 18.0 ± 2.8     17.2 ± 2.7  * 
1RM LE (kg) 85 ± 5   110 ± 6  * 
1RM LP (kg) 166 ± 9     202 ± 9  * 
      
Data are mean ± SEM. BMI, body mass index; HOMA, homeostatic model assessment; 
1RM, one repetition maximum; LE, leg extension; LP, leg press; * Significantly different to 
pre-training. 
 
 
Muscle fibre CSA  
A significant interaction for ‘time x fibre type’ was observed (P < 0.01) with pre-RT type II 
muscle fibre CSA significantly smaller than type I fibre CSA (5920 ± 305 type I vs 4678 ± 
333 µm
2
 type II fibres) (P < 0.01). After RT, there was no change in type I fibre CSA, but the 
mean type II fibre CSA increased by 24 ± 9% from 4678 ± 333 to 5654 ± 359 µm
2
 (P < 
0.01). This abolished the fibre type difference in CSA (5709 ± 359 type I vs 5654 ± 359 µm
2
 
type II fibres) (figure 3.1).  
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Figure 3.1. Mean type I and type II elderly skeletal muscle fibre cross sectional area 
(CSA) pre- and post-resistance-type exercise training. Data are mean ± SEM. * 
Significantly different compared with type I fibres; # Significantly different compared with 
pre-resistance type training (P < 0.01).  
 
Immunofluorescence  
FAK immunolabeling appeared strongest at the (sub)sarcolemmal regions of skeletal muscle 
fibres. The FAK (sub)sarcolemmal immunofluorescence intensity increased 27 ± 7% after 12 
weeks RT (figure 3.2) (P < 0.01). Higher magnification confocal immunofluorescence 
microscopy images suggests an increased (sub)sarcolemmal FAK immunofluorescence 
intensity in type I and type II skeletal muscle fibres (figure 3.3). There was no fibre type 
difference in sarcoplasmic FAK content pre- and post-RT (P > 0.05). However, there was a 
significant effect of time (P = 0.001) where mean type II fibre sarcoplasmic FAK content 
increased by 40 ± 13% (P < 0.01) after RT with a trend for type I fibre sarcoplasmic FAK 
content to increase after RT (16 ± 6.5%; P = 0.057) (figure 3.4). Lectin UEA-I successfully 
identified the endothelium in 7 of the 10 individuals, therefore, FAK immunofluorescence 
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intensity in the microvascular endothelial layer is presented for 7 people pre- and post-
training. The FAK immunofluorescence intensity was strong in the skeletal muscle 
microvasculature both before and after RT and increased 24 ± 8% in the endothelial layer 
after RT (P < 0.05) (figure 3.5).  
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Figure 3.2. Effect of 12 weeks resistance-type exercise training on (sub)sarcolemmal 
focal adhesion kinase (FAK) in the skeletal muscle fibres of elderly humans. A) Mean of 
the post-RT (sub)sarcolemmal FAK immunofluorescence intensity expressed as fold-change 
compared to pre-training. Mean ± SEM (n=10). * Significant effect of training (P < 0.01). B) 
Representative widefield immunofluorescence microscopy images of pre- (above) and post- 
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(below) intervention skeletal muscle visualising FAK (left; red) and dystrophin (right; green). 
Note the more intense FAK immunoreactivity at the (sub)sarcolemma post-intervention. Bars 
are 50 µm. 
 
 
 
 
Figure 3.3. Effect of 12 weeks resistance-type exercise training on (sub)sarcolemmal 
focal adhesion kinase (FAK) in the skeletal muscle fibres of elderly humans. 
Representative higher magnification confocal microscopy images of FAK (left; red) and 
myosin heavy chain type I (MHC type-I; right; green) using 8 x zoom. Note a more intense 
FAK immunoreactivity at the sarcolemma of a type II (small arrowhead) compared with type 
I fibre (large arrows). Bars are 10 µm.  
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Figure 3.4. Effect of 12 weeks resistance-type exercise training on the sarcoplasmic 
protein content of focal adhesion kinase (FAK) within the type I and type II skeletal 
muscle fibres of elderly humans. Mean of the post-RT sarcoplasmic FAK 
immunofluorescence intensity expressed as fold-change compared to pre-training. Mean ± 
SEM (n=10). # Significantly different from pre-training (P < 0.01). 
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Figure 3.5. Effect of 12 weeks resistance-type exercise training on focal adhesion kinase 
(FAK) in the microvascular endothelium of elderly human skeletal muscle. A) Mean 
post-RT FAK immunofluorescence intensity expressed as fold-change of pre-RT. Mean ± 
SEM (n=7). * Significant effect of training (P < 0.05). B) Representative pre- (above) and 
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post- (below) intervention widefield immunofluorescence microscopy images visualising 
FAK (left; red) in the skeletal muscle microvascular endothelium (right; green). Microvessels 
were visualised using Ulex Europaeus-FITC conjugated lectin (Lectin UEA-I). Note the more 
intense FAK immunoreactivity within the endothelium of post-intervention skeletal muscle 
(arrows). Bars are 50 µm.      
 
3.4. Discussion 
This is the first study to investigate FAK responses to 12 weeks RT in the skeletal muscle 
fibres and microvascular endothelium of previously untrained elderly humans. The novel 
findings are that FAK immunofluorescence intensity was significantly increased in the 
(sub)sarcolemmal areas of the muscle fibre. There were no fibre type differences in 
sarcoplasmic FAK content pre- or post-RT, but RT increased type II fibre sarcoplasmic FAK 
content with a trend to increase in type I fibres. FAK immunofluorescence intensity also 
increased in the skeletal muscle microvascular endothelium following RT in previously 
untrained elderly men.  The present study also demonstrates that 12 weeks RT increased 
skeletal muscle strength and stimulated hypertrophy specifically of the type II muscle fibres. 
These findings are in agreement with the most recent literature (Narici et al., 2011) showing a 
positive association between the increase in FAK content and the increase in muscle 
thickness. This suggests the increased FAK content at the (sub)sarcolemma and sarcoplasm 
plays a role in the mechanism leading to skeletal muscle fibre hypertrophy. These data 
confirm the usefulness of the recently developed immunofluorescence microscopy methods 
(chapter 2) for quantitating exercise-training associated changes in the protein content of 
human focal adhesion-associated proteins.  
The ACSM recommend RT as an effective strategy for increasing skeletal muscle 
strength and stimulating type II muscle fibre hypertrophy in elderly individuals (Chodzko-
122 
 
Zajko et al., 2009). In the present study, 1RM leg strength increased after 12 weeks RT (table 
3.1). As expected, baseline type II fibre CSA was significantly smaller than type I fibres in 
line with observations made previously (Andersen, 2003; Charette et al., 1991; Dreyer et al., 
2006; Essen-Gustavsson and Borges, 1986; Klitgaard et al., 1990; Kosek et al., 2006; Larsson 
et al., 1978; Lexell, 1995; Lexell and Downham, 1992; Lexell et al., 1986; Lexell et al., 1988; 
Orlander et al., 1978; Verdijk et al., 2007), but this difference was abolished post-training as 
type II fibre CSA increased without change in type I fibres CSA (figure 3.1).  
The increased (sub)sarcolemmal FAK content after RT (figure 3.2 and 3.3) suggests a 
remodelling of the costamere in response to the high forces generated by the contracting 
sarcomeres during high intensity RT. A remodelling of costamere-associated proteins in 
response to RT has been reported (Kosek and Bamman, 2008). A novel aspect of this study 
was to investigate the fibre type specific response of FAK to RT. In confirmation of chapter 2 
of this thesis, there were no fibre type differences in sarcoplasmic FAK protein content pre- 
or post-RT (figure 3.4). However, there was a type II fibre-specific increase in sarcoplasmic 
FAK content (with a trend to increase in type I fibres) after RT. This is in line with the type II 
fibre-specific increase in CSA and may be important in the hypertrophic response of type II 
skeletal muscle fibres to RT.  
The present study’s findings are consistent with and expand upon earlier studies that 
reported an increased FAK protein concentration in mechanically-overloaded animal skeletal 
muscle (Fluck et al., 1999). During the preparation of this chapter, Narici et al, (2011) and 
Flueck et al, (2011) published data investigating the effects of 12 weeks of skiing training on 
FAK protein content in the skeletal muscle of elderly individuals as measured using Western 
blot analyses (Flueck et al., 2011; Narici et al., 2011). Although the training intervention used in 
the latter studies differed to the present study, it is notable that muscle loading via both skiing training 
(Flueck et al., 2011; Narici et al., 2011) and RT (in the present study) increased the FAK protein 
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content in the skeletal muscle of elderly humans. Narici et al, (2011) recently reported the 
positive correlation between an increased FAK content and increased muscle thickness after 
skiing training. Furthermore, in rat cardiomyocytes, load-induced increases in FAK protein 
content and hypertrophy of the left ventricle was prevented and reversed by FAK inhibition 
in vivo (Clemente et al., 2007) with similar findings observed for left ventricle wall thickness 
after cardiomyocyte-specific gene deletion (DiMichele et al., 2006). These studies suggest 
that the increased FAK protein content at the (sub)sarcolemma and sarcoplasm may play an 
important role in the mechanism leading to the type II fibre-specific hypertrophy observed in 
the present study (figure 3.1).   
 The microvascular endothelium is exposed to a variety of mechanical and 
hemodynamic forces (Davies and Tripathi, 1993) and fluid shear stress is transmitted 
between the luminal glycocalyx and the abluminal focal adhesions by the cytoskeleton 
(Weinbaum et al., 2007). Fluid shear stress phosphorylates and activates FAK leading to its 
translocation to focal adhesions (Li et al., 2002; Li et al., 1997; Mattiussi et al., 2006). The 
latter leads to increased FAK-mediated mechanotransduction, but an increase in FAK protein 
content as observed in the present study (figure 3.5), may also contribute to the increased 
adhesion strength of endothelial cells to the extracellular matrix in response to the increased 
hemodynamic and mechanical forces that are applied to the endothelium during exercise 
(Balaban et al., 2001; Fabry et al., 2011; Riveline et al., 2001). Activation of FAK by 
hemodynamic forces also stimulates mechanotransduction pathways that regulate vascular 
function such as FMD. FAK has been shown to regulate shear stress-activated FMD of 
coronary arterioles through endothelial nitric oxide synthase (eNOS) phosphorylation 
(Koshida et al., 2005) and inhibition of FAK phosphorylation blocked shear-stimulated eNOS 
phosphorylation and FMD (Koshida et al., 2005). Alterations in the protein content and/ or 
activity of FAK with age (Rice et al., 2007) may contribute to the impaired FMD of arterioles 
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in rat skeletal muscle (Delp et al., 2008; Muller-Delp et al., 2002) and in the larger blood 
vessels of elderly humans (Celermajer et al., 1994; Donato et al., 2007; Eskurza et al., 2004). 
RT can increase plasma nitric oxide concentration (Maeda et al., 2006), basal limb blood 
flow and vascular conductance in elderly individuals (Anton et al., 2006; Miyachi et al., 
2005; Phillips et al., 2012) and the increased FAK content within the microvascular 
endothelium after RT may be an important mechanism.  
The time course for increased FAK protein content in response to exercise training in 
humans has not been investigated. In animals, loading rapidly increased FAK protein content 
upto 8 days of overload of the rat m. soleus, but returned to baseline after 13 days of stretch 
overload in the avian anterior latissimus dorsi (Fluck et al., 1999; Gordon et al., 2001). 
Muscle biopsies were only collected prior to training commencement and 4 days following training 
cessation.  Therefore, although the increase in FAK lasts for at least 4 days after the last training bout, 
it cannot be confirmed whether the increased FAK protein content observed in the present study 
represents an early adaptation to loading.  
In conclusion, this is the first study to report an increased FAK protein content in 
human skeletal muscle after 12 weeks RT in previously sedentary elderly men. 
Immunofluorescence microscopy enabled the identification and quantitation of the content of 
this focal adhesion-associated protein in specific regions of the skeletal muscle, specifically 
the (sub)sarcolemmal and sarcoplasmic regions of skeletal muscle fibres and within the 
skeletal muscle microvascular endothelium. FAK immunofluorescence intensity increased in 
both regions which suggests alterations in costameric and sarcoplasmic FAK content and a 
remodelling of endothelial focal adhesions in response to the higher overall mechanical load 
during RT compared with normal daily living tasks. The increased (sub)sarcolemmal and 
sarcoplasmic FAK content accompanied type II fibre-specific hypertrophy and increased 
muscle strength after RT. This study contributes to the growing literature implicating FAK in 
load-induced muscular adaptation. 
125 
 
3.6 Acknowledgements 
The antibodies against human slow myosin (A4.840-c) used in the study were developed by 
Dr. Blau and were obtained from the Developmental Studies Hybridoma Bank developed 
under the auspices of the NICHD and maintained by The University of Iowa, Department of 
Biological Sciences, Iowa City, IA 52242.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
126 
 
3.7. References 
Andersen, J.L. (2003). Muscle fibre type adaptation in the elderly human muscle. Scand J 
Med Sci Sports 13, 40-47. 
 
Anton, M.M., Cortez-Cooper, M.Y., DeVan, A.E., Neidre, D.B., Cook, J.N., and Tanaka, H. 
(2006). Resistance training increases basal limb blood flow and vascular conductance in 
aging humans. J Appl Physiol 101, 1351-1355. 
 
Balaban, N.Q., Schwarz, U.S., Riveline, D., Goichberg, P., Tzur, G., Sabanay, I., Mahalu, D., 
Safran, S., Bershadsky, A., Addadi, L., et al. (2001). Force and focal adhesion assembly: a 
close relationship studied using elastic micropatterned substrates. Nature cell biology 3, 466-
472. 
 
Celermajer, D.S., Sorensen, K.E., Spiegelhalter, D.J., Georgakopoulos, D., Robinson, J., and 
Deanfield, J.E. (1994). Aging is associated with endothelial dysfunction in healthy men years 
before the age-related decline in women. Journal of the American College of Cardiology 24, 
471-476. 
 
Charette, S.L., McEvoy, L., Pyka, G., Snow-Harter, C., Guido, D., Wiswell, R.A., and 
Marcus, R. (1991). Muscle hypertrophy response to resistance training in older women. J 
Appl Physiol 70, 1912-1916. 
 
Chodzko-Zajko, W.J., Proctor, D.N., Fiatarone Singh, M.A., Minson, C.T., Nigg, C.R., 
Salem, G.J., and Skinner, J.S. (2009). American College of Sports Medicine position stand. 
Exercise and physical activity for older adults. Medicine and science in sports and exercise 
41, 1510-1530. 
 
Clark, B.C., and Manini, T.M. (2008). Sarcopenia =/= dynapenia. The journals of 
gerontology Series A, Biological sciences and medical sciences 63, 829-834. 
 
Clemente, C.F., Tornatore, T.F., Theizen, T.H., Deckmann, A.C., Pereira, T.C., Lopes-
Cendes, I., Souza, J.R., and Franchini, K.G. (2007). Targeting focal adhesion kinase with 
small interfering RNA prevents and reverses load-induced cardiac hypertrophy in mice. Circ 
Res 101, 1339-1348. 
 
Davies, P.F., and Tripathi, S.C. (1993). Mechanical stress mechanisms and the cell. An 
endothelial paradigm. Circ Res 72, 239-245. 
 
Delp, M.D., Behnke, B.J., Spier, S.A., Wu, G., and Muller-Delp, J.M. (2008). Ageing 
diminishes endothelium-dependent vasodilatation and tetrahydrobiopterin content in rat 
skeletal muscle arterioles. J Physiol 586, 1161-1168. 
 
DiMichele, L.A., Doherty, J.T., Rojas, M., Beggs, H.E., Reichardt, L.F., Mack, C.P., and 
Taylor, J.M. (2006). Myocyte-restricted focal adhesion kinase deletion attenuates pressure 
overload-induced hypertrophy. Circ Res 99, 636-645. 
 
Doherty, T.J. (2003). Invited review: Aging and sarcopenia. J Appl Physiol 95, 1717-1727. 
 
127 
 
Donato, A.J., Eskurza, I., Silver, A.E., Levy, A.S., Pierce, G.L., Gates, P.E., and Seals, D.R. 
(2007). Direct evidence of endothelial oxidative stress with aging in humans: relation to 
impaired endothelium-dependent dilation and upregulation of nuclear factor-kappaB. Circ 
Res 100, 1659-1666. 
 
Dreyer, H.C., Blanco, C.E., Sattler, F.R., Schroeder, E.T., and Wiswell, R.A. (2006). Satellite 
cell numbers in young and older men 24 hours after eccentric exercise. Muscle & nerve 33, 
242-253. 
 
Ervasti, J.M. (2003). Costameres: the Achilles' heel of Herculean muscle. J Biol Chem 278, 
13591-13594. 
 
Eskurza, I., Monahan, K.D., Robinson, J.A., and Seals, D.R. (2004). Effect of acute and 
chronic ascorbic acid on flow-mediated dilatation with sedentary and physically active 
human ageing. J Physiol 556, 315-324. 
 
Essen-Gustavsson, B., and Borges, O. (1986). Histochemical and metabolic characteristics of 
human skeletal muscle in relation to age. Acta Physiol Scand 126, 107-114. 
 
Fabry, B., Klemm, A.H., Kienle, S., Schaffer, T.E., and Goldmann, W.H. (2011). Focal 
adhesion kinase stabilizes the cytoskeleton. Biophys J 101, 2131-2138. 
 
Fiatarone, M.A., Marks, E.C., Ryan, N.D., Meredith, C.N., Lipsitz, L.A., and Evans, W.J. 
(1990). High-intensity strength training in nonagenarians. Effects on skeletal muscle. JAMA : 
the journal of the American Medical Association 263, 3029-3034. 
 
Fluck, M., Carson, J.A., Gordon, S.E., Ziemiecki, A., and Booth, F.W. (1999). Focal 
adhesion proteins FAK and paxillin increase in hypertrophied skeletal muscle. Am J Physiol 
277, C152-162. 
 
Flueck, M., Eyeang-Bekale, N., Heraud, A., Girard, A., Gimpl, M., Seynnes, O.R., Rittweger, 
J., Niebauer, J., Mueller, E., and Narici, M. (2011). Load-sensitive adhesion factor expression 
in the elderly with skiing: relation to fiber type and muscle strength. Scand J Med Sci Sports 
21 Suppl 1, 29-38. 
 
Frontera, W.R., Meredith, C.N., O'Reilly, K.P., Knuttgen, H.G., and Evans, W.J. (1988). 
Strength conditioning in older men: skeletal muscle hypertrophy and improved function. J 
Appl Physiol 64, 1038-1044. 
 
Gordon, S.E., Fluck, M., and Booth, F.W. (2001). Selected Contribution: Skeletal muscle 
focal adhesion kinase, paxillin, and serum response factor are loading dependent. J Appl 
Physiol 90, 1174-1183; discussion 1165. 
 
Haskell, W.L., Lee, I.M., Pate, R.R., Powell, K.E., Blair, S.N., Franklin, B.A., Macera, C.A., 
Heath, G.W., Thompson, P.D., and Bauman, A. (2007). Physical activity and public health: 
updated recommendation for adults from the American College of Sports Medicine and the 
American Heart Association. Medicine and science in sports and exercise 39, 1423-1434. 
 
Janssen, I. (2006). Influence of sarcopenia on the development of physical disability: the 
Cardiovascular Health Study. Journal of the American Geriatrics Society 54, 56-62. 
128 
 
Janssen, I. (2010). Evolution of sarcopenia research. Applied physiology, nutrition, and 
metabolism = Physiologie appliquee, nutrition et metabolisme 35, 707-712. 
 
Janssen, I., Heymsfield, S.B., and Ross, R. (2002). Low relative skeletal muscle mass 
(sarcopenia) in older persons is associated with functional impairment and physical disability. 
Journal of the American Geriatrics Society 50, 889-896. 
 
Klitgaard, H., Zhou, M., Schiaffino, S., Betto, R., Salviati, G., and Saltin, B. (1990). Ageing 
alters the myosin heavy chain composition of single fibres from human skeletal muscle. Acta 
Physiol Scand 140, 55-62. 
 
Klossner, S., Durieux, A.C., Freyssenet, D., and Flueck, M. (2009). Mechano-transduction to 
muscle protein synthesis is modulated by FAK. Eur J Appl Physiol 106, 389-398. 
 
Kosek, D.J., and Bamman, M.M. (2008). Modulation of the dystrophin-associated protein 
complex in response to resistance training in young and older men. J Appl Physiol 104, 1476-
1484. 
 
Kosek, D.J., Kim, J.S., Petrella, J.K., Cross, J.M., and Bamman, M.M. (2006). Efficacy of 3 
days/wk resistance training on myofiber hypertrophy and myogenic mechanisms in young vs. 
older adults. J Appl Physiol 101, 531-544. 
 
Koshida, R., Rocic, P., Saito, S., Kiyooka, T., Zhang, C., and Chilian, W.M. (2005). Role of 
focal adhesion kinase in flow-induced dilation of coronary arterioles. Arteriosclerosis, 
thrombosis, and vascular biology 25, 2548-2553. 
 
Larsson, L., Sjodin, B., and Karlsson, J. (1978). Histochemical and biochemical changes in 
human skeletal muscle with age in sedentary males, age 22--65 years. Acta Physiol Scand 
103, 31-39. 
 
Lexell, J. (1995). Human aging, muscle mass, and fiber type composition. The journals of 
gerontology Series A, Biological sciences and medical sciences 50 Spec No, 11-16. 
 
Lexell, J., and Downham, D. (1992). What is the effect of ageing on type 2 muscle fibres? 
Journal of the neurological sciences 107, 250-251. 
 
Lexell, J., Downham, D., and Sjostrom, M. (1986). Distribution of different fibre types in 
human skeletal muscles. Fibre type arrangement in m. vastus lateralis from three groups of 
healthy men between 15 and 83 years. Journal of the neurological sciences 72, 211-222. 
 
Lexell, J., Downham, D.Y., Larsson, Y., Bruhn, E., and Morsing, B. (1995). Heavy-resistance 
training in older Scandinavian men and women: short- and long-term effects on arm and leg 
muscles. Scand J Med Sci Sports 5, 329-341. 
 
Lexell, J., Taylor, C.C., and Sjostrom, M. (1988). What is the cause of the ageing atrophy? 
Total number, size and proportion of different fiber types studied in whole vastus lateralis 
muscle from 15- to 83-year-old men. Journal of the neurological sciences 84, 275-294. 
 
129 
 
Li, S., Butler, P., Wang, Y., Hu, Y., Han, D.C., Usami, S., Guan, J.L., and Chien, S. (2002). 
The role of the dynamics of focal adhesion kinase in the mechanotaxis of endothelial cells. 
Proc Natl Acad Sci U S A 99, 3546-3551. 
 
Li, S., Kim, M., Hu, Y.L., Jalali, S., Schlaepfer, D.D., Hunter, T., Chien, S., and Shyy, J.Y. 
(1997). Fluid shear stress activation of focal adhesion kinase. Linking to mitogen-activated 
protein kinases. J Biol Chem 272, 30455-30462. 
 
Maeda, S., Otsuki, T., Iemitsu, M., Kamioka, M., Sugawara, J., Kuno, S., Ajisaka, R., and 
Tanaka, H. (2006). Effects of leg resistance training on arterial function in older men. British 
journal of sports medicine 40, 867-869. 
 
Mattiussi, S., Matsumoto, K., Illi, B., Martelli, F., Capogrossi, M.C., and Gaetano, C. (2006). 
Papilloma protein E6 abrogates shear stress-dependent survival in human endothelial cells: 
evidence for specialized functions of paxillin. Cardiovasc Res 70, 578-588. 
 
Mayhew, J.L., Prinster, J.L., Ware, J.S., Zimmer, D.L., Arabas, J.R., and Bemben, M.G. 
(1995). Muscular endurance repetitions to predict bench press strength in men of different 
training levels. The Journal of sports medicine and physical fitness 35, 108-113. 
 
Miyachi, M., Tanaka, H., Kawano, H., Okajima, M., and Tabata, I. (2005). Lack of age-
related decreases in basal whole leg blood flow in resistance-trained men. J Appl Physiol 99, 
1384-1390. 
 
Muller-Delp, J.M., Spier, S.A., Ramsey, M.W., and Delp, M.D. (2002). Aging impairs 
endothelium-dependent vasodilation in rat skeletal muscle arterioles. Am J Physiol Heart Circ 
Physiol 283, H1662-1672. 
 
Narici, M.V., Flueck, M., Koesters, A., Gimpl, M., Reifberger, A., Seynnes, O.R., Niebauer, 
J., Rittweger, J., and Mueller, E. (2011). Skeletal muscle remodeling in response to alpine 
skiing training in older individuals. Scand J Med Sci Sports 21 Suppl 1, 23-28. 
 
Orlander, J., Kiessling, K.H., Larsson, L., Karlsson, J., and Aniansson, A. (1978). Skeletal 
muscle metabolism and ultrastructure in relation to age in sedentary men. Acta Physiol Scand 
104, 249-261. 
 
Parcell, A.C., Woolstenhulme, M.T., and Sawyer, R.D. (2009). Structural protein alterations 
to resistance and endurance cycling exercise training. Journal of strength and conditioning 
research / National Strength & Conditioning Association 23, 359-365. 
 
Pardo, J.V., Siliciano, J.D., and Craig, S.W. (1983). A vinculin-containing cortical lattice in 
skeletal muscle: transverse lattice elements ("costameres") mark sites of attachment between 
myofibrils and sarcolemma. Proc Natl Acad Sci U S A 80, 1008-1012. 
 
Phillips, B., Williams, J., Atherton, P., Smith, K., Hildebrandt, W., Rankin, D., Greenhaff, P., 
Macdonald, I., and Rennie, M.J. (2012). Resistance exercise training improves age-related 
declines in leg vascular conductance and rejuvenates acute leg blood flow responses to 
feeding and exercise. J Appl Physiol 112, 347-353. 
 
130 
 
Rice, K.M., Desai, D.H., Kinnard, R.S., Harris, R., Wright, G.L., and Blough, E.R. (2007). 
Load-induced focal adhesion mechanotransduction is altered with aging in the Fischer 
344/NNiaHSd x Brown Norway/BiNia rat aorta. Biogerontology 8, 257-267. 
 
Riveline, D., Zamir, E., Balaban, N.Q., Schwarz, U.S., Ishizaki, T., Narumiya, S., Kam, Z., 
Geiger, B., and Bershadsky, A.D. (2001). Focal contacts as mechanosensors: externally 
applied local mechanical force induces growth of focal contacts by an mDia1-dependent and 
ROCK-independent mechanism. J Cell Biol 153, 1175-1186. 
 
Roe, B., Howell, F., Riniotis, K., Beech, R., Crome, P., and Ong, B.N. (2009). Older people 
and falls: health status, quality of life, lifestyle, care networks, prevention and views on 
service use following a recent fall. Journal of clinical nursing 18, 2261-2272. 
Rosenberg, I.R. (1989). Summary comments. Am J Clin Nutr 50. 
 
Ruiz, J.R., Sui, X., Lobelo, F., Morrow, J.R., Jr., Jackson, A.W., Sjostrom, M., and Blair, 
S.N. (2008). Association between muscular strength and mortality in men: prospective cohort 
study. Bmj 337, a439. 
 
Seals, D.R., Jablonski, K.L., and Donato, A.J. (2011). Aging and vascular endothelial 
function in humans. Clinical science 120, 357-375. 
 
Tinetti, M.E., and Williams, C.S. (1998). The effect of falls and fall injuries on functioning in 
community-dwelling older persons. The journals of gerontology Series A, Biological sciences 
and medical sciences 53, M112-119. 
 
Verdijk, L.B., Gleeson, B.G., Jonkers, R.A., Meijer, K., Savelberg, H.H., Dendale, P., and 
van Loon, L.J. (2009a). Skeletal muscle hypertrophy following resistance training is 
accompanied by a fiber type-specific increase in satellite cell content in elderly men. The 
journals of gerontology Series A, Biological sciences and medical sciences 64, 332-339. 
 
Verdijk, L.B., Jonkers, R.A., Gleeson, B.G., Beelen, M., Meijer, K., Savelberg, H.H., 
Wodzig, W.K., Dendale, P., and van Loon, L.J. (2009b). Protein supplementation before and 
after exercise does not further augment skeletal muscle hypertrophy after resistance training 
in elderly men. Am J Clin Nutr 89, 608-616. 
 
Verdijk, L.B., Koopman, R., Schaart, G., Meijer, K., Savelberg, H.H., and van Loon, L.J. 
(2007). Satellite cell content is specifically reduced in type II skeletal muscle fibers in the 
elderly. Am J Physiol Endocrinol Metab 292, E151-157. 
 
Weinbaum, S., Tarbell, J.M., and Damiano, E.R. (2007). The structure and function of the 
endothelial glycocalyx layer. Annual review of biomedical engineering 9, 121-167. 
 
Wilkinson, S.B., Phillips, S.M., Atherton, P.J., Patel, R., Yarasheski, K.E., Tarnopolsky, 
M.A., and Rennie, M.J. (2008). Differential effects of resistance and endurance exercise in 
the fed state on signalling molecule phosphorylation and protein synthesis in human muscle. J 
Physiol 586, 3701-3717. 
 
Woolstenhulme, M.T., Conlee, R.K., Drummond, M.J., Stites, A.W., and Parcell, A.C. 
(2006). Temporal response of desmin and dystrophin proteins to progressive resistance 
exercise in human skeletal muscle. J Appl Physiol 100, 1876-1882. 
131 
 
 Chapter 4 
 
 
Paxillin colocalises with focal adhesion 
kinase in human skeletal muscle and its 
associated microvasculature 
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4.1. Abstract 
Focal adhesion kinase (FAK) and paxillin are sensitive to hormonal and mechanical stimuli 
and evidence suggests these proteins are functionally linked. We aimed to describe the 
localisation of paxillin and test the hypothesis that FAK and paxillin colocalise in human 
skeletal muscle and its associated microvasculature.   
Percutaneous muscle biopsies were collected from the m. vastus lateralis of 7 healthy 
males and 5µm cryosections were stained with anti-paxillin and co-incubated with anti-
dystrophin to identify the plasma membrane, anti-myosin heavy chain type I for fibre-type 
differentiation, anti-dihydropyridine receptor (DHPR) to identify t-tubules, lectin UEA-I to 
identify the endothelium of capillaries and anti-α-smooth muscle actin to identify vascular 
smooth muscle cells (VSMC).  Colocalisation analysis (Pearson's colocalisation coefficient) 
was performed using confocal fluorescence microscopy.  
Paxillin was primarily localised in (sub)sarcolemmal regions and it colocalised with 
dystrophin (r=0.414±0.026) in skeletal muscle fibres. The (sub)sarcolemmal paxillin 
immunofluorescence intensity was ~2.4-fold higher than in sarcoplasmic regions (P<0.001) 
with sarcoplasmic paxillin immunofluorescence intensity ~10% higher in type I than in type 
II fibres (P<0.01). In some longitudinally orientated fibres, paxillin was distributed in 
uniform striations running across the fibre and these colocalised with DHPR. Paxillin 
immunostaining was highest in endothelial and VSMC and distributed heterogeneously in 
both cell types. FAK and paxillin colocalised at (sub)sarcolemmal regions and within the 
endothelium and VSMC (r=0.367±0.036).   
The first images of paxillin in human skeletal muscle suggest paxillin is localised to 
(sub)sarcolemmal regions of muscle fibres and in the microvascular endothelium and VSMC. 
The spatial colocalisation of FAK and paxillin in these distinct regions supports their 
suggested role in hormonal and mechano-sensitive signalling. 
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4.2. Introduction 
In skeletal muscle, costameres are specialised structures localised to the sarcolemma which 
convert mechanical stimuli into intracellular signalling (mechanotransduction) that activate 
signalling pathways and control gene transcription. Costameres anchor the z-disc of 
peripheral myofibrils to the sarcolemma (Ervasti, 2003; Pardo et al., 1983) and link the basal 
lamina with the actin cytoskeleton through its dystrophin/ glycoprotein complex and integrin-
associated complex. Stimulation of the integrin-associated complex leads to the formation of 
a focal adhesion complex (Fluck et al., 2002). Mechanotransduction occurs through integrin-
mediated signalling pathways, but non-integrin (e.g. hormonal) signalling can also operate 
(Schlaepfer et al., 1999). Focal adhesion kinase (FAK) and paxillin are two hormone- and 
mechano-sensitive proteins (Brown and Turner, 2004; Goldmann, 2012; Schlaepfer et al., 
1999; Turner et al., 1990; Turner et al., 1991) present within costameres (Fluck et al., 1999; 
Fluck et al., 2002; Gordon et al., 2001; Quach and Rando, 2006).  
Mechanical stimulation is associated with the phosphorylation and activation of FAK 
and paxillin in a variety of cell types (Fluck et al., 1999; Lipfert et al., 1992; Shikata et al., 
2005; Tang et al., 1999; Yano et al., 1996), and are events that have been implicated in the 
acute and chronic adaptive response of  animal (Fluck et al., 1999; Gordon et al., 2001; 
Klossner et al., 2009) and human skeletal muscle to increased mechanical loading (Wilkinson 
et al., 2008). The localisation of FAK to integrins is regulated by its N terminal domain and 
it’s C terminal domain contains two binding sites for paxillin (Scheswohl et al., 2008). 
Paxillin’s N-terminus also contains two binding sites for FAK (Brown et al., 1996) and is a 
direct binding partner for FAK (Hildebrand et al., 1995; Turner and Miller, 1994). Integrin-
mediated activation and subsequent binding of FAK to paxillin leads to the phosphorylation 
of paxillin at Tyr
31
 and Tyr
118
 residues (Bellis et al., 1995; Schaller and Parsons, 1995). These 
two paxillin phosphorylation sites are necessary for maximal FAK phosphorylation 
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(Scheswohl et al., 2008), normal FAK function (Hagel et al., 2002) and the maximal 
phosphorylation of downstream signalling proteins (Scheswohl et al., 2008). 
FAK is localised in the (sub)sarcolemmal regions of human (chapter 2) and animal 
skeletal muscle (Fluck et al., 1999; Fluck et al., 2002; Klossner et al., 2009), supporting its 
suggested role in mechanotransduction.  FAK and paxillin protein abundance corresponds 
with  muscle loading, with both FAK and paxillin protein concentration increased after 
chronic stretch-induced hypertrophy/ hyperplasia in rooster anterior latissimus dorsi (Fluck 
et al., 1999) and after 8 days of overload in rat m. soleus (surgical ablation of the 
gastrocnemius) and m. plantaris skeletal muscle (Fluck et al., 1999; Gordon et al., 2001). 
FAK protein content was also increased after 12 weeks resistance-type exercise training 
(chapter 3) and after 12 weeks ski-training in elderly human m. vastus lateralis skeletal 
muscle (Flueck et al., 2011; Narici et al., 2011). The role of FAK-associated signalling in 
training adaptation has not been fully elucidated. However, overexpression of FAK through 
electrogene transfer of a FAK-expressing plasmid has been associated with the increased 
gene expression for proteins associated with the slow oxidative phenotype  (Durieux et al., 
2009). FAK has also been associated with the protein synthesis signalling pathway through 
an Akt-mTOR-independent activation of p70S6K (Klossner et al., 2009).   
In the microvasculature of human skeletal muscle, FAK is highly concentrated in 
endothelial and vascular smooth muscle cells (VSMC) (chapter 2), but little is known about 
paxillin’s spatial distribution in these cells. Both endothelial FAK and paxillin are responsive 
to mechanical (e.g. fluid shear stress) (Li et al., 2002; Li et al., 1997; Mattiussi et al., 2006) 
and hormonal stimuli playing a role in vascular endothelial growth factor-mediated signalling 
(Abedi and Zachary, 1997). They also regulate the motility of endothelial cells (Zaidel-Bar et 
al., 2007). In VSMCs, paxillin is associated with VSMC spreading (Ishida et al., 1999), 
regulating actin cytoskeleton polymerisation and tension development and is sensitive to 
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angiotensin II- and thrombin-mediated stimulation (Brown and Turner, 1999; Ishida et al., 
1999). Collectively, these studies suggest paxillin plays an important role in the maintenance 
of vascular function. 
Paxillin has been visualised previously in the developing costameres of murine 
myoblasts and myotubes using immunofluorescence microscopy (Quach and Rando, 2006). 
However, the localisation and distribution of paxillin in human skeletal muscle and its 
associated microvasculature remain unresolved. Therefore, we aimed to generate the first 
visual images of paxillin and its localisation in human skeletal muscle. As evidence suggests 
FAK and paxillin are functionally linked, we aimed to test the hypothesis that FAK and 
paxillin colocalise in human skeletal muscle and its associated microvasculature.   
 
4.3. Materials and Methods 
Muscle samples 
Before the study commenced, all participants were fully informed of the study demands and 
provided their written informed consent for participation in the study which was approved by 
the local Birmingham East, North and Solihull and West Midlands Black Country NHS 
Research Ethics Committees. Resting percutaneous muscle biopsy samples were obtained 
from the m. vastus lateralis of 7 lean, fasted healthy males (mean ± SD; age 22 ± 4 y; BMI 
23.6 ± 0.9 kg/m
2
). The biopsies were taken using the Bergstrom needle biopsy technique 
(Bergstrom, 1975) adapted with suction (Evans et al., 1982). The muscle samples were 
blotted free of excess blood and any visible fat or connective tissue was discarded. The 
samples were then embedded in Tissue Tek OCT compound (Sakura Finetek Europe, 
Zoeterwoude, The Netherlands) and frozen immediately in liquid-nitrogen cooled isopentane 
(Sigma-Aldrich, Dorset, UK) ready for storage at -80°C. Five µm cryo-sections were cut at -
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30°C and placed on room-temperature, uncoated glass slides (VWR International Ltd, 
Leicestershire, UK).  
 
Antibody specificity and immunofluorescence staining 
All chemicals used in this study were purchased from Sigma-Aldrich (UK) unless otherwise 
stated. The sections were fixed in 3:1 ratio acetone and ethanol for 5 min and washed 3 x 5 
min in phosphate buffered saline (PBS; 137mM sodium chloride, 3 mM potassium chloride, 
8 mM disodium hydrogen phosphate and 3 mM potassium dihydrogen phosphate, pH of 7.4). 
Sections were then incubated for 2 h with 5% Normal Goat Serum and N-terminal specific 
monoclonal anti-paxillin clone 349 targeting amino acids 1 – 557 (BD transduction 
Laboratories, Oxford, UK) which has been used previously to visualise paxillin in murine 
myoblasts (Quach and Rando, 2006). The signal specificity of the paxillin antibody in human 
skeletal muscle was confirmed by western blot (described below) and a peptide competition 
experiment. The primary antibody was pre-incubated for 2 hours at room temperature with a 
10-fold excess concentration of a purified recombinant human paxillin protein (Origene, 
Rockville, USA; cat. no. TP313811). Sections on separate glass slides were incubated for 2 
hours with 1:100 dilution of anti-paxillin or anti-paxillin plus recombinant protein. The 
recombinant protein eliminated the paxillin immunoreactivity in transversely and 
longitudinally orientated muscle fibres.  
Fibre-type differences in sarcoplasmic paxillin content was assessed by co-staining 
muscle sections for 2 hours with 1:100 dilution of anti-paxillin and anti-myosin heavy chain 
type I (MHC type I; developed by Dr. Blau; DSHB; A4.840c) and 1:400 dilution of anti-
dystrophin (Sigma-Aldrich, UK). The MHC type I was specific to slow oxidative type I 
skeletal muscle fibres leaving type II fibres unstained. Anti-dystrophin was used to identify 
the sarcolemma since dystrophin is localised to the sarcoplasmic surface of the sarcolemma 
137 
 
(Davies and Nowak, 2006). The distribution of paxillin throughout longitudinally orientated 
muscle fibres was also investigated using anti-dihydropyridine receptor (DHPR) as in chapter 
2 of this thesis. 
To visualise paxillin within the skeletal muscle microvasculature, muscle sections 
were incubated with lectin FITC-conjugated Ulex europaeus Agglutinin I (Vector 
Laboratories) which identified the endothelium and anti-α-smooth muscle actin (α-SMA; 
Abcam ab7817) which identified the vascular smooth muscle of skeletal muscle arterioles. 
The incubation period was then proceeded by 3 x 5 min wash in PBS and then incubated for 
30 min with the appropriate fluorescently conjugated secondary antibodies including goat 
anti-mouse 488 and 594 IgG1 (paxillin), goat anti-mouse 350 IgM (MHC type I) and 488 
IgG2a (α-SMA) and IgG2b (dystrophin) fluorophores (Invitrogen, UK). The sections then 
underwent a 3 x 5 min wash in PBS and cover slips applied with a mounting solution 
(glycerol and mowiol 4-88 solution in 0.2 M Tris-buffer (pH 8.5) with the addition of 0.1% 
1,4-diazobicyclo-[2,2,2]-octane (DABCO) antifade medium).  To assess background 
fluorescence, negative controls were performed where the primary antibody was excluded. 
Controls were also performed to detect bleed-through of each fluorophore in the respective 
excitation filters. In all cases the fluorescence signal was abolished.  
To investigate colocalisation of paxillin with FAK, cryosections were first incubated 
with the anti-paxillin antibody as mentioned previously and then sections were washed 3 x 5 
min in PBS and the appropriate secondary antibody was applied (mouse 546 or 594 IgG1). 
Thirty minutes after the secondary antibody had been applied, sections were washed 3 x 5 
min in PBS before incubating sections with an anti-FAK antibody (A17, Santa Cruz, USA) 
which has been validated for use in human skeletal muscle using methods previously 
described (chapter 2). Sections were also co-stained with α-SMA as before to investigate 
colocalisation of FAK and paxillin in the smooth muscle. Sections were then washed 3 x 5 
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min in PBS and the appropriate secondary antibodies were applied (goat anti-mouse 594 IgG1 
or 546 IgG1, 633 IgG2a and goat anti-rabbit 488 IgG) before washing and applying the cover 
slips as described. 
 
Image capture and analysis 
Paxillin and FAK were visualised using widefield and confocal fluorescence microscopy. To 
analyse fibre-type differences in sarcoplasmic paxillin content, widefield images were 
captured using a Nikon E600 microscope with a 40 x NA objective with a SPOT RT KE 
colour three shot CCD camera (Diagnostic Instruments Inc., MI, USA). DAPI UV (340 – 380 
nm), FITC (465 – 495 nm) and Texas Red (540 – 580 nm) excitation filters were used to 
visualise the Alexa Fluor 350 (MHC type I), 488 (dystrophin) and 594 fluorophores 
(paxillin). Detailed digital images of the skeletal muscle and microvasculature were captured 
with an inverted confocal microscope (Leica DMIRE2, Leica Microsystems) with a 63 x 1.4 
NA oil immersion objective.  Confocal microscopy images were also used to investigate the 
colocalisation of paxillin with FAK. The Alexa Fluor 488 fluorophore (dystrophin, lectin 
UEA-I, paxillin and FAK) was excited by the 488 nm line of the argon laser and the Alexa 
Fluor 546, 594 (paxillin) and 633 (DHPR; α-SMA) fluorophores were excited by the 543, 
594 and 633 nm line of the Helium-Neon laser, respectively. Images were captured 
sequentially when investigating colocalisation of paxillin with FAK. 
Image processing was completed using Image-Pro Plus 5.1 (Media Cybernetics, MD, 
USA). Two serial sections were cut and placed on the same glass slide and duplicated on a 
second slide. For quantitation of sarcoplasmic paxillin immunoreactivity in type I and type II 
fibres, five regions of interest covering only transversely-orientated muscle fibres were 
captured per muscle section on the widefield microscope. A total of (mean ± SD) 119 ± 36 
transversely orientated muscle fibres were analysed per individual and fibre-type specificity 
139 
 
was determined from the mean fluorescence signal intensity of 46 ± 12 type I and 73 ± 33 
type II individual whole human muscle fibres, respectively. All longitudinally orientated 
muscle fibres were excluded from quantitation. The corresponding dystrophin images which 
identified complete individual muscle fibres were processed using a participant-specific 
intensity threshold to generate an outline of individual muscle fibres. The outline was then 
overlayed onto the raw paxillin image so sarcoplasmic paxillin immunoreactivity could be 
quantitated.      
Confocal microscopy images were used for comparison between the intensity of 
sarcolemmal and sarcoplasmic paxillin immunofluorescence. Duplicate slides were prepared 
and captured as above. The paxillin immunoreactivity at the plasma membrane of individual 
fibres was not measured due to limitations in the resolution of the confocal microscope to 
adequately determine the sarcolemma of one fibre from neighbouring fibres. Therefore, 
muscle fibres captured with confocal microscopy were pooled and the mean paxillin 
immunofluorescence at the plasma membrane surrounding a total of 76 ± 26 transversely 
orientated whole muscle fibres were analysed. Differences in sarcolemmal and sarcoplasmic 
paxillin immunofluorescence were quantified using the dystrophin outline as above.  
 
Colocalisation analysis 
The same images were also used to investigate colocalisation between paxillin and 
dystrophin. Colocalisation analysis was performed on 14 ± 1 whole images per participant 
totalling 246 ± 50 muscle fibres per participant. Colocalisation analysis of FAK with paxillin 
in skeletal muscle and microvessels was performed on a total of 19 ± 2 matched whole 
confocal microscopy images.  
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Western blot 
Western blots were performed as described in chapter 2. In brief, snap frozen muscle tissue 
was powdered in liquid nitrogen using a pestle and mortar and mixed on ice with lysis buffer 
(RIPA buffer; Cell signalling with a complete mini protease inhibitor tablet; Roche 
Diagnostics, Mannheim, Germany) and homogenised with a handheld homogeniser. The 
samples were centrifuged for 20 min at 10,000 g at 4ºC with the supernatant removed for 
protein determination (Pierce BCA assay kit; Pierce, Rockford, IL, USA).  The proteins were 
separated by electrophoresis on 12% SDS polyacrylamide gels (Thermo Scientific, Rockford, 
IL, USA) and transferred to a nitrocellulose membrane. The membrane was incubated 
overnight at 4°C with an anti-paxillin primary antibody (1:2000) and then treated for 1 hour 
to a HRP-conjugated anti-mouse IgG1 secondary antibody (1:20,000). Bands were identified 
using enhanced chemiluminescence HRO detection reagent (GE Healthcare, Amersham, UK) 
and imaged using ChemiDoc XRS+ (Bio-rad, UK).    
 
Statistical analysis 
Mean fluorescence intensity was used as a measure of total paxillin content at the plasma 
membrane and in the sarcoplasm of type I and type II fibre types. Data are expressed as mean 
± SEM and compared using a paired samples t-test (SPSS v15). Colocalisation was assessed 
using Pearson’s correlation coefficient. Significance was set at P < 0.05.  
 
4.4. Results 
Specificity of the paxillin antibody in human skeletal muscle 
Figure 4.1 shows a representative widefield fluorescence microscopy image of paxillin (A) in 
transversely orientated m. vastus lateralis human skeletal muscle fibres co-incubated with 
anti-dystrophin and anti-myosin heavy chain type I. A strong paxillin immunofluorescence 
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signal was detected at peripheral regions of the muscle fibre (A). This signal was abolished 
with control experiments excluding the primary antibody (B) and when anti-paxillin was pre-
incubated with a recombinant human paxillin protein (C). The antibody specificity and 
selectivity was confirmed further by western blot analysis (D) which identified a single band 
at ~68 kDa and this corresponded with paxillin’s molecular weight (Turner et al., 1990). 
These data demonstrate that the paxillin antibody is specific for paxillin in human skeletal 
muscle using both immunofluorescence and western blotting and supports previous reports in 
mouse skeletal muscle fibres (Quach and Rando, 2006).  
 
 
Figure 4.1. Immunofluorescent visualisation of paxillin in human skeletal muscle. A) 
Representative widefield microscopy image of paxillin in transversely orientated human 
skeletal muscle fibres. Sections were co-stained with anti-paxillin (red; left), anti-dystrophin 
(green; DYS) and anti-myosin heavy chain type I (blue; MHC type I) (right). Type II fibres 
were unstained. Paxillin staining exhibited a strong immunofluorescence signal at the 
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periphery of the muscle fibres in both fibre-types (arrows). B) Negative control experiment 
where the paxillin primary antibody was omitted. C) Representative image of paxillin pre-
incubated with a recombinant human paxillin protein which removed the paxillin-positive 
immunoreactivity. D) Western blot of the anti-paxillin antibody using homogenised m. vastus 
lateralis human skeletal muscle. Bars are 50 µm 
 
The intense paxillin immunoreactivity at the periphery of the fibre strongly suggests that 
paxillin is localised in (sub)sarcolemmal regions. Co-staining paxillin with dystrophin (used 
in this study as a marker for the sarcolemma) revealed partial colocalisation (r= 0.414 ± 
0.026) (figure 4.2A, B). Sarcolemmal paxillin staining intensity was 139 ± 16 % higher 
compared with the sarcoplasm (figure 4.2C) (P<0.001).  
Using widefield microscopy images of transversely orientated muscle fibres (figure 
4.3), quantitative image analysis revealed a small (~10%) but significantly greater 
sarcoplasmic paxillin content in type I compared with type II fibres (P<0.01). In some 
longitudinally orientated type I and type II fibres, paxillin was distributed evenly in the form 
of striations spanning the full width of the fibre and running perpendicular to the fibre’s 
direction (figure 4.4A, B, C). Representative confocal microscopy images of paxillin co-incubated 
with a t-tubule marker (DHPR) suggests paxillin colocalises with or is in close proximity to the t-
tubule network (figure 4.4B, C). 
FAK and paxillin interact in a variety of cell types, so we investigated their spatial 
correlation in human skeletal muscle fibres. Using confocal microscopy, representative whole 
images (figure 4A, B) show partial colocalisation between FAK and paxillin as denoted by 
areas of yellow pixels (r = 0.367 ± 0.036) (figure 4C) along the (sub)sarcolemma and in 
regions between the muscle fibres (e.g. the microvessels). These data suggest both proteins 
spatially colocalise at sarcolemmal and microvascular regions in human skeletal muscle.  
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Figure 4.2. Representative higher magnification confocal microscopy images showing 
colocalisation of paxillin with dystrophin. A) Cross-sections of human skeletal muscle 
were co-stained with dystrophin, a marker of the sarcolemma (green; left) and anti-paxillin 
(red; middle). Note that paxillin is localised to the sarcolemma (arrows) and merged images 
(right) show clear colocalisation. Colocalisation coefficient of paxillin and dystrophin are 
presented in the merged images. The mean Pearson’s correlation was calculated from 14 ± 1 
matched whole images. n=7. Bars are 5 µm. Data are mean ± SEM. B) Mean sarcolemmal 
and sarcoplasmic paxillin immunofluorescence of transversely orientated m. vastus lateralis 
human skeletal muscle fibres assessed using confocal microscopy. Data was quantified by 
pooling both fibre types with 76 ± 26 whole muscle fibres per participant analysed, 
respectively. Data are related to the sarcoplasm and are mean ± SEM. n=7. * Denotes 
significant difference (P<0.001). 
A 
B 
144 
 
 
Figure 4.3. Mean sarcoplasmic paxillin immunofluorescence intensity of type I and type 
II human m. vastus lateralis skeletal muscle fibres using widefield microscopy. A total of 
46 ± 12 type I and 73 ± 33 type II fibres were analysed per individual. Data are mean ± SEM. 
* Denotes significant difference (P<0.01).  
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Figure 4.4. Representative distribution of paxillin in longitudinally orientated skeletal 
muscle fibres. A) Higher magnification widefield microscopy images of paxillin (red; left) 
and merged images (right) of dystrophin (DYS; green) and myosin heavy chain type I (MHC 
type I; blue). B) Confocal microscopy image of a type I fibre detailing paxillin (green) and; 
C) is an 8x  magnification image. In both fibre types, paxillin was distributed along organised 
structures running perpendicular to the direction of the muscle fibre. C) Merged image of 
146 
 
paxillin with DHPR (a t-tubule marker) suggests paxillin is present at or near the t-tubule 
network (yellow pixels; arrows). Bars are 10 µm (A; B) and 5 µm (C).  
 
 
 
Figure 4.5. Representative confocal immunofluorescent microscopy images of focal 
adhesion kinase (FAK) and paxillin. FAK (green; left) and paxillin (red; middle) are 
present in high concentrations in the sarcolemmal regions and microvessels of transversely 
orientated human skeletal muscle fibres and the merged image (right) shows colocalisation. 
The mean Pearson’s correlation coefficient analysed from 19 ± 2 whole images using 
confocal microscopy is presented in the merged image and suggests partial colocalisation 
between FAK and paxillin. Note also the degree of colocalisation of FAK and paxillin in the 
microvessels as indicated by the abundance of yellow pixels. Bars are 50 µm. Data are mean 
± SEM  
 
Paxillin in the microvasculature   
Figure 4.6 shows representative confocal microscopy images of the endothelium surrounding 
the lumen of microvessels in human skeletal muscle. Lectin UEA-I successfully stained the 
endothelium of the microvasculature (left) and an intense paxillin immunofluorescence was 
detected in the endothelium (middle), with paxillin forming a ring-like structure around the 
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lumen and distributed heterogeneously in the form of clusters. Merged images (right) show 
clear colocalisation of paxillin with the endothelium. In figure 4.7, α-SMA successfully 
stained the vascular smooth muscle (left), with paxillin again forming a ring-like structure 
around the lumen and distributed heterogeneously in the form of clusters (middle). Merged 
images (right) show colocalisation of paxillin with α-SMA and taken together, suggests this 
protein is abundantly expressed in endothelial and vascular smooth muscle cell (VSMC) 
tissues. In figure 4.8, co-incubation of anti-αSMA (left), FAK (middle) and paxillin (right) 
demonstrate clear colocalisation between FAK and paxillin in the VSMC (far right) (figure 
4.8A). This suggests the clusters observed in both endothelial cells and VSMCs represent 
sites of focal adhesions.  
 
 
Figure 4.6. Representative immunofluorescence confocal microscopy image illustrating 
the presence of paxillin within the microvascular endothelium of human skeletal 
muscle. A) Microvessels (lectin UEA-I) (green; left) are presented amongst transversely 
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orientated skeletal muscle fibres. Sections were co-stained with lectin UEA-I for visualisation 
of the endothelium and paxillin (red; middle) with an intense paxillin immunoreactivity 
detected within the microvessels (upper; arrowheads). Merged images demonstrate clear 
colocalisation of paxillin with the endothelium. B) Higher magnification images of the region 
of interest illustrating the heterogeneous distribution of paxillin around the vessel lumen 
(arrowhead) and the ring-like structure (arrow). Bars are 50 and 10 µm, respectively. 
 
 
 
Figure 4.7. Representative immunofluorescence confocal microscopy illustrating the 
presence of paxillin in the vascular smooth muscle of human skeletal muscle. Sections 
were costained with anti-α-smooth muscle actin for the identification of arterioles (green; 
left; SMA; α-smooth muscle actin). Paxillin (red; middle) was largely punctate and 
heterogeneous in distribution, appearing to form clusters (arrowheads) within a ring-like 
structure. An intense immnuofluorescent signal for paxillin was detected at the periphery of 
each arteriole where it appeared to form intermittent straight lines. These may reflect focal 
adhesion recruitment to areas of applied force (arrow). Note also the clear areas of 
colocalisation of paxillin with the SMA as depicted by the yellow pixels (right; arrow). Bars 
are 5 µm.  
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Figure 4.8. Representative confocal immunofluorescent microscopy images of focal 
adhesion kinase (FAK) and paxillin in the vascular smooth muscle of human skeletal 
muscle fibres. The anti-α-smooth muscle actin was used to identify arterioles (blue; SMA; 
upper left) and serial staining of paxillin (red; upper right) and FAK (green; lower left) 
showed clear colocalisation (yellow pixels; arrows) between the two focal adhesion-
associated proteins (merged; lower right; arrows). Images were captured with a 4x zoom and 
bars are 10 µm.  
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4.5. Discussion 
This is the first study to report the localisation and distribution of the focal adhesion protein 
paxillin in human skeletal muscle and its associated microvasculature. Using widefield and 
confocal microscopy, we support and expand upon the findings previously observed in 
murine myoblasts (Quach and Rando, 2006) and present novel information regarding the 
spatial colocalisation of FAK and paxillin in human skeletal muscle fibres and the 
microvasculature.    
A strong paxillin immunofluorescence intensity was observed in the peripheral 
regions of the muscle fibres (figure 4.1) and colocalisation of paxillin with dystrophin 
suggests paxillin is localised to sarcolemmal regions (figure 4.2). Based on three-dimensional 
super resolution confocal microscopy, evidence suggests paxillin is localised <50 nm from 
the plasma membrane (Kanchanawong et al., 2010), but this observation cannot be confirmed 
in the present study. Paxillin immunofluorescence intensity in (sub)sarcolemmal regions was 
~2.4 fold more intense than in sarcoplasmic regions (figure 4.2) suggesting the majority of 
paxillin was localised in (sub)sarcolemmal regions with comparatively little sarcoplasmic 
paxillin content. These data mirrors that of FAK reported in human (chapter 2) and animal 
skeletal muscle (Fluck et al., 1999; Klossner et al., 2009) and are in agreement with paxillin’s 
presence in costameres (Fluck et al., 1999; Gordon et al., 2001; Quach and Rando, 2006).  
There is evidence in rat skeletal muscle that paxillin is expressed in a fibre-type 
specific manner with an ~50% greater paxillin protein content in the m. soleus compared to 
the m. plantaris or m. gastrocnemius (Gordon et al., 2001). It was postulated that the greater 
paxillin content in oxidative skeletal muscle may reflect the habitual loading state of the 
muscles (Gordon et al., 2001). To test this hypothesis, we investigated the sarcoplasmic 
paxillin content of human m. vastus lateralis type I and type II muscle fibres using widefield 
microscopy. We observed a slightly (10%) higher sarcoplasmic paxillin fluorescence in type I 
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compared with type II fibres (figure 4.3) which is in line with previous reports in rodent 
skeletal muscle (Gordon et al., 2001), but contrast with observations in FAK intracellular 
immunofluorescence where no fibre-type specificity was observed (chapter 2). We did not 
measure fibre-type specific sarcolemmal paxillin immunofluorescence intensity due to the 
resolution required to separate the sarcolemma of one fibre from the sarcolemma of 
neighbouring fibres, but single fibre analysis may offer a suitable alternative.  
  In longitudinally orientated type I and type II skeletal muscle fibres, paxillin staining 
revealed uniform striations which ran perpendicular to the direction of the fibre and these 
striations spanned the fibre’s width (figure 4.4A, B, C).  The striations resembled that of FAK 
(chapter 2) and the t-tubular network (Lauritzen et al., 2008a; Lauritzen et al., 2008b; 
Lauritzen et al., 2006). Anti-DHPR was used as a marker for the t-tubule network and this 
study reports the first visual images of paxillin’s spatial colocalisation with DHPR in human 
skeletal muscle. T-tubules contain key insulin signalling proteins such as the insulin receptor 
and PI3-K, are a docking target of GLUT-4 vesicles and have been suggested to be the major 
site for insulin-stimulated glucose uptake (Lauritzen et al., 2008a; Lauritzen et al., 2008b; 
Lauritzen et al., 2006). FAK regulates insulin-stimulated GLUT-4 translocation in L6 and 
C2C12 skeletal muscle cells (Bisht and Dey, 2008; Bisht et al., 2007; Huang et al., 2006) and 
given paxillin’s close interaction with FAK, and paxillin’s sensitivity to insulin signalling in 
C2C12 skeletal muscle cells (Goel and Dey, 2002), it is possible that FAK and paxillin 
interact at the t-tubular membrane to collectively regulate the fine tuning of insulin-
stimulated glucose uptake, but this warrants confirmation. However, as these striations were 
observed in comparatively few longitudinally orientated skeletal muscle fibres, it is likely 
that the striations represent costameres  (Anastasi et al., 2008; Ervasti, 2003; Mondello et al., 
1996; Pardo et al., 1983; Quach and Rando, 2006) and that paxillin overlies the t-tubule 
network of peripheral myofibrils.   
152 
 
The colocalisation between FAK and paxillin has been reported in neonatal rat ventricular 
cardiomyocytes (Heidkamp et al., 2002) and we add to the existing knowledge with the first 
evidence of FAK and paxillin colocalisation in human skeletal muscle. FAK and paxillin 
colocalised predominantly in sarcolemmal regions of the muscle fibres and showed 
substantial colocalisation in the endothelial and smooth muscle layer of the skeletal muscle 
microvasculature (figure 4.5 and 4.8). Colocalisation at the sarcolemmal regions point at the 
presence of costameres in human muscle fibres and accumulating evidence suggests these 
protein complexes play an important role in regulating protein synthesis and the hypertrophic 
response in animal (Durieux et al., 2009; Fluck et al., 1999; Gordon et al., 2001; Klossner et 
al., 2009) and human skeletal muscle (chapter 3) (Narici et al., 2011). The adaptive response 
to loading is likely mediated through a FAK- and paxillin-mediated actin remodelling where 
actin is anchored to cell membrane focal adhesion complexes which facilitates 
mechanotransduction (Schaller, 2001; Turner, 2000). These complexes may also be important 
in insulin-stimulated glucose uptake since cytoskeletal reorganisation is necessary for insulin-
stimulated glucose uptake in C2C12 muscle cells (Bisht and Dey, 2008).  
We have visualised paxillin in the microvascular endothelium and VSMCs (likely 
arterioles) with paxillin appearing to form clusters in both tissues (figure 4.6 and 4.7) which 
might reflect paxillin or focal adhesion complexes in the unstimulated state awaiting 
mechanical- or hormonal-mediated recruitment.  Representative confocal microscopy images 
of both the endothelium and VSMC suggest some evidence, particularly in the VSMCs, of 
accumulation of paxillin which appear to partially align along the periphery of the tissue 
(figure 4.7, large arrows). Whether this distribution is associated with vasodilation or 
constriction warrants further investigation. In unstimulated endothelial cells in vitro, paxillin 
was heterogeneously distributed in intracellular regions (Li et al., 2002; Li et al., 1997; 
Mattiussi et al., 2006). In response to fluid shear stress paxillin redistributed towards the 
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plasma membrane where it aligned in the direction of laminar flow (Li et al., 2002; Li et al., 
1997; Mattiussi et al., 2006). Analysis of post-exercise skeletal muscle would ascertain 
whether a distinct and prolonged exercise-induced increase in fluid shear stress affects the 
distribution of paxillin in human endothelial cells and VSMCs. The heterogeneous 
distribution of paxillin also mirrors that of FAK as shown in the representative colocalisation 
images (figure 4.8) and as previously reported (chapter 2 and chapter 3). Colocalisation 
between FAK and paxillin was strong in the human endothelium and VSMC as evidenced by 
the abundance of yellow pixels (figure 4.8) which is in line with the observations that FAK 
and paxillin closely interact in these cell types (Abedi and Zachary, 1997; Zaidel-Bar et al., 
2007).  
In conclusion, we report the first visual images of paxillin in human skeletal muscle 
and its associated microvasculature using widefield and confocal immunofluorescence 
microscopy. We confirmed the specificity of the paxillin antibody, identified paxillin at 
(sub)sarcolemmal regions along with a higher immunofluorescence in the sarcoplasm of type 
I fibres. We also observed a high content in the endothelium and VSMCs and significant 
colocalisation with FAK in these distinct tissues and regions. The newly developed 
immunofluorescence microscopy methods are expected to be a powerful tool to elucidate the 
response of FAK and paxillin and their interaction to hormonal and mechanical stimuli. 
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Chapter 5 
 
 
Six weeks of endurance- and resistance-
type exercise training both lead to 
increases in FAK and paxillin content in 
human skeletal muscle fibres and its 
microvascular endothelium 
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5.1. Abstract 
Focal adhesion kinase (FAK) and paxillin are mechano-sensitive proteins highly expressed in 
skeletal muscle fibres and vascular endothelial cells. FAK and paxillin are modulated by the 
loading state of the skeletal muscle and through alterations in hemodynamic forces (e.g. shear 
stress), but little is known about the effect of endurance- (ET) and resistance- (RT) type 
exercise training on these focal adhesion-associated proteins in young, previously sedentary 
humans. Therefore, this study aimed to make the first investigations of FAK and paxillin 
responses to ET and RT in human skeletal muscle fibres and its microvascular endothelium.  
Sixteen young sedentary males completed 6 weeks of either ET (5 d·wk
-1
 ~65% 
VO2peak cycling) or whole body RT (3 d·wk
-1
) and skeletal muscle biopsies were collected 
pre- and post-training from the m. vastus lateralis. Changes in FAK and paxillin protein 
content in (sub)sarcolemmal regions and the microvascular endothelium was investigated 
using immunofluorescence microscopy. Measures of cross-sectional area (CSA) were also 
made.  
FAK and paxillin immunofluorescence intensity increased at (sub)sarcolemmal 
regions by 41 ± 8% and 23 ± 8% (P<0.001) following ET. In the microvascular endothelium, 
FAK immunofluorescence intensity increased after ET (23 ± 4%) and RT (17 ± 4%) 
(P<0.001) with no difference between training modes. Paxillin immunofluorescence intensity 
also increased after ET (21 ± 9%) and RT (16 ± 4%) (P<0.001) within the endothelium with 
no difference between training modes. RT did not affect type I or type II fibre CSA.  
These are the first data to show that human skeletal muscle FAK and paxillin are 
increased after 6 weeks ET and RT, particularly in (sub)sarcolemmal and microvascular 
endothelial regions. As skeletal muscle fibre CSA was unchanged by RT, these data suggest 
the increased FAK and paxillin protein content may precede fibre hypertrophy.  
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5.2. Introduction 
Skeletal muscle demonstrates considerable plasticity in response to mechanical stimulation 
(Hoppeler and Fluck, 2002) and it is well known that endurance-type exercise training (ET) 
and resistance-type exercise training (RT) stimulate divergent adaptive responses (Gollnick et 
al., 1973; Gollnick et al., 1972; Holloszy, 1967; Holloszy et al., 1977). However, it remains 
unclear how skeletal muscle fibres and the skeletal muscle microvasculature convert 
exercise-associated mechanical stimuli into the intracellular signalling that regulates their 
adaptation (mechanotransduction) to exercise training (Coffey and Hawley, 2007).  
Focal adhesion kinase (FAK) and its direct binding partner paxillin (Bellis et al., 
1995; Hildebrand et al., 1995; Scheswohl et al., 2008) are mechano-sensitive focal adhesion-
associated proteins localised to focal adhesions (Kanchanawong et al., 2010). These are 
protein-dense structures that resist mechanical forces (Balaban et al., 2001; Fabry et al., 2011; 
Riveline et al., 2001) and stimulate mechanotransduction in which FAK and paxillin are 
critical components (for review see (Deakin and Turner, 2008; Parsons, 2003; Schlaepfer et 
al., 1999). In skeletal muscle fibres, focal adhesions are contained in subsarcolemmal protein 
structures called costameres. These align in register with the Z-disk of peripheral myofibrils, 
anchor the Z-disk to the sarcolemma and facilitate the lateral transmission of force from the 
sarcomere to the sarcolemma and extracellular matrix (Ervasti, 2003; Pardo et al., 1983). 
FAK and paxillin colocalise and are highly expressed in regions corresponding to 
costameres in human skeletal muscle fibres (chapter 4 of this thesis). They are also highly 
expressed in the animal skeletal muscles that bear the higher overall mechanical load (Fluck 
et al., 2002; Gordon et al., 2001). FAK and paxillin’s protein abundance are increased after 
mechanical loading of animal (Fluck et al., 1999) and human skeletal muscle (Flueck et al., 
2011; Narici et al., 2011) (chapter 3 in this thesis) and FAK is implicated in the increased 
expression of genes associated with the slow-oxidative skeletal muscle fibre type (Durieux et 
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al., 2009) and the protein synthesis signalling pathway after mechanical loading (Klossner et 
al., 2009). FAK is also sensitive to insulin-like growth factor-I (IGF-I) in vitro, appearing to 
play a role in IGF-I-mediated increases in mammalian target of rapamycin (mTOR)-
dependent signalling and muscle protein synthesis (Crossland et al., 2013).  
The positive effects of ET and RT on skeletal muscle insulin sensitivity are well 
known (Iglay et al., 2007; King et al., 1987; Miller et al., 1994; Miller et al., 1984; Rogers et 
al., 1990). FAK and paxillin are both phosphorylated by insulin (Goel and Dey, 2002) and 
FAK plays a regulatory role in skeletal muscle insulin sensitivity in L6 and C2C12 muscle 
cells in vitro and in rat skeletal muscle in vivo (Bisht and Dey, 2008; Bisht et al., 2007; Bisht 
et al., 2008; Huang et al., 2006). Taken together, these studies suggest FAK and paxillin play 
an important role in the mechanisms that regulate adaptation to mechanical loading. 
The vascular endothelium is also exposed to tension, compression and fluid shear 
stress forces (Davies and Tripathi, 1993). The latter are transmitted from the luminal 
glycocalyx, via the cytoskeleton, to abluminal focal adhesions at the endothelial membrane 
(for review see (Weinbaum et al., 2007)). Chapter 2 and 4 of this thesis reported a high FAK 
and paxillin protein content in the microvasculature of human skeletal muscle. Both focal 
adhesion-associated proteins are rapidly phosphorylated in response to increased laminar 
shear stress in endothelial cells in vitro (Li et al., 2002; Li et al., 1997; Mattiussi et al., 2006). 
It is thought that their increased phosphorylation is an important event in endothelial 
mechanotransduction since FAK and paxillin play a critical role in regulating vascular 
function, shear stress-induced flow mediated dilation and angiogenesis (Hagel et al., 2002; 
Ilic et al., 1995; Koshida et al., 2005; Peng et al., 2004; Shen et al., 2005).  
To date, no studies have investigated the effect of ET and RT on FAK and paxillin 
protein content in previously sedentary young individuals. This study aimed to make the first 
investigations of FAK and paxillin responses at the (sub)sarcolemma of skeletal muscle fibres 
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and within the skeletal muscle microvascular endothelium using the novel 
immunofluorescence microscopy methods developed in chapters 2 and 4. It was hypothesised 
that ET and RT would increase skeletal muscle FAK and paxillin protein content, particularly 
at the (sub)sarcolemmal regions due to the regular periods of increased force generation by 
contracting myofibrils. It was also hypothesised that both focal adhesion-associated proteins 
would increase in the endothelium of the skeletal muscle microvasculature after both training 
modes due to altered mechanical and hemodynamic stresses acting on the microvasculature 
during exercise.  
 
5.3. Materials and Methods 
Participants and muscle samples 
Sixteen previously sedentary male participants (defined as completing less than 1 h per week 
of organised physical exercise) completed 6 weeks ET (n=8) and RT (n=8) and were well 
matched according to age, height, BMI and VO2max (table 1). This uses a subset of the 
participants reported previously (Cocks et al., 2013; Shepherd et al., 2013)(Cocks M, 2012, 
PhD Thesis; Shepherd S, 2013 PhD Thesis; University of Birmingham). Participants provided 
their written informed consent.  The study was approved by the Black Country NHS 
Research Ethics Committee which adhered to the Declaration of Helsinki.  
 
Endurance-type exercise testing 
The methods for establishing participant peak oxygen consumption (VO2peak) and details of 
the ET and RT programme have been described in detail previously (Cocks et al., 2013; 
Shepherd et al., 2013)(Cocks 2012, PhD Thesis; Shepherd 2013, PhD Thesis). In brief, 
VO2peak was established pre- and post-ET and RT using an incremental exercise test to 
exhaustion. Participants cycled on an electromagnetically braked ergometer at 95 watts and 
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the intensity increased by 35 watts every 3 min until volitional fatigue. VO2peak corresponded 
to the highest value achieved over a 15 s recording period. Repeat tests were performed at 
week 4 and before the last training session.   
 
Dietary controls 
The participant’s diets were standardised 24 hours before and during the pre- and post-
training testing assessments. Participants completed a 3-day food diary and mean energy 
intake was estimated using diet analysis software (WISP). The standardised diet was matched 
to the participant’s habitual energy intake and had a macronutrient content of 50% 
carbohydrate, 35% fat and 15% protein. 
 
Bloods 
Between 3 and 7 days after the incremental exercise test, participants arrived at the laboratory 
after an overnight fast for a 2 h oral glucose tolerance test. Participants ingested a 25% 
glucose beverage containing 75g glucose made up in 300 mL of water. Additional blood 
samples (10 ml) were collected at 30, 60, 90 and 120 min. Plasma was separated, stored at -
80°C and then analysed for plasma insulin (enzyme linked immuno-sorbent assay kit; 
Invitrogen, UK) and plasma glucose concentrations (IL ILab 650 Chemistry Analyzer, 
Diamond Diagnostics, USA). Insulin sensitivity was calculated using the Matsuda Index 
(Matsuda and DeFronzo, 1999). 
 
Endurance-type exercise training  
The training programme began 48 h after the pre-training testing. In the first 3 weeks, 
supervised training consisted of continuous cycling at 65% VO2peak 5 days per week. In the 
first 10 sessions participants cycled for 40 min, rising to 50 min for sessions 11 – 20 and 60 
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min for sessions 21 – 30. After 3 weeks of training, the workload was adjusted after the 
second incremental test to exhaustion. 
 
Resistance-type exercise training  
The one repetition maximum (1RM) for each participant was determined on 8 motion guided 
resistance machines which included the leg extension, leg press, chest press, hamstring curl, 
lateral pulldown, seated biceps curl and arm extension movements (Cybex International Inc., 
MA, USA). The 1RM was determined (Kraemer and Fry, 1995) where a warm-up of 6 
repetitions at an estimated 50% 1RM, 4 repetitions at an estimated 70% 1RM, and 2 
repetitions at ~80% 1RM with 2 min recovery between sets. The 1RM was then estimated 
and attempted. A lift was valid where the load was lifted through the entire motion without 
assistance. Subsequent loads were adjusted based on the number of repetitions performed at 
the estimated 1RM. This was repeated until only 1 repetition was achieved which became 
their 1RM. Post-RT 1RM was established before the final training bout and was performed 
on the leg extension, leg press, chest press and shoulder pull-down.  
The RT group trained 3 days per week and completed at least 16 sessions and a 
maximum of 18 sessions over the 6 weeks. In week 1, participants completed 3 sets of 10-12 
repetitions each at 50%, 60% and then 70% 1RM. In week 2, participants completed 2 sets of 
10-12 repetitions each with set 3 comprising 12 repetitions at 80% 1RM performed to 
volitional fatigue. Thereafter, once 3 sets of 12 repetitions were successfully completed, the 
resistance load was increased by 2.5 kg to ensure training progression.   
 
Muscle biopsy 
Percutaneous needle muscle biopsy samples from the m. vastus lateralis was performed pre- 
and post 6 weeks ET and RT using the Bergstrom needle biopsy technique (Bergstrom, 1975) 
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adapted with suction (Evans et al., 1982). Muscle samples were collected 48 h following the 
last exercise session. The muscle samples were blotted free of excess blood and any visible 
fat or connective tissue was removed. The samples were then embedded in Tissue Tek OCT 
compound (Sakura Finetek Europe, Zoeterwoude, The Netherlands) and immediately frozen 
in liquid-nitrogen cooled isopentane (Sigma-Aldrich, Dorset, UK) for storage at -80°C. Three 
5 µm cryo-sections per section were cut at -30°C from the same pre- and post-exercise 
training biopsies used in the studies published by this research group (Cocks et al., 2013; 
Shepherd et al., 2013) (Shepherd, 2013, PhD thesis; Cocks, 2012, PhD thesis, University of 
Birmingham 2013). For staining efficiency and to allow comparisons between ET and RT, 
muscle sections from pre- and post-training for both training modes were placed on the same 
room-temperature, uncoated glass slides (VWR International Ltd, Leicestershire, UK) and 
duplicated on a second slide.  
 
Immunofluorescence staining 
All chemicals used in this study were purchased from Sigma-Aldrich unless otherwise stated. 
At least two pre- and post-training cryo-sections from ET and RT were placed on the same 
glass slide in duplicate to ensure identical staining efficiency between sections and to allow 
comparisons between training modes. The sections were fixed in 3:1 ratio acetone and 
ethanol for 5 min and washed 3 x 5 min in phosphate buffered saline (PBS). Sections were 
then incubated for 2 h with 5% Normal Goat Serum and polyclonal FAK A17 (Santa Cruz, 
USA) or monoclonal anti-paxillin (BD transduction Laboratories, Oxford, UK) as described 
in chapters 2, 3 and 4 of this thesis. Differences in (sub)sarcolemmal FAK and paxillin 
content pre- and post-exercise training were investigated by co-staining the muscle sections 
with anti-dystrophin (Sigma-Aldrich, UK). Sarcoplasmic fibre-type differences were 
investigated using anti-myosin heavy chain type I (MHC type I developed by Dr. Blau; 
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DSHB; A4.840c) which was specific to slow oxidative type I skeletal muscle fibres leaving 
type II fibres unstained. After incubation with the primary antibodies, sections were washed 3 
x 5 min in PBS and then incubated for 30 min in the appropriate fluorescently conjugated 
secondary antibodies as described in chapters 2, 3 and 4.  
To visualise FAK and paxillin within the skeletal muscle microvasculature, anti-FAK 
and anti-paxillin were applied to muscle sections as before. The incubation period was then 
proceeded by 3 x 5 min wash in PBS, blotted dry and then co-incubated for 30 min with 
lectin FITC-conjugated Ulex europaeus Agglutinin I (Vector Laboratories).  To assess 
background fluorescence and non-specific secondary antibody binding, negative controls 
were performed where the primary antibody was excluded. In all cases the fluorescence 
signal was abolished. The sections underwent a 3 x 5 min wash in PBS and cover slips 
applied as previously described. 
 
Image capture and analysis 
FAK and paxillin was visualised using confocal and widefield microscopy. Fluorescence 
intensity of positively labelled FAK and paxillin was used to assess protein content in 
(sub)sarcolemmal regions and the microvascular endothelium. To quantify FAK 
immunofluorescence, detailed digital images of the skeletal muscle were captured with an 
inverted confocal microscope (Leica DMIRE2, Leica Microsystems) with a 63 x 1.4 NA oil 
immersion objective.  The Alexa Fluor 488 fluorophore was excited by the 488 nm line of the 
argon laser and the Alexa Fluor 594 fluorophore was excited by the 594 nm line of the 
Helium-Neon laser, respectively. Widefield microscopy was used to capture and investigate 
endothelial FAK and paxillin immunofluorescence intensity pre- and post-exercise training as 
described in chapter 3.  
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Image-Pro Plus 5.1 (Media Cybernetics, MD, USA) was used to process each image across 
the duplicate slides. Approximately 5 regions of interest were captured per muscle section 
using confocal immunofluorescence microscopy. For ET, FAK immunofluorescence intensity 
at (sub)sarcolemmal regions was quantitated from the mean fluorescence signal intensity 
from a total of (mean ± SD) 151 ± 56 whole muscle fibres per individual, summed across the 
duplicate slides. Similarly, paxillin immunofluorescence intensity was quantitated from a 
total of 176 ± 49 whole muscle fibres for ET. Longitudinally orientated muscle fibres were 
excluded from quantitation. Quantitation of FAK and paxillin immunofluorescence intensity 
at (sub)sarcolemmal regions for RT are not presented due to sarcolemmal-specific damage in 
>50% of RT muscle. Fibre-type specific (sub)sarcolemmal FAK and paxillin content was not 
investigated due to the limitations of the confocal microscope resolution (200 nm) to 
sufficiently determine the sarcolemma of one fibre from its neighbouring fibre. 
Quantitation of FAK within the microvascular endothelium of widefield-captured 
images was determined from the mean fluorescence signal intensity from a total of 450 ± 198 
microvessels in ET and 269 ± 119 microvessels for RT. For quantitation of paxillin, a total of 
364 ± 204 microvessels in ET and 228 ± 104 microvessels in RT were analysed. 
Muscle fibre cross-sectional area (CSA) (µm
2
) was determined pre- and post-RT 
through an automated method based on individual specific threshold settings or, where 
necessary, by manually tracing along the dystrophin-stained border. The images were 
calibrated using a stage micrometer. Only fibres determined as transversely-orientated were 
included in the CSA analysis if the fibre roundness factor was <1.639 (roundness = 
perimeter
2/4πarea where a perfect circle = 1.0, pentagon = 1.163, square = 1.266 and 
equilateral triangle = 0.639) (Kosek et al., 2006). A total of 66 ± 15 and 122 ± 20 type I and 
type II transversely orientated muscle fibres were analysed per individual for CSA.  
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Statistical analysis 
Data were checked for normal distribution. Between group differences in baseline participant 
characteristics was assessed using an independent t-test. Sarcolemmal immunofluorescence 
intensity for ET was analysed using a paired t-test. All other data were assessed using a two-
way ANOVA with a between factor (group; endurance training versus resistance training) 
and a within factor (time; pre-training versus post-training). Data are presented as mean ± 
SEM and statistical significance was set at P<0.05. 
 
5.4. Results 
Participant characteristics 
There were no differences between groups in age or anthropometric values (table 1). ET 
induced a 15% increase in VO2peak (P<0.05) but there was no significant change following 
RT (P > 0.05). With RT, 1RM leg extension, leg press, chest press and shoulder press 
increased by 32%, 40%, 34% and 39%, respectively (P<0.05). Insulin sensitivity increased 
27% after ET and 32% after RT, respectively. 
 
Effect of ET and RT on (sub)sarcolemmal FAK immunofluorescence intensity  
A strong immunostaining for FAK was observed at the (sub)sarcolemmal regions of the 
skeletal muscle fibres compared with the sarcoplasm. ET significantly increased FAK 
immunofluorescence intensity at (sub)sarcolemmal regions by 41 ± 8 % (P<0.001) (figure 
5.1).  
Quantitation of (sub)sarcolemmal FAK in response to RT is not reported due to 
sarcolemma-specific frost damage in many of the skeletal muscle samples. Representative 
confocal microscopy images from undamaged skeletal muscle of FAK at the 
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(sub)sarcolemma are shown in figure 5.2. An intense FAK immunolabeling was detected at 
(sub)sarcolemmal regions and the immunofluorescence intensity appeared stronger after RT.  
 
Table 5.1. Participant characteristics 
  ET RT 
Characteristics Pre Post Pre Post 
Age(y) 21 ± 1 - 20 ± 1 - 
Height (cm) 177 ± 3 - 172 ± 3  - 
Body mass (kg) 70.8 ± 4.4 70.8 ± 4.5 71.6 ± 2.4 71.1 ± 2.2 
BMI (kg/m
2
) 22.6 ± 1.6  22.6 ± 1.2 24.4 ± 0.9 24.2 ± 0.8 
ISI Matsuda 3.7 ± 0.5 4.7 ± 0.7* 2.8 ± 0.2 3.7 ± 0.3* 
VO2peak (mL/kg/min) 41.7 ± 4.1 48.2 ± 5.0* 41.1 ± 2.0 43.2 ± 2.3 
1RM Leg Extension (kg) - - 116 ± 5 151 ± 6* 
1RM Leg Press (kg) - - 189 ± 10 264 ± 15* 
1RM Chest Press (kg) - - 52 ± 3 69 ± 4* 
1 RM Shoulder Press (kg - - 45 ± 2 62 ± 3* 
  
Data are mean ± SEM; n = 8 for ET and 8 for RT; ISI, insulin sensitivity index; * P<0.05 
main effect of training 
 
Effect of ET and RT on (sub)sarcolemmal paxillin 
A strong immunostaining for paxillin was also observed at (sub)sarcolemmal regions of 
skeletal muscle fibres. ET significantly increased paxillin immunofluorescence intensity at 
(sub)sarcolemmal regions by 23 ± 8% (P<0.001) (figure 5.3). Representative confocal 
microscopy images of paxillin in response to ET are shown in figure 5.4.  
Representative confocal microscopy images from undamaged skeletal muscle in 
response to RT showing paxillin at the (sub)sarcolemma are shown in figure 5.5. An intense 
paxillin immunolabeling was detected at (sub)sarcolemmal regions and the 
immunofluorescence intensity appeared stronger after RT in this individual. There was no 
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change in muscle fibre CSA in either type I or type II fibres following 6 weeks of RT (figure 
5.6). 
 
 
 
Figure 5.1. Effect of 6 weeks endurance-type exercise training (ET) on FAK content at 
the (sub)sarcolemma. Mean FAK immunofluorescence intensity at (sub)sarcolemmal 
regions of skeletal muscle fibres related to pre-training. Data are mean ± SEM and calculated 
from (mean ± SD) 151 ± 56 whole skeletal muscle fibres. Type I and type II fibre types are 
pooled in both instances. * Significantly different from pre-training (P<0.001). n = 8. 
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Figure 5.2. Effect of 6 weeks endurance-type exercise training (ET) on (sub)sarcolemmal FAK 
and paxillin immunofluorescence intensity. Representative confocal microscopy images of 
transversely orientated human m. vastus lateralis skeletal muscle fibres showing FAK (red) at 
(sub)sarcolemmal regions pre- (above) and post- (below) ET (A) and RT (B). Dystrophin is shown in 
green. Bar = 50 µm. (n = 8 for ET and n = 4 for RT). Higher magnification confocal microscopy 
image of FAK at (sub)sarcolemmal regions of pre- (above) and post- (below) ET (C) and RT (D) 
using a 4x zoom. Bar = 10 µm. Note the accumulation of FAK at (sub)sarcolemmal regions after ET 
(arrows) and a potential capillary (D) (small arrow). 
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Figure 5.3. Effect of 6 weeks endurance-type exercise training (ET) on paxillin expression at the 
(sub)sarcolemma. Mean paxillin immunofluorescence intensity at (sub)sarcolemmal regions of 
skeletal muscle fibres related to pre-training. Data are mean ± SEM and calculated from (mean ± SD) 
176 ± 49 whole skeletal muscle fibres. Type I and type II fibre types are pooled in both instances. * 
Significantly different from pre-training (P<0.05). n = 8. 
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Figure 5.4. Effect of 6 weeks endurance-type exercise training (ET) on paxillin 
(sub)sarcolemmal expression. Representative confocal microscopy images of transversely orientated 
human m. vastus lateralis skeletal muscle fibres showing FAK (red) at (sub)sarcolemmal regions pre- 
(above) and post- (below) ET (A) and RT (B). Dystrophin is shown in green. Bar = 50 µm. n = 8 for 
ET and n = 4 for RT. 
 
  
Figure 5.5. Mean type I and type II skeletal muscle fibre cross-sectional area (CSA) after 
resistance-type exercise training (RT). There was no effect of training on either fibre type. Data are 
mean ± SEM. n = 8.  
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Microvascular endothelial FAK and paxillin immunofluorescence intensity 
FAK immunolabeling was strong in the skeletal muscle microvasculature. There was a main effect of 
training (P<0.001) on microvascular endothelial FAK immunofluorescence intensity with no 
difference between training modes (P>0.05). ET significantly increased microvascular endothelial 
FAK content by 23 ± 4%, (figure 5.6). RT significantly increased endothelial FAK content by 17 ± 
4% (figure 5.6). Representative widefield microscopy images are presented in figure 5.7. 
Paxillin immunolabeling was also strong in the skeletal muscle microvasculature. There was a 
main effect of training on microvascular endothelial paxillin content (P<0.001) with no difference 
between training modes (P>0.05). Paxillin immunofluorescence intensity was 21 ± 9% higher after 
ET and 16 ± 4% higher after RT (figure 5.6). Representative widefield microscopy images are 
presented in figure 5.8. 
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Figure 5.6. FAK and paxillin immunofluorescence intensity in the endothelium of the skeletal 
muscle microvasculature. A) Mean FAK endothelial immunofluorescence intensity pre- and post-ET 
and RT calculated from 450 ± 198 microvessels in ET and 269 ± 120 microvessels in RT.  B) Mean 
paxillin endothelial immunofluorescence intensity pre- and post-ET and RT calculated from 364 ± 
204 microvessels for ET and 228 ± 104 in RT.  Data are mean ± SEM and related to pre-training. n = 
8/ training mode.  Data are mean ± SEM and related to pre-training. * Significantly different from 
pre-training P<0.001.  
 
 
* 
* 
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Figure 5.7. Effect of 6 weeks endurance- (ET) and resistance-type exercise training (RT) on 
endothelial FAK immunofluorescence intensity. Representative widefield microscopy images of 
FAK (red) in the microvascular endothelium (green) of human m. vastus lateralis skeletal muscle pre- 
(above) and post- (below) ET (A) and RT (B). Bar = 50 µm. n = 8/group. 
A 
B 
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Figure 5.8. Effect of 6 weeks endurance training (ET) and resistance training (RT) on 
endothelial paxillin immunofluorescence intensity. Representative widefield microscopy images of 
paxillin (red) in the microvascular endothelium (green) of human m. vastus lateralis skeletal muscle 
pre- (above) and post- (below) ET (A) and RT (B). n = 8/group.  Bar = 50 µm.  
A 
B 
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5.5. Discussion 
This is the first study to investigate FAK and paxillin responses to 6 weeks ET and RT in the 
skeletal muscle fibres and microvascular endothelium of previously sedentary humans. The 
novel findings of the study are that the protein expression of both focal adhesion proteins 
increased significantly in skeletal muscle after both training modes. The highest protein 
expression of FAK and paxillin in the skeletal muscle fibre was at the (sub)sarcolemma and 
their immunofluorescence intensity was significantly increased in this location after ET. A 
high protein expression of both focal adhesion proteins was also present in the endothelial 
layer of the microvasculature of skeletal muscle. ET and RT also led to significant increases 
in the protein expression of FAK and paxillin in this location. These data confirm that FAK 
and paxillin are highly expressed in the (sub)sarcolemmal regions and microvascular 
endothelium before training and that their abundance is increased after both ET and RT in 
young previously sedentary men. These data build on chapters 2, 3 and 4 of this thesis to 
demonstrate that the recently developed immunofluorescence microscopy techniques can be 
used to quantitate ET- and RT-associated changes in the protein content of human focal 
adhesion proteins.  
The increased FAK and paxillin expression at the (sub)sarcolemma of skeletal muscle 
fibres after ET are in agreement with and expand upon previous investigations of whole 
muscle homogenates from mechanically overloaded animal skeletal muscle (Fluck et al., 
1999; Gordon et al., 2001) and after 12 weeks skiing training in elderly human skeletal 
muscle (Flueck et al., 2011; Narici et al., 2011). This implies a significant remodelling of the 
costamere in response to the higher mechanical forces generated by the contracting 
sarcomeres during ET compared with common daily living activities (figure 5.1, 5.2). A 
remodelling of other costamere-associated proteins has been reported after RT (Kosek and 
Bamman, 2008). 
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As well as its known role in force transmission (Bloch and Gonzalez-Serratos, 2003), the 
costamere is also a nexus for mechanotransduction (Burkholder, 2007). FAK overexpression 
has been linked with the increased expression of genes associated with slow oxidative 
skeletal muscle and the increased protein content of skeletal muscle mitochondrial enzymes 
(Durieux et al., 2009). In cardiomyocytes, FAK depletion prevented the stretch-induced 
elevation in markers of mitochondrial biogenesis such as mitochondrial DNA and 
mitochondrial enzymes (Tornatore et al., 2011). Paxillin has also been suggested to play a 
role in lung cell mitochondrial biogenesis (Kawada et al., 2013) which suggests a potential 
role for both FAK and paxillin in the mechanisms that stimulated the increased mitochondrial 
density reported by Shepherd et al in the full cohort of subjects after both modes of exercise 
training (Shepherd et al., 2013)(Shepherd, S. 2013 PhD thesis).  
FAK is also necessary for load-induced left ventricle hypertrophy in rats (Clemente et 
al., 2007; DiMichele et al., 2006) and the change in FAK protein content in human skeletal 
muscle after exercise training is positively correlated with the change in muscle thickness 
(Narici et al., 2011). The mechanotransduction pathways that link FAK to load-induced-
hypertrophy of striated muscle are not fully elucidated but may include mTOR-dependent 
(Marin et al., 2008) or –independent pathways (Klossner et al., 2009). However, the present 
study did not observe a measureable change in type I or type II muscle fibre CSA after high 
intensity RT in the sampled muscle (figure 5.5). This contrasts with a previous study 
reporting increased type II fibre CSA after 4 weeks RT in untrained individuals 
(Woolstenhulme et al., 2006) and hypertrophy of the whole m. vastus lateralis muscle after 
~3 weeks RT when measured using magnetic resonance imaging (Seynnes et al., 2007). 
Measures of muscle fibre CSA can vary between 15 – 20% across multiple biopsy sites 
(Halkjaer-Kristensen and Ingemann-Hansen, 1981) and muscle fibre CSA do not fully 
account for whole muscle CSA (D'Antona et al., 2006). Therefore, it is possible that 
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additional measures and methodologies may have detected muscle fibre hypertrophy in the 
present study. Alternatively, the training duration may have been insufficient to observe 
measureable hypertrophy in the sampled muscle of these previously sedentary individuals 
and training durations of 8 weeks or more may have been necessary to observe an affect 
(Campos et al., 2002; Wilkinson et al., 2006)(chapter 3 of this thesis).  Although no direct 
measures of (sub)sarcolemmal FAK are presented for RT, evidence from ET and the 
microvascular endothelium after RT suggests that FAK expression in the skeletal muscle 
fibres after RT would have increased., It is possible, therefore, that costameric remodelling in 
the present study precedes muscle fibre hypertrophy in these previously sedentary 
individuals.  
The skeletal muscle microvasculature is exposed to tensile, compressive and fluid 
shear stress (Davies and Tripathi, 1993). Force transmission between the luminal glycocalyx 
via the cytoskeleton to abluminal focal adhesions (Weinbaum et al., 2007) leads to the rapid 
phosphorylation and recruitment of FAK and paxillin to focal adhesions in endothelial cells 
in vitro (Li et al., 2002; Mattiussi et al., 2006; Zebda et al., 2012). The latter is thought to lead 
to a strengthening of the adhesion of endothelial cells to its extracellular matrix during 
periods of elevated shear stress (Wechezak et al., 1989). An increase in the protein abundance 
of focal adhesions, including FAK and paxillin (figure 5.7, 5.8), might be an adaptive 
response to the multiple periods of elevated fluid shear stress and mechanical forces sustained 
by the endothelium during exercise training. The increased FAK protein content may also 
play a critical role in the many FAK-mediated mechanotransduction signalling pathways 
within the endothelium (Zebda et al., 2012). Shear stress stimulates flow-mediated dilation in 
the vascular endothelium of arterioles through increased nitric oxide (NO) production by 
endothelial nitric oxide synthase (eNOS) (Green et al., 2004). FAK has been shown to 
regulate fluid shear stress-induced phosphorylation of eNOS and FMD of rat coronary 
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arterioles (Koshida et al., 2005). The increased FAK expression may therefore contribute to 
the improved FMD reported after exercise training in rat skeletal muscle arterioles (Spier et 
al., 2007) and human arteries (Rakobowchuk et al., 2008; Tinken et al., 2010). 
The increased content of both focal adhesion proteins may also regulate the 
angiogenic response to exercise training since they are targets of pro-angiogenic growth 
factors (Abedi and Zachary, 1997; Kim et al., 2000; Qi and Claesson-Welsh, 2001) and are 
necessary for angiogenesis (Hagel et al., 2002; Ilic et al., 1995; Peng et al., 2004; Shen et al., 
2005). It is well known that skeletal muscle angiogenesis occurs in humans after ET 
(Andersen and Henriksson, 1977; Klausen et al., 1981) and the two focal adhesion proteins 
may have played a key role in the mechanisms leading to the increased capillary density 
previously reported after ET (Cocks et al., 2013). Whereas some studies have reported an 
increase in capillary density after RT (Green et al., 1999; McCall et al., 1996), others have 
not (Luthi et al., 1986; Tesch et al., 1990; Wang et al., 1993). There was no change in 
capillary density after RT in the present study’s participants (Cocks, PhD thesis). The authors 
attributed this to a lack of change in fibre CSA after training and so the diffusion distance 
between the fibre and surrounding capillaries was maintained (Cocks, PhD thesis) (Green et 
al., 1999; McCall et al., 1996). This suggests other mechanisms in addition to FAK regulate 
angiogenesis during RT. 
Whole body insulin sensitivity was increased in these participants after both training 
modes (table 5.1) (Cocks et al., 2013; Shepherd et al., 2013) (Shepherd 2013, PhD thesis). 
Insulin stimulates FAK and paxillin phosphorylation in C2C12 skeletal muscle cells (Goel 
and Dey, 2002) and FAK plays a key regulatory role in skeletal muscle insulin-stimulated 
glucose uptake in vitro (Bisht and Dey, 2008; Bisht et al., 2007) and in vivo (Bisht et al., 
2008). It could be speculated therefore, that the insulin-sensitising effects of both training 
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modes (Shepherd et al, 2013; Shepherd, S. 2013 PhD thesis) are partly attributable to the 
increase in the two focal adhesion proteins.  
Insulin-stimulated increases in microvascular blood flow is an important response 
determining insulin and glucose delivery to the muscle fibre and contributes to insulin-
mediated glucose uptake (Barrett et al., 2009). Insulin-induced microvascular recruitment is 
dependent upon NO production by eNOS in the microvascular endothelium (Vincent et al., 
2003). As FAK regulates shear stress-mediated increases in NO production by eNOS 
(Koshida et al., 2005), it is possible that FAK within the microvascular endothelium is an 
important mechanism in insulin-stimulated vasodilation. Furthermore, the increased FAK 
protein expression following exercise training may contribute to the exercise training-
associated improvements in insulin-mediated microvascular blood flow (Inyard et al., 2007; 
Rattigan et al., 2001) and improved insulin-mediated glucose disposal (Rattigan et al., 2001). 
 In conclusion, this is the first study to report an increased FAK and paxillin protein 
expression in human skeletal muscle after 6 weeks ET and RT. Immunofluorescence 
microscopy enabled the identification and quantitation of the content of these focal adhesion 
proteins in specific regions of the skeletal muscle which is a major advantage of this method 
compared with western blot analyses. FAK and paxillin were increased in the 
(sub)sarcolemmal regions of skeletal muscle fibres after ET and within the microvascular 
endothelium of skeletal muscle after both types of exercise training. This suggests a 
remodelling of the skeletal muscle costamere and endothelial focal adhesions in response the 
higher overall mechanical load generated during exercise training. As muscle fibre CSA did 
not change after RT, the accumulation of costameric FAK and paxillin may precede muscle 
fibre hypertrophy in these participants. FAK may also play a role in the improved insulin 
sensitivity that was seen in these participants via mechanisms that may both involve 
increased insulin sensitivity of skeletal muscle fibres and the endothelium of the skeletal 
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muscle microvasculature.  This could be relevant for future research in obese, type II diabetic 
and elderly individuals. The use of immunofluorescence microscopy techniques is a powerful 
and informative approach to investigate tissue and region specific responses to exercise 
training. 
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6.1. Background and aims of the PhD project 
Global population ageing is an unprecedented achievement for humanity. However, the age-
associated risk of developing cardiovascular disease (Najjar et al., 2005), type II diabetes 
(Wild et al., 2004) and the functional impairments associated with sarcopenia (Janssen et al., 
2002) will be a considerable challenge for future health care provision. The development of 
sarcopenia has been linked to the age-associated decline in physical activity rates (Doherty, 
2003; HSfE, 2010), but the mechanisms by which physical (in)activity and the alterations in 
contractile and hemodynamic forces that regulate skeletal muscle mass, vascular function and 
metabolic health are incompletely understood. FAK and paxillin are focal adhesion-
associated proteins implicated in the acute and chronic mechanotransduction of (un)loading 
(de Boer et al., 2007; Durieux et al., 2009; Fluck et al., 1999; Glover et al., 2008; Gordon et 
al., 2001; Klossner et al., 2009) and hemodynamic forces within the (micro)vasculature 
(Koshida et al., 2005; Zebda et al., 2012). Age-associated defects in the load-induced 
activation of FAK (Rice et al., 2007) may underlie the impaired anabolic response of skeletal 
muscle to acute and chronic contractile activity (Durham et al., 2010; Fry et al., 2011; Kosek 
and Bamman, 2008; Kosek et al., 2006; Kumar et al., 2009; Williamson et al., 2003) and the 
impaired FMD of arteries (Celermajer et al., 1994; Donato et al., 2007; Eskurza et al., 2004) 
and skeletal muscle arterioles with age (Delp et al., 2008; Muller-Delp et al., 2002).  
 When the research described in this thesis began, knowledge of the spatial distribution 
of FAK was limited to avian and rat skeletal muscle fibres (Durieux et al., 2009; Fluck et al., 
1999; Fluck et al., 2002; Klossner et al., 2009) and there was no information on the spatial 
distribution of paxillin in mammalian skeletal muscle in vivo. In addition, the chronic 
response of FAK and paxillin total protein content to mechanical overload was restricted to 
whole muscle homogenates of avian and rat skeletal muscle (Fluck et al., 1999; Gordon et al., 
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2001). Consequently, there was no information regarding the spatial distribution of FAK and 
paxillin in human skeletal muscle fibres and the microvascular endothelium and VSMCs of 
young and elderly individuals. Furthermore, it was not known how exercise training affected 
the content of FAK and paxillin within skeletal muscle fibres and the skeletal muscle 
microvascular endothelium of young and elderly populations. 
 Therefore, the principle aims of this thesis were to; 1) develop novel 
immunofluorescence microscopy methods to make the first investigations of the spatial 
distribution of FAK in skeletal muscle and its associated microvasculature of young, 
recreationally active men; 2) investigate the effect of 12 weeks RT on FAK protein content 
and spatial distribution in skeletal muscle and the endothelium of its associated 
microvasculature in previously untrained elderly men using the novel immunofluorescence 
microscopy methods developed in chapter 2; 3) develop novel immunofluorescence 
microscopy methods to perform the first investigations of the paxillin protein content and 
spatial distribution in human skeletal muscle and the endothelium of its associated 
microvasculature and to investigate the colocalisation of FAK and paxillin in these tissues; 4) 
investigate the effect of 6 weeks ET and RT on FAK and paxillin protein content in skeletal 
muscle fibres and the skeletal muscle microvascular endothelium of young, previously 
sedentary individuals using the novel immunofluorescence microscopy techniques developed 
in chapter 2 and 4.  
 
6.2. Immunofluorescence microscopy to investigate focal adhesion-associated 
proteins in skeletal muscle and its microvasculature 
6.2.1. Spatial distribution of FAK and paxillin in skeletal muscle fibres 
The highest content of FAK and paxillin was at the (sub)sarcolemma of skeletal muscle fibres 
in the m. vastus lateralis of young and elderly individuals. Both focal adhesion proteins 
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formed a relatively continuous distribution around the fibre perimeter (chapter 2, 3, 4, 5). 
These findings are the first to be presented in young and elderly individuals and are in 
agreement with the distribution of FAK and their localisation to costameres in animal skeletal 
muscle fibres (Fluck et al., 2002; Klossner et al., 2009; Klossner et al., 2013; Quach and 
Rando, 2006). However, during the final revisions of this thesis, Li et al (Li et al., 2013) 
presented images of a distinctly fragmented distribution of FAK at the sarcolemma of m. 
vastus lateralis skeletal muscle fibres of young individuals following immunostaining with 
the C-terminal-specific FAK antibody (Li et al., 2013). These observations are dissimilar to 
those presented in chapter 2 following immunolabeling with both N-terminal- and C-
terminal-specific FAK antibodies.  
There was no difference in sarcoplasmic FAK content of type I and type II skeletal 
muscle fibres (chapter 2) and the sarcoplasmic paxillin content was only slightly higher  in 
type I compared with type II fibres  (chapter 4). These findings are in disagreement with 
Durieux et al (Durieux et al., 2009) who reported an intense sarcoplasmic FAK 
immunostaining in type I versus type II rat m. soleus skeletal muscle fibres after the 
combined effects of 10 days mechanical overload with FAK overexpression (gene electro-
transfer of a FAK-containing plasmid) (Durieux et al., 2009). The contrasting findings with 
Durieux et al, (Durieux et al., 2009) may be attributable to the skeletal muscles and species 
investigated  and may also be a phenomenon of the gene electrotransfer methodology 
employed by Durieux et al, (Durieux et al., 2009).  
 The high (sub)sarcolemmal content of FAK supports its direct interaction with the 
transmembrane insulin receptor (Goel and Dey, 2002b). Skeletal muscle is the principle site 
of insulin-stimulated glucose uptake during a hyperinsulinemic-euglycemic clamp (DeFronzo 
et al., 1981) and FAK regulates insulin–stimulated glucose uptake in rodent skeletal muscle 
in vivo and in C2C12 and L6 myotubes in vitro (Bisht and Dey, 2008; Bisht et al., 2007; 
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Bisht et al., 2008; Huang et al., 2006). In longitudinally orientated fibres, FAK was 
distributed as striations which spanned the width of the fibre and ran perpendicular to the 
fibre’s direction (chapter 2). This distribution was also observed for paxillin in longitudinally 
orientated fibres, but far more rarely. The distribution of both focal adhesion proteins was 
similar to the rib-like distribution of vinculin (a marker for costameres) (Pardo et al., 1983) 
and t-tubules (which are deep invaginations of the sarcolemma) (Lauritzen et al., 2006; Ploug 
et al., 1998). Cryosections were co-incubated with a marker for the t-tubules (anti-DHPR) 
and both FAK and paxillin appeared to colocalise with the t-tubules, suggesting they are at or 
in close proximity to the t-tubules (chapter 2 and 4). The t-tubules are the most important site 
of GLUT-4 docking in mouse skeletal muscle (Lauritzen et al., 2008a; Lauritzen et al., 
2008b; Lauritzen et al., 2006) and support the bulk of insulin-stimulated glucose uptake in 
mice (Wang et al., 1996). In the case of paxillin, the striations which are rarely observed in 
longitudinally orientated fibres are more likely to be costameres (Mondello et al., 1996; 
Pardo et al., 1983) and the colocalisation of paxillin with DHPR represents the close 
proximity of costameres to the underlying peripheral myofibrils.  
 
  
6.2.2. Spatial distribution of FAK and paxillin in the skeletal muscle microvasculature 
FAK and paxillin play a critical role in vascular development and angiogenesis (Hagel et al., 
2002; Ilic et al., 1995; Peng et al., 2004; Shen et al., 2005). FAK and paxillin had a high 
protein content and degree of colocalisation in the endothelium of the skeletal muscle 
microvasculature of young and elderly individuals both in capillaries and arterioles (chapter 
2, 3, 4 and 5). FAK and paxillin were distributed heterogeneously around the lumen in both 
the endothelium and VSMCs of arterioles and appeared to form clusters which probably 
reflected the formation of focal adhesions in both cell types in the rested, fasted state. There 
was also some evidence that FAK (chapter 2) and paxillin (chapter 4) aligned along parts of 
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the periphery of the VSMC. A similar distribution has also been observed in the monolayers 
of cultured endothelial cells in response to laminar shear stress (12 dyne/ cm
2
) (Li et al., 
1997) and in tracheal smooth muscle after acetylcholine-stimulated contraction (Opazo Saez 
et al., 2004). Human femoral artery blood flow is low in the resting state (~0.3 l/ min) (Saltin 
et al., 1998) and therefore the fluid shear stress in human skeletal muscle capillaries is also 
likely to be low (~12 dyne/ cm
2
) (Dawson and Hudlicka, 1993). It is yet to be determined if 
higher rates of blood flow (and fluid shear stress) during an acute bout of endurance- and 
resistance-type exercise in the untrained and exercise-trained state acutely affect the 
distribution of FAK and paxillin within the skeletal muscle microvasculature.  
  
6.2.3. Effect of exercise training on FAK and paxillin in skeletal muscle fibres 
Chapter 3 and 5 are the first to demonstrate in humans that exercise training of between 6 and 
12 weeks leads to increases in FAK and paxillin protein content at the (sub)sarcolemma of 
skeletal muscle fibres in young and elderly individuals. The chapters also demonstrate that 
FAK and paxillin are increased in the skeletal muscle microvascular endothelium after 
exercise training. These data provide a greater insight into the findings previously reported in 
whole muscle homogenates from animal skeletal muscle after loading (Fluck et al., 1999; 
Gordon et al., 2001) and elderly individuals  after exercise training (Flueck et al., 2011; 
Narici et al., 2011).  
The accumulation of FAK and paxillin after both training modes (chapter 3 and 5) 
likely reflects a remodelling of mature costameres in response to the higher forces repeatedly 
generated by the contracting myofibrils during exercise compared with normal daily living 
activities. The remodelling may also be FAK mediated since local overexpression of FAK 
(gene electrotransfer) in the rat m. soleus increased costamere-associated protein levels for 
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β1-integrins and meta-vinculin (Klossner et al., 2013). The increased FAK content may also 
represent the formation of new costameres (Quach and Rando, 2006) which may be required 
to link the Z-disk of newly generated myofibrils to the sarcolemma following RT.   
The role of FAK and paxillin in skeletal muscle mechanotransduction and training 
adaptation is not fully understood. An increase in the aerobic capacity (chapter 5) and 
mitochondrial density was reported in the previously sedentary individuals after ET 
(Shepherd 2013, PhD thesis). In the rat m. soleus, local overexpression of FAK was achieved 
through gene electrotransfer of a FAK-containing plasmid (Durieux et al., 2009). FAK 
protein content was 2.6 fold higher after 8 days of overexpression compared with 
contralateral controls transfected with an empty plasmid and led to the upregulation of genes 
and proteins associated with mitochondrial oxidative metabolism (Durieux et al., 2009). The 
effect of FAK overexpression was muted after unloading the hindlimbs through tail 
suspension and were absent after co-expression with FRNK (Durieux et al., 2009).  
The mechanism that links FAK with mitochondrial biogenesis is not fully resolved. In 
neonatal rat ventricular myocytes, cyclic stretch (2-12 h) increased important mediators of 
mitochondrial biogenesis such as peroxisome proliferator activated γ coactivator-1α 
(PGC1α), nuclear respiratory factor-1 (NRF-1) and mitochondrial transcription factor A 
(Tfam). Prolonged stretching also led to increased mitochondrial biogenesis (as measured by 
mitochondrial DNA and increased protein content of the oxidative enzyme cytochrome 
oxidase IV (Tornatore et al., 2011). Stretching increased FAK Tyr
397
 phosphorylation after 2 
h and this was accompanied by the nuclear translocation and association of FAK with PGC1α 
(Tornatore et al., 2011). FAK was shown to predominantly interact with nuclear PGC1α via 
its C-terminal domain and depletion of FAK protein through siRNA inhibited basal levels of 
PGC1α and the stretch-associated upregulation of PGC1α, NRF-1, mitochondrial DNA and 
cytochrome oxidase IV (Tornatore et al., 2011). FAK depletion in the left ventricle of mice 
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also suppressed the upregulation of PGC1α, NRF-1 and mitochondrial DNA by pressure-
overload in vivo (Tornatore et al., 2011). These experiments suggest a critical role for FAK in 
the regulation of mitochondrial biogenesis by mechanical load. It is expected that the age-
associated decline in physical activity rates leads to a reduction in the phosphorylation and 
protein content of FAK (de Boer et al., 2007; Glover et al., 2008; Gordon et al., 2001; Li et 
al., 2013). This will lead to a decline in mitochondrial protein synthesis rates, mitochondrial 
biogenesis, mitochondrial density, reduced exercise capacity and glucose tolerance with age 
(Rooyackers et al., 1996; Short et al., 2005). 
The increased FAK content in elderly individuals after 12 weeks RT was 
accompanied by specific type II fibre hypertrophy (chapter 3). This is in agreement with two 
companion studies published during this thesis (Flueck et al., 2011; Narici et al., 2011). In 
these studies, 20 – 22 elderly males and females aged ~67 years skied 3.5 hours per training 
session 2-3 times per week over 12 weeks. The authors reported a 1.9 fold increase in total 
FAK protein content in the m. vastus lateralis of males without change in females after skiing 
training (Flueck et al., 2011). The change in FAK content after training was also positively 
correlated with the change in muscle thickness (r=0.59) (Narici et al., 2011). Interestingly, 
load-induced hypertrophy of the left ventricle of mice was prevented and reversed by FAK 
siRNA in vivo (Clemente et al., 2007) and FAK deletion prevented pressure-overload-
induced hypertrophy of the left ventricle in mice (DiMichele et al., 2006). In addition, IGF-I-
stimulated C2C12 myotube cell growth (based on myotube diameter and protein content) was 
suppressed in FAK knockdown-containing myotubes (Crossland et al., 2013). The time 
course association between load-induced changes in FAK content and muscle fibre CSA are 
unknown, but chapter 5 demonstrated an increase in FAK and paxillin protein content 
without a measureable change in type II fibre CSA following 6 weeks RT in the sampled 
muscle (chapter 5). It is possible, therefore, that FAK may play an important role in load-
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induced skeletal muscle hypertrophy and the accumulation of FAK at (sub)sarcolemmal 
regions after 6 weeks RT may be an adaptation that precedes skeletal muscle hypertrophy.  
The molecular pathways that link load-induced activation of FAK and paxillin to 
skeletal muscle hypertrophy are poorly understood. In neonatal rat ventricular myocytes, 
FAK is thought to signal through an mTOR-dependent signalling pathway (Marin et al., 
2008). siRNA-mediated FAK depletion led to a blunted cyclic stretch-induced 
phosphorylation of FAK, Src, Akt, TSC2, and p70S6K and stretch-induced myocyte 
hypertrophy (Marin et al., 2008). In EDL skeletal muscle fibres, local overexpression of FAK 
by gene electrotransfer in combination with contractile activity also stimulated the activation 
of p70S6K in an Akt-independent in EDL muscle fibres (Klossner et al., 2009).  
Recently, Crossland and colleagues showed that FAK was required for normal and 
IGF-I-stimulated C2C12 cell growth (measured using cell diameter) in vitro (Crossland et al., 
2013). Lentiviral-mediated knockdown of FAK resulted in 87% depletion of FAK and a 35% 
smaller myotube diameter at day 4 of myotube differentiation when compared to a negative 
control (C2C12 cells with scrambled shRNA).  
When scrambled shRNA cells were treated with IGF-I for 24 h, the increased cell 
diameter (41%) and total protein content (44%) were attenuated in FAK knockdown C2C12 
cells (Crossland et al., 2013). At the molecular level, FAK knockdown was associated with 
attenuated IGF-I-mediated increases in FAK Tyr
397
, TSC2 Thr
1462
, 4EBP1 Thr
37/46
 and 
p70S6K phosphorylation (Thr
389
  and Thr
421
/ Ser
424
). IGF-I-mediated increases in Akt Ser473 
and Thr308 were relatively unaffected by FAK knockdown. FAK knockdown was also 
associated with impaired IGF-I-mediated binding of eIF4E to eIF4G to form the translation 
initiation complex eIF4F. Formation of eIF4F and phosphorylation of p70S6K are important 
events that lead to increased protein synthesis and IGF-I-stimulated muscle protein synthesis 
(incorporation of puromycin into newly synthesised peptide chains) in scrambled shRNA 
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cells was attenuated after FAK knockdown. When scrambled shRNA C2C12 cells were 
treated with an inhibitor of FAK Tyr
397 
phosphorylation, IGF-I-stimulated FAK Tyr
397
, Akt 
Ser
473
, p70S6K Thr
389
 and 4EBP1 Thr
37/46
 phosphorylation were all suppressed.  
Taken together, these data suggest an important role for FAK in IGF-I-mediated 
stimulation of the mTOR-p70S6K and -4EBP1 signalling pathways and the upregulation of 
protein synthesis in cell culture. The role and importance of IGF-I in load-induced skeletal 
muscle hypertrophy in vivo has been challenged (Miyazaki et al., 2011; Philp et al., 2011; 
Spangenburg, 2010; Spangenburg et al., 2008), but these data are in line with those presented 
in load-induced cardiomyocytes (Marin et al., 2008) and imply an important role for FAK in 
regulating load-induced hypertrophy. A summary of the potential signalling pathways though 
which load-induced activation of FAK leads to mitochondrial biogenesis and stimulation of 
skeletal muscle protein synthesis is presented in figure 6.1. 
Chapter 5 showed that an increased FAK protein content following 6 weeks ET and 
RT was accompanied by increased insulin sensitivity. FAK has been shown to regulate 
insulin-stimulated glucose uptake in rat skeletal muscle in vivo and in C2C12 and L6 
myotubes in vitro (Bisht and Dey, 2008; Bisht et al., 2007; Bisht et al., 2008). Depletion of 
C2C12 skeletal muscle cells of FAK protein by siRNA inhibited insulin-stimulated 
cytoskeletal remodelling in vitro leading to impairments in GLUT4-translocation and glucose 
uptake both in vitro and rats in vivo (Bisht and Dey, 2008; Bisht et al., 2008). A reduction in 
insulin-induced FAK phosphorylation was also observed in insulin resistant skeletal muscle 
cells which led to impaired glucose uptake (Bisht et al., 2007). Conversely, overexpression of 
FAK increased insulin-stimulated glucose uptake in C2C12 skeletal muscle cells (Bisht and 
Dey, 2008) and restored skeletal muscle insulin sensitivity and glucose uptake in insulin 
resistant C2C12 muscle cells (Bisht et al., 2007). These studies collectively demonstrate the 
importance of FAK in regulating insulin-stimulated skeletal muscle glucose uptake.
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Figure 6.1. Proposed FAK-mediated regulation of load- and growth factor-induced 
skeletal muscle adaptation. Endurance- (ET) or resistance-type exercise (RT) activates 
integrins leading to FAK autophosphorylation and the binding of FAK with Src and paxillin. 
Evidence suggests FAK may increase oxidative capacity and mitochondrial biogenesis 
through its nuclear translocation where it directly interacts with peroxisome proliferator 
activated γ coactovator-1α to increase the transcription of nuclear-encoded genes (e.g. 
cytochrome oxidase IV; COX IV) by nuclear respiratory factor-1 (NRF-1) (Tornatore et al., 
2011). Recent evidence suggests FAK may increase skeletal muscle protein synthesis and 
skeletal muscle hypertrophy through a FAK-mediated phosphorylation and inactivation of 
tuberous sclerosis complex 1/ 2 (TSC 1/ 2). This leads to the subsequent activation of 
mammalian target of rapamycin (mTOR) and the phosphorylation of downstream 
intermediates (Crossland et al., 2013).  
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They also demonstrate how impairments in insulin-stimulated glucose uptake can be averted 
or overcome by maintaining or increasing the FAK protein content and phosphorylation 
within the skeletal muscle cells. The hypothesis is that endurance- and strength-trained 
individuals are protected from insulin resistance because they have a high FAK protein 
content and FAK phosphorylation status compared with untrained individuals. This enhances 
skeletal muscle insulin sensitivity and glucose disposal in trained individuals compared with 
those who lead a sedentary lifestyle (Clevenger et al., 2002; Fujitani et al., 1998; King et al., 
1987; Seals et al., 1984).  
 
6.2.4. Effect of exercise training on FAK and paxillin in the microvasculature 
The frequent exposure of microvascular endothelial cells to periods of elevated hemodynamic 
and mechanical forces during exercise training seems to require an increase in the content of 
focal adhesion-associated proteins. This may increase the adhesion strength of endothelial 
cells to the ECM during periods of elevated fluid shear stress (Balaban et al., 2001; Fabry et 
al., 2011; Riveline et al., 2001; Wechezak et al., 1989) since abluminal focal adhesions are 
exposed to the same level of shear stress to that which is applied at the apical surface, 
independent of the presence of the luminal glycocalyx, due to the force required to maintain 
the position of the endothelial cell  (Tarbell et al., 2005). 
Laminar fluid shear stress rapidly phosphorylates and activates FAK (Li et al., 2002; 
Li et al., 1997) and inhibition of FAK phosphorylation prevented shear-stress-induced eNOS 
phosphorylation (and thus NO production) and FMD of rat coronary arterioles (Koshida et 
al., 2005). Load-induced FAK phosphorylation may be impaired with age (Rice et al., 2007) 
which could be central to the age-associated decline in NO bioavailability (Maeda et al., 
2004; Taddei et al., 2000) and the FMD of arteries (Celermajer et al., 1994; Donato et al., 
2007; Eskurza et al., 2004; Jensen-Urstad et al., 1999) and skeletal muscle arterioles (Delp et 
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al., 2008; Muller-Delp et al., 2002; Spier et al., 2007). The increased FAK content after both 
training modes may be among the principle mechanisms that lead to increased NO 
bioavailability and improved FMD after exercise training (Clarkson et al., 1999; Maeda et al., 
2004; Sciacqua et al., 2003; Watts et al., 2004). This may also explain why physically active 
and exercise trained elderly individuals are protected against the age-associated decline in 
FMD (Jensen-Urstad et al., 1999; Rywik et al., 1999) and the development of atherosclerosis  
and  cardiovascular disease (Myers et al., 2002). 
Given FAK’s direct interaction with the insulin receptor, IRS-1 and PI3-K signalling 
intermediates (Baron et al., 1998; Goel and Dey, 2002a, b; Lebrun et al., 1998), it is possible 
that increased FAK protein content may also facilitate improvements in insulin-stimulated 
skeletal muscle glucose uptake and insulin-stimulated microvascular blood flow through 
increased NO production by eNOS. This may be an important mechanism contributing to the 
higher insulin sensitivity reported after exercise training (chapter 5) (Henriksen, 2002; 
Wojtaszewski and Richter, 2006; Zierath, 2002) and in young and elderly individuals who 
habitually engage in ET and RT (King et al., 1987; King et al., 1990; Lanza et al., 2008; 
Miller et al., 1994; Rogers et al., 1990).   
RT is recommended for older people as it is an effective intervention for reversing the 
effects of sarcopenia and dynapenia and can improve insulin sensitivity (Chodzko-Zajko et 
al., 2009; Haskell et al., 2007). The findings in chapter 3 are consistent with the literature in 
that 12 weeks RT increased 1RM leg strength and reversed the specific type II fibre atrophy 
observed at baseline (Andersen, 2003; Charette et al., 1991; Klitgaard et al., 1990; Kosek et 
al., 2006; Larsson et al., 1978; Lexell, 1995; Lexell and Downham, 1992; Lexell et al., 1986; 
Lexell et al., 1988; Verdijk et al., 2007). A blunted chronic hypertrophic response of type I 
and type II skeletal muscle fibres to RT has been reported in the elderly compared with 
younger individuals (Hakkinen et al., 2001; Kosek and Bamman, 2008; Kosek et al., 2006; 
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Mero et al., 2013). FRNK is an endogenous inhibitor of FAK and is present in elderly 
skeletal muscle, particularly in females (Flueck et al., 2011). FRNK, FAK and paxillin 
protein content was higher in the aged rat aorta compared with young rats (Rice et al., 2007), 
but the phosphorylation of FAK and paxillin by increased intraluminal pressure overload of 
the aorta was inhibited in elderly compared with young rats (Rice et al., 2007).  This suggests 
FRNK may play a role in the blunted adaptation to exercise training in the elderly and 
warrants further research in human skeletal muscle. 
  
6.3. Future research 
6.3.1. Role of FAK and paxillin in insulin-stimulated glucose uptake 
The novel findings in this thesis, coupled with the recently published complimentary 
literature, have led to the hypothesis that maintaining high rates of physical activity and 
habitual exercise training lead to an increase in FAK and paxillin protein content and 
phosphorylation status. This will lead to a chronic enhancement of the insulin sensitivity of 
skeletal muscle and its associated microvasculature (as observed in chapter 5) and may 
contribute to the increased rates of insulin-stimulated glucose uptake observed in the 48 h 
period after an acute bout of exercise (Mikines et al., 1988; Perseghin et al., 1996). 
 Conversely, insufficient mechanical stimulation through immobilisation (de Boer et 
al., 2007; Glover et al., 2008; Gordon et al., 2001; Li et al., 2013) or chronic adoption of a 
sedentary state, particularly in the elderly, would lead to a loss of FAK protein content and 
impaired insulin- and exercise-induced FAK Tyr
397
 phosphorylation. In the short term, this 
will lead to progressively higher fasting and post-prandial plasma glucose concentrations and 
in the long term, will lead to glucose intolerance, the development of insulin resistance and 
overt pathology such as type II diabetes and cardiovascular disease. The time course of such 
changes is only partially known. However, the observation that just two weeks of reduced 
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physical activity leads to impairments in glucose tolerance in healthy elderly individuals 
(Breen et al., 2013) and uninterrupted sitting leads to excursions in post-prandial plasma 
glucose concentrations (Dunstan et al., 2012) suggest that these adaptations may occur in 
periods as brief as 4-5 h of sitting behind a desk. Incredibly, interrupting sitting behaviour 
with just 2 min of moderate intensity exercise every 20 min is enough to reduce meal induced 
glucose excursions (Dunstan et al., 2012). Future research should investigate whether FAK 
and paxillin are the upstream signals that control both the acute metabolic and health benefits 
of exercise and the molecular and metabolic adaptation during exercise training regimens last 
6 weeks or more. 
The novel immunofluorescent microscopy methods developed in this thesis could be 
used to investigate the role of FAK and paxillin in the regulation of insulin sensitivity in 
human skeletal muscle and its microvasculature in greater detail. In particular, information on 
the time course of FAK activation and downstream signalling is currently lacking. Future 
research should focus on FAK Tyr
397
 (autophosphorylation site) and Tyr
576/577 
phosphorylation (necessary for maximum FAK activation) following insulin and exercise 
stimulation. Such measures should be made alongside parallel measurements of downstream 
targets (e.g. Akt, mTOR, p70S6K and PGC1α) and on differences that occur between 
sedentary and trained individuals. 
The response of FAK and paxillin to insulin and exercise stimulation should be 
investigated at all the principle sites of insulin action within skeletal muscle that have been 
identified in this thesis; namely the (sub)sarcolemma and t-tubules of skeletal muscle fibres, 
and the microvascular endothelium and VSMCs of terminal arterioles. An important strength 
of immunofluorescence microscopy is that it allows simultaneous measures of FAK 
responses to insulin at focal adhesion sites in all these tissues. Consequently, the novel 
methods developed in this thesis, coupled with new assays to investigate the phosphorylation 
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status of FAK and paxillin and their downstream targets, are expected to generate a wealth of 
new information concerning the acute and chronic adaptive response to exercise and the 
adoption of a sedentary state. T-tubules are the principle site of skeletal muscle glucose 
uptake in mice (Lauritzen et al., 2006; Wang et al., 1996). Three-dimensional reconstruction 
of the t-tubules using confocal microscopy (Jayasinghe and Launikonis, 2013) could be used 
to confirm the observations made in chapter 2 that FAK is at or in close proximity to the t-
tubules of skeletal muscle. Intravital imaging of the skeletal muscle of living animals in 
combination with investigations of GLUT-4 trafficking (for review (Lauritzen, 2013)) would 
be expected to provide a considerable insight into the functional relevance of FAK at the t-
tubules and the role and temporal response of FAK Tyr
397
 and Tyr
576/577
 phosphorylation in 
insulin- (Lauritzen et al., 2006) and contraction-induced GLUT-4 trafficking (Lauritzen et al., 
2010).  
As an acute bout of exercise potentiates microvascular insulin action (Rattigan et al., 
2001). Future studies should therefore investigate the functional consequences of acute or 
chronic exercise-induced increases in FAK and paxillin protein content and phosphorylation 
status in insulin- and exercise-induced microvascular blood flow and capillary recruitment. 
Contrast enhanced ultrasound could be used (Vincent et al., 2004) to test the hypothesis that a 
high FAK and paxillin protein content and phosphorylation status leads to superior insulin-
stimulated microvascular capillary recruitment and higher rates of skeletal muscle glucose 
disposal relative to sedentary individuals (Rattigan et al., 2001).  
Immunofluorescence microscopy and contrast enhanced ultrasound could also be used 
to investigate the role of FAK and paxillin in the mechanisms leading to the improved insulin 
sensitivity, mitochondrial biogenesis and (micro)vascular function in untrained and type II 
diabetic patients after high-intensity interval training (HIT) involving repeated short (~30 s) 
exercise bouts (Babraj et al., 2009; Cocks et al., 2013; Little et al., 2011; Richards et al., 
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2010; Shepherd et al., 2013). Despite the considerably lower energy expenditure and time 
spent exercising with HIT, the improvements are comparable to the more traditional 
endurance-type exercise training (Burgomaster et al., 2008; Cocks et al., 2013; Gibala et al., 
2006; Shepherd et al., 2013). The contractile demands of both exercise modes are 
considerably different yet FAK is responsive to low and high contractile forces (chapter 3 and 
5). It would be interesting to see if the high contractile forces generated during each sprint 
lead to increases in FAK and paxillin protein content and phosphorylation. Moreover, future 
research should compare the effect of acute exercise bouts and exercise training interventions 
on FAK content and phosphorylation to better understand why the adaptation to ET and HIT 
are similar but RT is not.  
 
6.3.2. Role of FAK and paxillin in the adaptation of skeletal muscle to (un)loading 
The role of FAK and paxillin in the adaptation of skeletal muscle to mechanical (un)loading 
is still largely unexplored. Several studies have linked the load-associated increase in FAK 
and paxillin with increased skeletal muscle mass (Fluck et al., 1999; Gordon et al., 2001), 
muscle thickness (Narici et al., 2011) and type II fibre hypertrophy (chapter 3 of this thesis). 
However, it is obvious from these studies that a major limitation in the literature is the lack of 
evidence for cause and effect.  
Because knockout of either FAK or paxillin genes are lethal (Hagel et al., 2002; Ilic et 
al., 1995), future investigations should take inspiration from a study by Clemente et al., 
(2007) who used siRNA to deplete the cardiomyocytes of FAK whilst subjecting the heart to 
an aortic band. After 12 weeks of increased load, siRNA inhibition of FAK prevented the 
load-induced hypertrophy of the left ventricle (Clemente et al., 2007). These experiments 
should be complemented with studies of FAK overexpression where gene electrotransfer a 
FAK-containing plasmid into the skeletal muscle may provide an important insight into the 
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mechanisms of FAK-mediated hypertrophy (Durieux et al., 2009; Klossner et al., 2009; 
Klossner et al., 2013).  
These studies will clearly provide an insight into the impact of increases in FAK and 
paxillin protein content and activity in skeletal muscle hypertrophy and will also provide the 
ideal opportunity to study further the interaction between FAK and paxillin and other FAK-
paxillin binding proteins. It will be of great interest to investigate the response of FAK- and 
paxillin-activated downstream signalling intermediates which may be involved in stimulating 
skeletal muscle protein synthesis and skeletal muscle hypertrophy. At present, load-activated 
FAK in skeletal muscle has been linked to the Akt-independent phosphorylation of p70S6K 
(Klossner et al., 2009), but studies in cardiomyocytes (Clemente et al., 2012; Marin et al., 
2008) and in C2C12 skeletal muscle cells after IGF-I stimulation (Crossland et al., 2013) 
suggest FAK may also signal through mTOR-dependent pathways.  
The immunofluorescence methodology developed in this thesis could be used to 
investigate FAK and paxillin at the (sub)sarcolemma and t-tubules of skeletal muscle fibres 
in response to siRNA inhibition, overexpression and increased mechanical loading. In 
addition, it should be investigated whether the gene electrotransfer technique introduces FAK 
overexpression into the microvasculature. It would be of great interest to see whether 
overexpression of FAK in the microvasculature leads to increased FAK-mediated 
angiogenesis (Peng et al., 2004) and improved microvascular function in insulin-resistant 
rats. 
 To date, chapter 5 is the only study that has reported the response of FAK protein 
content after ET but very little is known about the functional relevance and downstream 
signalling. FAK overexpression in the m. soleus was associated with the upregulation of 
nuclear-encoded mitochondrial enzymes such as cytochrome oxidase IV (Durieux et al., 
2009) and FAK was linked to mitochondrial biogenesis following cyclic stretch in 
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cardiomyocytes (Tornatore et al., 2011). Little is known about the role of paxillin in 
mitochondrial biogenesis. Moreover, the mechanistic link between FAK and changes in 
oxidative capacity and mitochondrial biogenesis with (un)loading are lacking. It has been 
shown that cyclic stretch stimulates the nuclear interaction of FAK with PGC1α in 
cardiomyocytes (Tornatore et al., 2011). This was associated with the cyclic stretch-induced 
increase in mitochondrial DNA and inhibition of FAK by siRNA abolished the stretch-
induced increase in mitochondrial DNA (Tornatore et al., 2011). These studies suggest FAK 
is heavily involved in load-induced increases in oxidative capacity and mitochondrial 
biogenesis but this requires further investigation with immunofluorescence microscopy, 
especially in human skeletal muscle. These techniques may reveal the colocalisation of FAK 
and PGC1α in skeletal muscle and confirm that load-induced activation of FAK (and paxillin) 
is the common factor that leads to comparable increases in oxidative capacity and 
mitochondrial biogenesis following ET and HIT (Burgomaster et al., 2006; Burgomaster et 
al., 2008; Gibala et al., 2006; Shepherd et al., 2013) and after RT (Frontera et al., 1990; 
Jubrias et al., 2001; Tang et al., 2006) despite the comparatively different contractile 
demands of each training regimen.  
 
6.3.3. Ageing and anabolic resistance 
Ageing is associated with an attenuation of the chronic hypertrophic response of skeletal 
muscle to mechanical loading in rats (Degens and Alway, 2003) and humans (Kosek and 
Bamman, 2008; Kosek et al., 2006). This is of great clinical significance since periods of 
immobilisation (e.g. bed rest or cast immobilisation) also lead to a loss of skeletal muscle 
mass and a resistance to load-induced hypertrophy (Hvid et al., 2010; Suetta et al., 2013; 
Suetta et al., 2009) will have important ramifications for the accretion of myofibrillar proteins 
and the accelerated development of sarcopenia. There is evidence that the post-exercise 
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increases in mTOR, p70S6K and ERK 1/2 phosphorylation are blunted in healthy elderly 
individuals compared with the young (Drummond et al., 2008; Fry et al., 2011; Kumar et al., 
2009) leading to impaired elevations in post-exercise muscle protein synthesis rates 
(Drummond et al., 2008; Durham et al., 2010; Fry et al., 2011; Kumar et al., 2009). This may 
contribute to the development of sarcopenia and suggests impairments in contraction-
stimulated mechanotransduction. Whether there are defects in signalling upstream of mTOR 
remains unclear.  
 The hypothesis is that the decline in physical activity rates with age will reduce the 
mechanical load upon the skeletal muscle and its associated microvasculature. As FAK and 
paxillin are mechano-sensitive proteins, this will result in reduced FAK and paxillin protein 
content and basal phosphorylation status in the skeletal muscle and its microvascular tissues 
(de Boer et al., 2007; Glover et al., 2008; Gordon et al., 2001; Li et al., 2013) when compared 
to a physically active young cohort. This would be observed predominately at the 
(sub)sarcolemmal and intracellular regions of skeletal muscle fibres and within the 
endothelium and VSMC of the skeletal muscle microvasculature. In the skeletal muscle 
fibres, the reduced FAK and paxillin protein content and basal phosphorylation status may 
attenuate the response of FAK to subsequent periods of loading in elderly individuals when 
compared to a young cohort (Rice et al., 2007). This would lead to the blunted activation of 
mTOR and p70S6K in response to RT (Drummond et al., 2008; Fry et al., 2011; Kumar et al., 
2009) and an attenuated rise in  post-exercise skeletal muscle protein synthesis (Drummond 
et al., 2008; Durham et al., 2010; Fry et al., 2011; Kumar et al., 2009). The net consequence 
of a chronic reduction in FAK and paxillin basal and post-exercise phosphorylation status and 
protein content would be type II fibre atrophy and a loss of skeletal muscle strength in elderly 
individuals when compared with a young cohort.  
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The association of FAK with PGC1α (Tornatore et al., 2011) in skeletal muscle fibres may 
also be impaired post-exercise leading to impairments in the post-exercise stimulation of 
protein synthesis and mitochondrial biogenesis compared with young individuals (Durham et 
al., 2010). This would manifest as a lower oxidative capacity and reduced mitochondrial 
content of skeletal muscle and a lower aerobic capacity in elderly compared with young 
individuals (Coggan et al., 1992; Rooyackers et al., 1996). 
The decline in mechanical forces (e.g. fluid shear stress) that act on the 
microvasculature and the subsequent loss of endothelial FAK and paxillin with age may lead 
to a reduction in the FAK-associated activation of eNOS (Koshida et al., 2005). This would 
be associated with a decline in NO bioavailability (Maeda et al., 2004; Taddei et al., 2000) 
and impaired fluid shear stress-induced endothelial-dependent vasodilation in elderly 
compared with young individuals (Delp et al., 2008; Muller-Delp et al., 2002; Spier et al., 
2007). The reduced content and activation of FAK and paxillin may also impair endothelial 
cell migration and angiogenesis (Ilic et al., 1995; Shen et al., 2005) leading to a loss of 
capillaries and a decline in capillary density when compared to a young cohort (Coggan et al., 
1992; Degens et al., 1993). 
Cross-sectional studies should therefore investigate age-associated differences in the 
protein content and basal phosphorylation status of FAK and paxillin at (sub)sarcolemmal 
and intracellular regions of skeletal muscle in young and elderly individuals alongside age-
matched elderly master athletes. The differences in physical activity levels and protein 
content and phosphorylation of both focal adhesion-associated proteins could then be related 
to and compared against the molecular (e.g. mTOR and p70S6K) and protein synthetic 
response to an acute bout of endurance- and/ or resistance-type exercise. There is also 
evidence for gender-specific differences in the FRNK content (endogenous inhibitor of FAK) 
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of elderly skeletal muscle (Flueck et al., 2011). It would be interesting to investigate the 
effect of age on FRNK and whether this plays a role in anabolic resistance.  
There is evidence that age-associated insulin resistance also leads to impairments in 
the insulin-stimulated blunting of skeletal muscle protein breakdown (Wilkes et al., 2009).  In 
this study, basal rates of leg protein breakdown were not different between the young and 
elderly, but physiological elevations in the insulin concentration (15 microIU/mL) reduced 
the rates of leg protein breakdown by 47% in the young, but only 12% in the elderly (Wilkes 
et al., 2009). Consequently, an impaired inability to increase skeletal muscle protein synthesis 
rates after exercise, coupled with the reduced ability of insulin to suppress rates of skeletal 
muscle protein breakdown, may explain the gradual decline in skeletal muscle mass with age. 
If future studies confirm a role for FAK in human skeletal muscle insulin signalling, then 
FAK may play a critical role in the maintenance of skeletal muscle mass through inhibition of 
protein breakdown as well as activation of protein synthesis.   
 
6.4. Conclusions 
An important contribution of this PhD thesis is the development of novel 
immunofluorescence microscopy methods. These methods have subsequently been used to 
generate the first information on the spatial distribution, relative protein content and 
colocalisation of FAK and paxillin in human skeletal muscle fibres and within the skeletal 
muscle microvascular endothelium and vascular smooth muscle cell layers. The experimental 
chapters have generated important new information on the effect of exercise training on their 
protein content in the skeletal muscle and its microvasculature of young and elderly 
individuals and suggest an important role for both focal adhesion-associated proteins in the 
adaptive response of these tissues to ET and RT. Future studies should aim to investigate the 
hypothesis that the focal adhesion-associated proteins are key components in the mechano-
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sensing mechanisms that act upstream of the insulin signalling cascade and mTOR and are 
upregulated by various modes of exercise training and downregulated in the sedentary state, 
obesity, metabolic syndrome and ageing. In trained and healthy young physically active 
individuals, this will lead to a high FAK and paxillin content within the skeletal muscle and 
powerful activation of both focal adhesion-associated proteins by insulin and exercise within 
the skeletal muscle and its microvasculature.  As a result, both tissues will be insulin 
sensitive, type II skeletal muscle fibres will hypertrophy in response to RT, and the rate of 
mitochondrial biogenesis and angiogenesis will increase considerably in response to ET. In 
sedentary and especially elderly sedentary or bed-ridden individuals, the FAK and paxillin 
protein levels will fall and the ability of insulin and exercise to activate the focal adhesion 
proteins will be impaired. As a result, both muscle and its microvasculature become insulin 
resistant, anabolic resistance to RT will lead to sarcopenia, rates of mitochondrial biogenesis 
and angiogenesis will fall and rarefaction and endothelial dysfunction of the muscle 
microvasculature will limit the supply of insulin, fuels and oxygen to the skeletal muscle 
fibres. The novel methods developed in this PhD thesis, in combination with previously 
developed microscopy methods and complementary methods to measure FAK and paxillin 
activation and functional measures, will provide a unique tool to investigate these hypotheses 
and the effect of exercise, diet and pharmacological interventions. 
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